AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|COUNT|ICCC_GROUP|POPULATION|AGE|RACE|SEX|YEAR|CRUDE_CI_LOWER|CRUDE_CI_UPPER|CRUDE_RATE
144.0|150.4|147.2|8023|All ICCC Groups Combined|54648012|0-14|All Races|Male and Female|1999|||
44.5|48.2|46.3|2528|I Leukemias, myeloproliferative & myelodysplastic diseases|54648012|0-14|All Races|Male and Female|1999|||
34.9|38.1|36.5|1991|I(a) Lymphoid leukemias|54648012|0-14|All Races|Male and Female|1999|||
7.0|8.5|7.7|419|I(b) Acute myeloid leukemias|54648012|0-14|All Races|Male and Female|1999|||
0.4|0.8|0.6|32|I(c) Chronic myeloproliferative diseases|54648012|0-14|All Races|Male and Female|1999|||
~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|54648012|0-14|All Races|Male and Female|1999|||
1.1|1.8|1.4|76|I(e) Unspecified and other specified leukemias|54648012|0-14|All Races|Male and Female|1999|||
14.5|16.7|15.6|850|II Lymphomas and reticuloendothelial neoplasms|54648012|0-14|All Races|Male and Female|1999|||
4.9|6.1|5.5|298|II(a) Hodgkin lymphomas|54648012|0-14|All Races|Male and Female|1999|||
5.5|6.8|6.1|335|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|54648012|0-14|All Races|Male and Female|1999|||
2.1|3.0|2.6|140|II(c) Burkitt lymphoma|54648012|0-14|All Races|Male and Female|1999|||
0.7|1.2|0.9|51|II(d) Miscellaneous lymphoreticular neoplasms|54648012|0-14|All Races|Male and Female|1999|||
0.3|0.7|0.5|26|II(e) Unspecified lymphomas|54648012|0-14|All Races|Male and Female|1999|||
30.3|33.3|31.8|1738|III CNS and misc intracranial and intraspinal neoplasms|54648012|0-14|All Races|Male and Female|1999|||
2.5|3.4|3.0|161|III(a) Ependymomas and choroid plexus tumor|54648012|0-14|All Races|Male and Female|1999|||
13.5|15.5|14.5|792|III(b) Astrocytomas|54648012|0-14|All Races|Male and Female|1999|||
7.3|8.8|8.0|438|III(c) Intracranial and intraspinal embryonal tumors|54648012|0-14|All Races|Male and Female|1999|||
4.6|5.8|5.2|284|III(d) Other gliomas|54648012|0-14|All Races|Male and Female|1999|||
0.3|0.7|0.5|27|III(e) Other specified intracranial & intraspinal neoplasms|54648012|0-14|All Races|Male and Female|1999|||
0.5|0.9|0.7|36|III(f) Unspecified intracranial and intraspinal neoplasms|54648012|0-14|All Races|Male and Female|1999|||
9.7|11.5|10.6|574|IV Neuroblastoma and other peripheral nervous cell tumors|54648012|0-14|All Races|Male and Female|1999|||
9.6|11.3|10.4|565|IV(a) Neuroblastoma and ganglioneuroblastoma|54648012|0-14|All Races|Male and Female|1999|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|54648012|0-14|All Races|Male and Female|1999|||
8.7|10.4|9.5|520|IX Soft tissue and other extraosseous sarcomas|54648012|0-14|All Races|Male and Female|1999|||
4.4|5.6|5.0|272|IX(a) Rhabdomyosarcomas|54648012|0-14|All Races|Male and Female|1999|||
0.7|1.3|1.0|53|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|54648012|0-14|All Races|Male and Female|1999|||
~|~|~|~|IX(c) Kaposi sarcoma|54648012|0-14|All Races|Male and Female|1999|||
2.2|3.1|2.6|143|IX(d) Other specified soft tissue sarcomas|54648012|0-14|All Races|Male and Female|1999|||
0.7|1.2|0.9|51|IX(e) Unspecified soft tissue sarcomas|54648012|0-14|All Races|Male and Female|1999|||
0.2|0.5|0.3|16|Not classified by ICCC|54648012|0-14|All Races|Male and Female|1999|||
3.8|5.0|4.4|237|V Retinoblastoma|54648012|0-14|All Races|Male and Female|1999|||
7.3|8.8|8.0|437|VI Renal tumors|54648012|0-14|All Races|Male and Female|1999|||
6.8|8.3|7.5|411|VI(a) Nephroblastoma and other nonepithelial renal tumors|54648012|0-14|All Races|Male and Female|1999|||
0.3|0.6|0.4|23|VI(b) Renal carcinomas|54648012|0-14|All Races|Male and Female|1999|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|54648012|0-14|All Races|Male and Female|1999|||
1.7|2.4|2.0|110|VII Hepatic tumors|54648012|0-14|All Races|Male and Female|1999|||
1.3|2.0|1.6|88|VII(a) Hepatoblastoma|54648012|0-14|All Races|Male and Female|1999|||
0.3|0.6|0.4|22|VII(b) Hepatic carcinomas|54648012|0-14|All Races|Male and Female|1999|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|54648012|0-14|All Races|Male and Female|1999|||
6.6|8.0|7.3|397|VIII Malignant bone tumors|54648012|0-14|All Races|Male and Female|1999|||
3.7|4.8|4.2|230|VIII(a) Osteosarcomas|54648012|0-14|All Races|Male and Female|1999|||
~|~|~|~|VIII(b) Chondrosarcomas|54648012|0-14|All Races|Male and Female|1999|||
2.0|2.9|2.4|133|VIII(c) Ewing tumor and related sarcomas of bone|54648012|0-14|All Races|Male and Female|1999|||
0.2|0.5|0.3|17|VIII(d) Other specified malignant bone tumors|54648012|0-14|All Races|Male and Female|1999|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|54648012|0-14|All Races|Male and Female|1999|||
4.4|5.6|5.0|270|X Germ cell, trophoblastic tumors & neoplasms of gonads|54648012|0-14|All Races|Male and Female|1999|||
1.1|1.7|1.3|73|X(a) Intracranial & intraspinal germ cell tumors|54648012|0-14|All Races|Male and Female|1999|||
1.0|1.7|1.3|71|X(b) Malignant extracranial & extragonadal germ cell tumors|54648012|0-14|All Races|Male and Female|1999|||
1.7|2.5|2.1|114|X(c) Malignant gonadal germ cell tumors|54648012|0-14|All Races|Male and Female|1999|||
~|~|~|~|X(d) Gonadal carcinomas|54648012|0-14|All Races|Male and Female|1999|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|54648012|0-14|All Races|Male and Female|1999|||
5.2|6.5|5.8|318|XI Other malignant epithelial neoplasms and malignant melanomas|54648012|0-14|All Races|Male and Female|1999|||
~|~|~|~|XI(a) Adrenocortical carcinomas|54648012|0-14|All Races|Male and Female|1999|||
1.6|2.3|1.9|104|XI(b) Thyroid carcinomas|54648012|0-14|All Races|Male and Female|1999|||
0.2|0.5|0.4|19|XI(c) Nasopharyngeal carcinomas|54648012|0-14|All Races|Male and Female|1999|||
1.4|2.2|1.8|97|XI(d) Malignant melanomas|54648012|0-14|All Races|Male and Female|1999|||
~|~|~|~|XI(e) Skin carcinomas|54648012|0-14|All Races|Male and Female|1999|||
1.2|1.9|1.5|82|XI(f) Other and unspecified carcinomas|54648012|0-14|All Races|Male and Female|1999|||
0.3|0.7|0.5|28|XII Other and unspecified malignant neoplasms|54648012|0-14|All Races|Male and Female|1999|||
~|~|~|~|XII(a) Other specified malignant tumors|54648012|0-14|All Races|Male and Female|1999|||
0.2|0.5|0.3|17|XII(b) Other unspecified malignant tumors|54648012|0-14|All Races|Male and Female|1999|||
146.7|153.2|149.9|8420|All ICCC Groups Combined|56294656|0-14|All Races|Male and Female|2000|||
44.4|48.0|46.2|2588|I Leukemias, myeloproliferative & myelodysplastic diseases|56294656|0-14|All Races|Male and Female|2000|||
35.7|38.9|37.3|2088|I(a) Lymphoid leukemias|56294656|0-14|All Races|Male and Female|2000|||
6.0|7.3|6.6|371|I(b) Acute myeloid leukemias|56294656|0-14|All Races|Male and Female|2000|||
0.5|1.0|0.7|42|I(c) Chronic myeloproliferative diseases|56294656|0-14|All Races|Male and Female|2000|||
~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|56294656|0-14|All Races|Male and Female|2000|||
1.1|1.7|1.4|77|I(e) Unspecified and other specified leukemias|56294656|0-14|All Races|Male and Female|2000|||
15.7|17.8|16.7|944|II Lymphomas and reticuloendothelial neoplasms|56294656|0-14|All Races|Male and Female|2000|||
5.3|6.6|5.9|335|II(a) Hodgkin lymphomas|56294656|0-14|All Races|Male and Female|2000|||
5.4|6.6|6.0|337|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|56294656|0-14|All Races|Male and Female|2000|||
2.4|3.3|2.9|162|II(c) Burkitt lymphoma|56294656|0-14|All Races|Male and Female|2000|||
1.0|1.6|1.3|73|II(d) Miscellaneous lymphoreticular neoplasms|56294656|0-14|All Races|Male and Female|2000|||
0.5|0.9|0.7|37|II(e) Unspecified lymphomas|56294656|0-14|All Races|Male and Female|2000|||
31.6|34.7|33.1|1863|III CNS and misc intracranial and intraspinal neoplasms|56294656|0-14|All Races|Male and Female|2000|||
2.3|3.2|2.7|153|III(a) Ependymomas and choroid plexus tumor|56294656|0-14|All Races|Male and Female|2000|||
16.0|18.2|17.1|960|III(b) Astrocytomas|56294656|0-14|All Races|Male and Female|2000|||
6.9|8.4|7.6|427|III(c) Intracranial and intraspinal embryonal tumors|56294656|0-14|All Races|Male and Female|2000|||
4.1|5.2|4.6|259|III(d) Other gliomas|56294656|0-14|All Races|Male and Female|2000|||
0.3|0.6|0.4|24|III(e) Other specified intracranial & intraspinal neoplasms|56294656|0-14|All Races|Male and Female|2000|||
0.5|1.0|0.7|40|III(f) Unspecified intracranial and intraspinal neoplasms|56294656|0-14|All Races|Male and Female|2000|||
9.2|10.8|10.0|557|IV Neuroblastoma and other peripheral nervous cell tumors|56294656|0-14|All Races|Male and Female|2000|||
9.0|10.7|9.9|550|IV(a) Neuroblastoma and ganglioneuroblastoma|56294656|0-14|All Races|Male and Female|2000|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|56294656|0-14|All Races|Male and Female|2000|||
9.6|11.4|10.5|589|IX Soft tissue and other extraosseous sarcomas|56294656|0-14|All Races|Male and Female|2000|||
4.7|5.9|5.3|296|IX(a) Rhabdomyosarcomas|56294656|0-14|All Races|Male and Female|2000|||
0.7|1.2|0.9|53|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|56294656|0-14|All Races|Male and Female|2000|||
~|~|~|~|IX(c) Kaposi sarcoma|56294656|0-14|All Races|Male and Female|2000|||
2.7|3.7|3.2|178|IX(d) Other specified soft tissue sarcomas|56294656|0-14|All Races|Male and Female|2000|||
0.8|1.4|1.1|61|IX(e) Unspecified soft tissue sarcomas|56294656|0-14|All Races|Male and Female|2000|||
~|~|~|~|Not classified by ICCC|56294656|0-14|All Races|Male and Female|2000|||
3.8|5.0|4.4|244|V Retinoblastoma|56294656|0-14|All Races|Male and Female|2000|||
8.0|9.5|8.7|488|VI Renal tumors|56294656|0-14|All Races|Male and Female|2000|||
7.6|9.1|8.3|465|VI(a) Nephroblastoma and other nonepithelial renal tumors|56294656|0-14|All Races|Male and Female|2000|||
0.2|0.6|0.4|22|VI(b) Renal carcinomas|56294656|0-14|All Races|Male and Female|2000|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|56294656|0-14|All Races|Male and Female|2000|||
1.8|2.6|2.2|123|VII Hepatic tumors|56294656|0-14|All Races|Male and Female|2000|||
1.6|2.4|2.0|110|VII(a) Hepatoblastoma|56294656|0-14|All Races|Male and Female|2000|||
~|~|~|~|VII(b) Hepatic carcinomas|56294656|0-14|All Races|Male and Female|2000|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|56294656|0-14|All Races|Male and Female|2000|||
5.9|7.3|6.6|373|VIII Malignant bone tumors|56294656|0-14|All Races|Male and Female|2000|||
3.1|4.1|3.6|203|VIII(a) Osteosarcomas|56294656|0-14|All Races|Male and Female|2000|||
~|~|~|~|VIII(b) Chondrosarcomas|56294656|0-14|All Races|Male and Female|2000|||
2.3|3.1|2.7|151|VIII(c) Ewing tumor and related sarcomas of bone|56294656|0-14|All Races|Male and Female|2000|||
~|~|~|~|VIII(d) Other specified malignant bone tumors|56294656|0-14|All Races|Male and Female|2000|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|56294656|0-14|All Races|Male and Female|2000|||
4.3|5.5|4.9|276|X Germ cell, trophoblastic tumors & neoplasms of gonads|56294656|0-14|All Races|Male and Female|2000|||
1.1|1.8|1.4|81|X(a) Intracranial & intraspinal germ cell tumors|56294656|0-14|All Races|Male and Female|2000|||
0.8|1.4|1.1|61|X(b) Malignant extracranial & extragonadal germ cell tumors|56294656|0-14|All Races|Male and Female|2000|||
1.8|2.6|2.2|124|X(c) Malignant gonadal germ cell tumors|56294656|0-14|All Races|Male and Female|2000|||
~|~|~|~|X(d) Gonadal carcinomas|56294656|0-14|All Races|Male and Female|2000|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|56294656|0-14|All Races|Male and Female|2000|||
5.0|6.3|5.6|319|XI Other malignant epithelial neoplasms and malignant melanomas|56294656|0-14|All Races|Male and Female|2000|||
0.2|0.5|0.3|17|XI(a) Adrenocortical carcinomas|56294656|0-14|All Races|Male and Female|2000|||
1.5|2.2|1.8|103|XI(b) Thyroid carcinomas|56294656|0-14|All Races|Male and Female|2000|||
0.2|0.5|0.3|19|XI(c) Nasopharyngeal carcinomas|56294656|0-14|All Races|Male and Female|2000|||
1.4|2.1|1.7|96|XI(d) Malignant melanomas|56294656|0-14|All Races|Male and Female|2000|||
~|~|~|~|XI(e) Skin carcinomas|56294656|0-14|All Races|Male and Female|2000|||
1.1|1.8|1.4|81|XI(f) Other and unspecified carcinomas|56294656|0-14|All Races|Male and Female|2000|||
0.5|1.0|0.7|42|XII Other and unspecified malignant neoplasms|56294656|0-14|All Races|Male and Female|2000|||
~|~|~|~|XII(a) Other specified malignant tumors|56294656|0-14|All Races|Male and Female|2000|||
0.3|0.7|0.5|29|XII(b) Other unspecified malignant tumors|56294656|0-14|All Races|Male and Female|2000|||
154.8|161.4|158.1|8818|All ICCC Groups Combined|55815598|0-14|All Races|Male and Female|2001|||
49.6|53.4|51.5|2857|I Leukemias, myeloproliferative & myelodysplastic diseases|55815598|0-14|All Races|Male and Female|2001|||
37.8|41.2|39.5|2185|I(a) Lymphoid leukemias|55815598|0-14|All Races|Male and Female|2001|||
6.8|8.2|7.5|417|I(b) Acute myeloid leukemias|55815598|0-14|All Races|Male and Female|2001|||
1.3|2.0|1.7|94|I(c) Chronic myeloproliferative diseases|55815598|0-14|All Races|Male and Female|2001|||
1.3|2.0|1.7|93|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|55815598|0-14|All Races|Male and Female|2001|||
0.9|1.5|1.2|68|I(e) Unspecified and other specified leukemias|55815598|0-14|All Races|Male and Female|2001|||
15.2|17.4|16.3|913|II Lymphomas and reticuloendothelial neoplasms|55815598|0-14|All Races|Male and Female|2001|||
5.3|6.6|5.9|332|II(a) Hodgkin lymphomas|55815598|0-14|All Races|Male and Female|2001|||
6.0|7.4|6.7|373|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|55815598|0-14|All Races|Male and Female|2001|||
1.9|2.7|2.3|128|II(c) Burkitt lymphoma|55815598|0-14|All Races|Male and Female|2001|||
0.8|1.3|1.0|58|II(d) Miscellaneous lymphoreticular neoplasms|55815598|0-14|All Races|Male and Female|2001|||
0.2|0.6|0.4|22|II(e) Unspecified lymphomas|55815598|0-14|All Races|Male and Female|2001|||
31.6|34.6|33.0|1840|III CNS and misc intracranial and intraspinal neoplasms|55815598|0-14|All Races|Male and Female|2001|||
2.4|3.3|2.8|156|III(a) Ependymomas and choroid plexus tumor|55815598|0-14|All Races|Male and Female|2001|||
15.4|17.5|16.4|915|III(b) Astrocytomas|55815598|0-14|All Races|Male and Female|2001|||
6.6|8.1|7.3|407|III(c) Intracranial and intraspinal embryonal tumors|55815598|0-14|All Races|Male and Female|2001|||
4.9|6.1|5.5|304|III(d) Other gliomas|55815598|0-14|All Races|Male and Female|2001|||
0.5|0.9|0.7|37|III(e) Other specified intracranial & intraspinal neoplasms|55815598|0-14|All Races|Male and Female|2001|||
0.2|0.6|0.4|21|III(f) Unspecified intracranial and intraspinal neoplasms|55815598|0-14|All Races|Male and Female|2001|||
10.9|12.7|11.8|658|IV Neuroblastoma and other peripheral nervous cell tumors|55815598|0-14|All Races|Male and Female|2001|||
10.8|12.6|11.7|651|IV(a) Neuroblastoma and ganglioneuroblastoma|55815598|0-14|All Races|Male and Female|2001|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|55815598|0-14|All Races|Male and Female|2001|||
9.8|11.5|10.6|593|IX Soft tissue and other extraosseous sarcomas|55815598|0-14|All Races|Male and Female|2001|||
4.7|5.9|5.2|291|IX(a) Rhabdomyosarcomas|55815598|0-14|All Races|Male and Female|2001|||
1.0|1.6|1.3|72|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|55815598|0-14|All Races|Male and Female|2001|||
~|~|~|~|IX(c) Kaposi sarcoma|55815598|0-14|All Races|Male and Female|2001|||
2.6|3.6|3.1|173|IX(d) Other specified soft tissue sarcomas|55815598|0-14|All Races|Male and Female|2001|||
0.8|1.3|1.0|57|IX(e) Unspecified soft tissue sarcomas|55815598|0-14|All Races|Male and Female|2001|||
~|~|~|~|Not classified by ICCC|55815598|0-14|All Races|Male and Female|2001|||
3.8|4.9|4.4|244|V Retinoblastoma|55815598|0-14|All Races|Male and Female|2001|||
7.9|9.4|8.6|477|VI Renal tumors|55815598|0-14|All Races|Male and Female|2001|||
7.5|9.0|8.2|456|VI(a) Nephroblastoma and other nonepithelial renal tumors|55815598|0-14|All Races|Male and Female|2001|||
0.2|0.5|0.3|19|VI(b) Renal carcinomas|55815598|0-14|All Races|Male and Female|2001|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|55815598|0-14|All Races|Male and Female|2001|||
1.7|2.5|2.1|117|VII Hepatic tumors|55815598|0-14|All Races|Male and Female|2001|||
1.4|2.1|1.7|94|VII(a) Hepatoblastoma|55815598|0-14|All Races|Male and Female|2001|||
0.2|0.6|0.4|22|VII(b) Hepatic carcinomas|55815598|0-14|All Races|Male and Female|2001|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|55815598|0-14|All Races|Male and Female|2001|||
6.3|7.7|7.0|395|VIII Malignant bone tumors|55815598|0-14|All Races|Male and Female|2001|||
3.3|4.3|3.8|213|VIII(a) Osteosarcomas|55815598|0-14|All Races|Male and Female|2001|||
~|~|~|~|VIII(b) Chondrosarcomas|55815598|0-14|All Races|Male and Female|2001|||
2.3|3.2|2.8|155|VIII(c) Ewing tumor and related sarcomas of bone|55815598|0-14|All Races|Male and Female|2001|||
~|~|~|~|VIII(d) Other specified malignant bone tumors|55815598|0-14|All Races|Male and Female|2001|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|55815598|0-14|All Races|Male and Female|2001|||
4.6|5.8|5.1|290|X Germ cell, trophoblastic tumors & neoplasms of gonads|55815598|0-14|All Races|Male and Female|2001|||
1.0|1.6|1.3|73|X(a) Intracranial & intraspinal germ cell tumors|55815598|0-14|All Races|Male and Female|2001|||
1.1|1.8|1.4|80|X(b) Malignant extracranial & extragonadal germ cell tumors|55815598|0-14|All Races|Male and Female|2001|||
1.7|2.5|2.1|119|X(c) Malignant gonadal germ cell tumors|55815598|0-14|All Races|Male and Female|2001|||
~|~|~|~|X(d) Gonadal carcinomas|55815598|0-14|All Races|Male and Female|2001|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|55815598|0-14|All Races|Male and Female|2001|||
6.1|7.4|6.7|380|XI Other malignant epithelial neoplasms and malignant melanomas|55815598|0-14|All Races|Male and Female|2001|||
~|~|~|~|XI(a) Adrenocortical carcinomas|55815598|0-14|All Races|Male and Female|2001|||
2.0|2.8|2.4|134|XI(b) Thyroid carcinomas|55815598|0-14|All Races|Male and Female|2001|||
0.2|0.5|0.3|18|XI(c) Nasopharyngeal carcinomas|55815598|0-14|All Races|Male and Female|2001|||
1.7|2.4|2.0|113|XI(d) Malignant melanomas|55815598|0-14|All Races|Male and Female|2001|||
~|~|~|~|XI(e) Skin carcinomas|55815598|0-14|All Races|Male and Female|2001|||
1.4|2.1|1.7|97|XI(f) Other and unspecified carcinomas|55815598|0-14|All Races|Male and Female|2001|||
0.5|1.0|0.7|39|XII Other and unspecified malignant neoplasms|55815598|0-14|All Races|Male and Female|2001|||
0.2|0.6|0.4|21|XII(a) Other specified malignant tumors|55815598|0-14|All Races|Male and Female|2001|||
0.2|0.5|0.3|18|XII(b) Other unspecified malignant tumors|55815598|0-14|All Races|Male and Female|2001|||
152.9|159.4|156.1|8839|All ICCC Groups Combined|56622973|0-14|All Races|Male and Female|2002|||
48.0|51.7|49.8|2807|I Leukemias, myeloproliferative & myelodysplastic diseases|56622973|0-14|All Races|Male and Female|2002|||
35.8|39.0|37.4|2101|I(a) Lymphoid leukemias|56622973|0-14|All Races|Male and Female|2002|||
7.2|8.7|7.9|451|I(b) Acute myeloid leukemias|56622973|0-14|All Races|Male and Female|2002|||
1.3|2.0|1.6|91|I(c) Chronic myeloproliferative diseases|56622973|0-14|All Races|Male and Female|2002|||
1.3|2.0|1.6|92|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|56622973|0-14|All Races|Male and Female|2002|||
1.0|1.6|1.3|72|I(e) Unspecified and other specified leukemias|56622973|0-14|All Races|Male and Female|2002|||
14.6|16.7|15.6|893|II Lymphomas and reticuloendothelial neoplasms|56622973|0-14|All Races|Male and Female|2002|||
4.8|6.0|5.4|310|II(a) Hodgkin lymphomas|56622973|0-14|All Races|Male and Female|2002|||
5.5|6.8|6.2|350|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|56622973|0-14|All Races|Male and Female|2002|||
2.3|3.2|2.8|156|II(c) Burkitt lymphoma|56622973|0-14|All Races|Male and Female|2002|||
0.9|1.5|1.1|65|II(d) Miscellaneous lymphoreticular neoplasms|56622973|0-14|All Races|Male and Female|2002|||
~|~|~|~|II(e) Unspecified lymphomas|56622973|0-14|All Races|Male and Female|2002|||
33.2|36.3|34.7|1958|III CNS and misc intracranial and intraspinal neoplasms|56622973|0-14|All Races|Male and Female|2002|||
3.2|4.2|3.7|207|III(a) Ependymomas and choroid plexus tumor|56622973|0-14|All Races|Male and Female|2002|||
15.3|17.5|16.4|924|III(b) Astrocytomas|56622973|0-14|All Races|Male and Female|2002|||
6.8|8.3|7.5|425|III(c) Intracranial and intraspinal embryonal tumors|56622973|0-14|All Races|Male and Female|2002|||
5.4|6.7|6.0|338|III(d) Other gliomas|56622973|0-14|All Races|Male and Female|2002|||
0.5|1.0|0.7|41|III(e) Other specified intracranial & intraspinal neoplasms|56622973|0-14|All Races|Male and Female|2002|||
0.3|0.6|0.4|23|III(f) Unspecified intracranial and intraspinal neoplasms|56622973|0-14|All Races|Male and Female|2002|||
10.2|11.9|11.0|622|IV Neuroblastoma and other peripheral nervous cell tumors|56622973|0-14|All Races|Male and Female|2002|||
10.0|11.8|10.9|615|IV(a) Neuroblastoma and ganglioneuroblastoma|56622973|0-14|All Races|Male and Female|2002|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|56622973|0-14|All Races|Male and Female|2002|||
10.2|12.0|11.1|627|IX Soft tissue and other extraosseous sarcomas|56622973|0-14|All Races|Male and Female|2002|||
4.9|6.1|5.5|309|IX(a) Rhabdomyosarcomas|56622973|0-14|All Races|Male and Female|2002|||
0.9|1.5|1.2|69|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|56622973|0-14|All Races|Male and Female|2002|||
~|~|~|~|IX(c) Kaposi sarcoma|56622973|0-14|All Races|Male and Female|2002|||
2.9|3.9|3.4|195|IX(d) Other specified soft tissue sarcomas|56622973|0-14|All Races|Male and Female|2002|||
0.7|1.2|0.9|54|IX(e) Unspecified soft tissue sarcomas|56622973|0-14|All Races|Male and Female|2002|||
0.2|0.5|0.3|19|Not classified by ICCC|56622973|0-14|All Races|Male and Female|2002|||
3.2|4.3|3.7|211|V Retinoblastoma|56622973|0-14|All Races|Male and Female|2002|||
7.5|9.0|8.3|464|VI Renal tumors|56622973|0-14|All Races|Male and Female|2002|||
7.3|8.8|8.0|451|VI(a) Nephroblastoma and other nonepithelial renal tumors|56622973|0-14|All Races|Male and Female|2002|||
~|~|~|~|VI(b) Renal carcinomas|56622973|0-14|All Races|Male and Female|2002|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|56622973|0-14|All Races|Male and Female|2002|||
1.6|2.3|1.9|110|VII Hepatic tumors|56622973|0-14|All Races|Male and Female|2002|||
1.3|1.9|1.6|89|VII(a) Hepatoblastoma|56622973|0-14|All Races|Male and Female|2002|||
0.2|0.5|0.3|20|VII(b) Hepatic carcinomas|56622973|0-14|All Races|Male and Female|2002|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|56622973|0-14|All Races|Male and Female|2002|||
6.3|7.7|7.0|402|VIII Malignant bone tumors|56622973|0-14|All Races|Male and Female|2002|||
3.3|4.3|3.8|217|VIII(a) Osteosarcomas|56622973|0-14|All Races|Male and Female|2002|||
~|~|~|~|VIII(b) Chondrosarcomas|56622973|0-14|All Races|Male and Female|2002|||
2.2|3.1|2.6|149|VIII(c) Ewing tumor and related sarcomas of bone|56622973|0-14|All Races|Male and Female|2002|||
0.2|0.5|0.4|20|VIII(d) Other specified malignant bone tumors|56622973|0-14|All Races|Male and Female|2002|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|56622973|0-14|All Races|Male and Female|2002|||
4.8|6.1|5.4|311|X Germ cell, trophoblastic tumors & neoplasms of gonads|56622973|0-14|All Races|Male and Female|2002|||
1.2|1.8|1.5|85|X(a) Intracranial & intraspinal germ cell tumors|56622973|0-14|All Races|Male and Female|2002|||
1.2|1.9|1.5|87|X(b) Malignant extracranial & extragonadal germ cell tumors|56622973|0-14|All Races|Male and Female|2002|||
1.9|2.7|2.3|129|X(c) Malignant gonadal germ cell tumors|56622973|0-14|All Races|Male and Female|2002|||
~|~|~|~|X(d) Gonadal carcinomas|56622973|0-14|All Races|Male and Female|2002|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|56622973|0-14|All Races|Male and Female|2002|||
5.9|7.3|6.6|378|XI Other malignant epithelial neoplasms and malignant melanomas|56622973|0-14|All Races|Male and Female|2002|||
~|~|~|~|XI(a) Adrenocortical carcinomas|56622973|0-14|All Races|Male and Female|2002|||
1.6|2.4|2.0|113|XI(b) Thyroid carcinomas|56622973|0-14|All Races|Male and Female|2002|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|56622973|0-14|All Races|Male and Female|2002|||
2.0|2.8|2.4|135|XI(d) Malignant melanomas|56622973|0-14|All Races|Male and Female|2002|||
~|~|~|~|XI(e) Skin carcinomas|56622973|0-14|All Races|Male and Female|2002|||
1.4|2.0|1.7|97|XI(f) Other and unspecified carcinomas|56622973|0-14|All Races|Male and Female|2002|||
0.5|0.9|0.6|37|XII Other and unspecified malignant neoplasms|56622973|0-14|All Races|Male and Female|2002|||
0.2|0.6|0.4|21|XII(a) Other specified malignant tumors|56622973|0-14|All Races|Male and Female|2002|||
0.2|0.5|0.3|16|XII(b) Other unspecified malignant tumors|56622973|0-14|All Races|Male and Female|2002|||
148.9|155.2|152.0|9058|All ICCC Groups Combined|59442844|0-14|All Races|Male and Female|2003|||
46.1|49.6|47.8|2833|I Leukemias, myeloproliferative & myelodysplastic diseases|59442844|0-14|All Races|Male and Female|2003|||
34.7|37.7|36.2|2137|I(a) Lymphoid leukemias|59442844|0-14|All Races|Male and Female|2003|||
6.8|8.2|7.5|446|I(b) Acute myeloid leukemias|59442844|0-14|All Races|Male and Female|2003|||
1.2|1.8|1.5|87|I(c) Chronic myeloproliferative diseases|59442844|0-14|All Races|Male and Female|2003|||
1.4|2.1|1.8|106|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|59442844|0-14|All Races|Male and Female|2003|||
0.7|1.2|1.0|57|I(e) Unspecified and other specified leukemias|59442844|0-14|All Races|Male and Female|2003|||
15.0|17.0|16.0|955|II Lymphomas and reticuloendothelial neoplasms|59442844|0-14|All Races|Male and Female|2003|||
5.3|6.5|5.8|353|II(a) Hodgkin lymphomas|59442844|0-14|All Races|Male and Female|2003|||
5.7|6.9|6.3|374|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|59442844|0-14|All Races|Male and Female|2003|||
2.3|3.1|2.7|157|II(c) Burkitt lymphoma|59442844|0-14|All Races|Male and Female|2003|||
0.8|1.4|1.1|64|II(d) Miscellaneous lymphoreticular neoplasms|59442844|0-14|All Races|Male and Female|2003|||
~|~|~|~|II(e) Unspecified lymphomas|59442844|0-14|All Races|Male and Female|2003|||
31.4|34.3|32.8|1946|III CNS and misc intracranial and intraspinal neoplasms|59442844|0-14|All Races|Male and Female|2003|||
2.2|3.0|2.5|151|III(a) Ependymomas and choroid plexus tumor|59442844|0-14|All Races|Male and Female|2003|||
15.3|17.3|16.3|966|III(b) Astrocytomas|59442844|0-14|All Races|Male and Female|2003|||
6.5|7.9|7.2|426|III(c) Intracranial and intraspinal embryonal tumors|59442844|0-14|All Races|Male and Female|2003|||
5.0|6.3|5.6|334|III(d) Other gliomas|59442844|0-14|All Races|Male and Female|2003|||
0.6|1.1|0.8|50|III(e) Other specified intracranial & intraspinal neoplasms|59442844|0-14|All Races|Male and Female|2003|||
0.2|0.5|0.3|19|III(f) Unspecified intracranial and intraspinal neoplasms|59442844|0-14|All Races|Male and Female|2003|||
9.8|11.5|10.6|634|IV Neuroblastoma and other peripheral nervous cell tumors|59442844|0-14|All Races|Male and Female|2003|||
9.7|11.3|10.5|625|IV(a) Neuroblastoma and ganglioneuroblastoma|59442844|0-14|All Races|Male and Female|2003|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|59442844|0-14|All Races|Male and Female|2003|||
9.7|11.4|10.5|630|IX Soft tissue and other extraosseous sarcomas|59442844|0-14|All Races|Male and Female|2003|||
4.5|5.7|5.1|301|IX(a) Rhabdomyosarcomas|59442844|0-14|All Races|Male and Female|2003|||
0.8|1.3|1.0|61|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|59442844|0-14|All Races|Male and Female|2003|||
~|~|~|~|IX(c) Kaposi sarcoma|59442844|0-14|All Races|Male and Female|2003|||
3.0|4.0|3.5|208|IX(d) Other specified soft tissue sarcomas|59442844|0-14|All Races|Male and Female|2003|||
0.7|1.2|1.0|58|IX(e) Unspecified soft tissue sarcomas|59442844|0-14|All Races|Male and Female|2003|||
0.2|0.4|0.3|16|Not classified by ICCC|59442844|0-14|All Races|Male and Female|2003|||
3.5|4.5|4.0|239|V Retinoblastoma|59442844|0-14|All Races|Male and Female|2003|||
7.8|9.3|8.6|507|VI Renal tumors|59442844|0-14|All Races|Male and Female|2003|||
7.4|8.9|8.2|483|VI(a) Nephroblastoma and other nonepithelial renal tumors|59442844|0-14|All Races|Male and Female|2003|||
0.2|0.5|0.3|20|VI(b) Renal carcinomas|59442844|0-14|All Races|Male and Female|2003|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|59442844|0-14|All Races|Male and Female|2003|||
2.1|2.9|2.5|150|VII Hepatic tumors|59442844|0-14|All Races|Male and Female|2003|||
1.7|2.5|2.1|123|VII(a) Hepatoblastoma|59442844|0-14|All Races|Male and Female|2003|||
0.3|0.7|0.4|27|VII(b) Hepatic carcinomas|59442844|0-14|All Races|Male and Female|2003|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|59442844|0-14|All Races|Male and Female|2003|||
6.1|7.4|6.7|407|VIII Malignant bone tumors|59442844|0-14|All Races|Male and Female|2003|||
3.3|4.3|3.7|227|VIII(a) Osteosarcomas|59442844|0-14|All Races|Male and Female|2003|||
~|~|~|~|VIII(b) Chondrosarcomas|59442844|0-14|All Races|Male and Female|2003|||
1.9|2.7|2.3|136|VIII(c) Ewing tumor and related sarcomas of bone|59442844|0-14|All Races|Male and Female|2003|||
0.2|0.5|0.3|17|VIII(d) Other specified malignant bone tumors|59442844|0-14|All Races|Male and Female|2003|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|59442844|0-14|All Races|Male and Female|2003|||
4.5|5.7|5.1|306|X Germ cell, trophoblastic tumors & neoplasms of gonads|59442844|0-14|All Races|Male and Female|2003|||
0.9|1.5|1.2|71|X(a) Intracranial & intraspinal germ cell tumors|59442844|0-14|All Races|Male and Female|2003|||
1.1|1.8|1.4|86|X(b) Malignant extracranial & extragonadal germ cell tumors|59442844|0-14|All Races|Male and Female|2003|||
1.8|2.6|2.2|133|X(c) Malignant gonadal germ cell tumors|59442844|0-14|All Races|Male and Female|2003|||
~|~|~|~|X(d) Gonadal carcinomas|59442844|0-14|All Races|Male and Female|2003|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|59442844|0-14|All Races|Male and Female|2003|||
5.8|7.1|6.4|390|XI Other malignant epithelial neoplasms and malignant melanomas|59442844|0-14|All Races|Male and Female|2003|||
~|~|~|~|XI(a) Adrenocortical carcinomas|59442844|0-14|All Races|Male and Female|2003|||
1.8|2.6|2.2|133|XI(b) Thyroid carcinomas|59442844|0-14|All Races|Male and Female|2003|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|59442844|0-14|All Races|Male and Female|2003|||
1.6|2.3|2.0|119|XI(d) Malignant melanomas|59442844|0-14|All Races|Male and Female|2003|||
~|~|~|~|XI(e) Skin carcinomas|59442844|0-14|All Races|Male and Female|2003|||
1.5|2.2|1.8|111|XI(f) Other and unspecified carcinomas|59442844|0-14|All Races|Male and Female|2003|||
0.5|1.0|0.7|45|XII Other and unspecified malignant neoplasms|59442844|0-14|All Races|Male and Female|2003|||
0.2|0.5|0.3|19|XII(a) Other specified malignant tumors|59442844|0-14|All Races|Male and Female|2003|||
0.3|0.6|0.4|26|XII(b) Other unspecified malignant tumors|59442844|0-14|All Races|Male and Female|2003|||
156.2|162.5|159.3|9704|All ICCC Groups Combined|60651802|0-14|All Races|Male and Female|2004|||
49.3|52.9|51.1|3097|I Leukemias, myeloproliferative & myelodysplastic diseases|60651802|0-14|All Races|Male and Female|2004|||
37.2|40.3|38.7|2342|I(a) Lymphoid leukemias|60651802|0-14|All Races|Male and Female|2004|||
7.2|8.7|7.9|485|I(b) Acute myeloid leukemias|60651802|0-14|All Races|Male and Female|2004|||
1.2|1.8|1.5|92|I(c) Chronic myeloproliferative diseases|60651802|0-14|All Races|Male and Female|2004|||
1.2|1.8|1.5|92|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60651802|0-14|All Races|Male and Female|2004|||
1.1|1.7|1.4|86|I(e) Unspecified and other specified leukemias|60651802|0-14|All Races|Male and Female|2004|||
15.1|17.1|16.1|984|II Lymphomas and reticuloendothelial neoplasms|60651802|0-14|All Races|Male and Female|2004|||
4.7|5.9|5.3|324|II(a) Hodgkin lymphomas|60651802|0-14|All Races|Male and Female|2004|||
6.2|7.6|6.9|419|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60651802|0-14|All Races|Male and Female|2004|||
2.1|2.9|2.5|148|II(c) Burkitt lymphoma|60651802|0-14|All Races|Male and Female|2004|||
1.0|1.6|1.3|80|II(d) Miscellaneous lymphoreticular neoplasms|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|II(e) Unspecified lymphomas|60651802|0-14|All Races|Male and Female|2004|||
33.2|36.2|34.7|2098|III CNS and misc intracranial and intraspinal neoplasms|60651802|0-14|All Races|Male and Female|2004|||
2.5|3.4|2.9|179|III(a) Ependymomas and choroid plexus tumor|60651802|0-14|All Races|Male and Female|2004|||
16.1|18.2|17.1|1038|III(b) Astrocytomas|60651802|0-14|All Races|Male and Female|2004|||
7.1|8.5|7.8|471|III(c) Intracranial and intraspinal embryonal tumors|60651802|0-14|All Races|Male and Female|2004|||
4.9|6.1|5.4|327|III(d) Other gliomas|60651802|0-14|All Races|Male and Female|2004|||
0.6|1.1|0.8|49|III(e) Other specified intracranial & intraspinal neoplasms|60651802|0-14|All Races|Male and Female|2004|||
0.4|0.8|0.6|34|III(f) Unspecified intracranial and intraspinal neoplasms|60651802|0-14|All Races|Male and Female|2004|||
10.2|11.8|11.0|673|IV Neuroblastoma and other peripheral nervous cell tumors|60651802|0-14|All Races|Male and Female|2004|||
10.0|11.6|10.8|660|IV(a) Neuroblastoma and ganglioneuroblastoma|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60651802|0-14|All Races|Male and Female|2004|||
9.8|11.4|10.6|648|IX Soft tissue and other extraosseous sarcomas|60651802|0-14|All Races|Male and Female|2004|||
4.1|5.3|4.7|284|IX(a) Rhabdomyosarcomas|60651802|0-14|All Races|Male and Female|2004|||
1.0|1.5|1.2|76|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|IX(c) Kaposi sarcoma|60651802|0-14|All Races|Male and Female|2004|||
3.2|4.2|3.6|224|IX(d) Other specified soft tissue sarcomas|60651802|0-14|All Races|Male and Female|2004|||
0.8|1.3|1.0|63|IX(e) Unspecified soft tissue sarcomas|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|Not classified by ICCC|60651802|0-14|All Races|Male and Female|2004|||
3.8|4.8|4.3|265|V Retinoblastoma|60651802|0-14|All Races|Male and Female|2004|||
7.4|8.9|8.1|494|VI Renal tumors|60651802|0-14|All Races|Male and Female|2004|||
7.1|8.5|7.8|472|VI(a) Nephroblastoma and other nonepithelial renal tumors|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.5|0.4|22|VI(b) Renal carcinomas|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60651802|0-14|All Races|Male and Female|2004|||
2.3|3.1|2.7|164|VII Hepatic tumors|60651802|0-14|All Races|Male and Female|2004|||
2.0|2.8|2.3|144|VII(a) Hepatoblastoma|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|VII(b) Hepatic carcinomas|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60651802|0-14|All Races|Male and Female|2004|||
6.4|7.7|7.0|432|VIII Malignant bone tumors|60651802|0-14|All Races|Male and Female|2004|||
3.6|4.6|4.1|250|VIII(a) Osteosarcomas|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.4|0.3|17|VIII(b) Chondrosarcomas|60651802|0-14|All Races|Male and Female|2004|||
1.9|2.7|2.3|142|VIII(c) Ewing tumor and related sarcomas of bone|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.5|0.3|18|VIII(d) Other specified malignant bone tumors|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60651802|0-14|All Races|Male and Female|2004|||
5.0|6.2|5.6|346|X Germ cell, trophoblastic tumors & neoplasms of gonads|60651802|0-14|All Races|Male and Female|2004|||
1.3|1.9|1.6|96|X(a) Intracranial & intraspinal germ cell tumors|60651802|0-14|All Races|Male and Female|2004|||
1.1|1.6|1.3|82|X(b) Malignant extracranial & extragonadal germ cell tumors|60651802|0-14|All Races|Male and Female|2004|||
2.0|2.8|2.4|148|X(c) Malignant gonadal germ cell tumors|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|X(d) Gonadal carcinomas|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60651802|0-14|All Races|Male and Female|2004|||
6.6|8.0|7.3|447|XI Other malignant epithelial neoplasms and malignant melanomas|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.4|0.3|16|XI(a) Adrenocortical carcinomas|60651802|0-14|All Races|Male and Female|2004|||
2.2|3.0|2.5|157|XI(b) Thyroid carcinomas|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.6|0.4|24|XI(c) Nasopharyngeal carcinomas|60651802|0-14|All Races|Male and Female|2004|||
2.1|3.0|2.5|155|XI(d) Malignant melanomas|60651802|0-14|All Races|Male and Female|2004|||
~|~|~|~|XI(e) Skin carcinomas|60651802|0-14|All Races|Male and Female|2004|||
1.2|1.8|1.4|89|XI(f) Other and unspecified carcinomas|60651802|0-14|All Races|Male and Female|2004|||
0.5|0.9|0.7|42|XII Other and unspecified malignant neoplasms|60651802|0-14|All Races|Male and Female|2004|||
0.2|0.5|0.3|18|XII(a) Other specified malignant tumors|60651802|0-14|All Races|Male and Female|2004|||
0.3|0.6|0.4|24|XII(b) Other unspecified malignant tumors|60651802|0-14|All Races|Male and Female|2004|||
152.1|158.4|155.2|9445|All ICCC Groups Combined|60519046|0-14|All Races|Male and Female|2005|||
47.4|51.0|49.2|2986|I Leukemias, myeloproliferative & myelodysplastic diseases|60519046|0-14|All Races|Male and Female|2005|||
35.9|39.0|37.4|2268|I(a) Lymphoid leukemias|60519046|0-14|All Races|Male and Female|2005|||
6.6|8.0|7.3|446|I(b) Acute myeloid leukemias|60519046|0-14|All Races|Male and Female|2005|||
1.1|1.7|1.4|84|I(c) Chronic myeloproliferative diseases|60519046|0-14|All Races|Male and Female|2005|||
1.3|2.0|1.6|99|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60519046|0-14|All Races|Male and Female|2005|||
1.2|1.8|1.5|89|I(e) Unspecified and other specified leukemias|60519046|0-14|All Races|Male and Female|2005|||
15.7|17.8|16.7|1016|II Lymphomas and reticuloendothelial neoplasms|60519046|0-14|All Races|Male and Female|2005|||
5.3|6.5|5.9|360|II(a) Hodgkin lymphomas|60519046|0-14|All Races|Male and Female|2005|||
5.9|7.2|6.5|396|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60519046|0-14|All Races|Male and Female|2005|||
2.2|3.0|2.6|155|II(c) Burkitt lymphoma|60519046|0-14|All Races|Male and Female|2005|||
1.2|1.8|1.5|91|II(d) Miscellaneous lymphoreticular neoplasms|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|II(e) Unspecified lymphomas|60519046|0-14|All Races|Male and Female|2005|||
31.0|33.9|32.4|1960|III CNS and misc intracranial and intraspinal neoplasms|60519046|0-14|All Races|Male and Female|2005|||
2.8|3.8|3.3|198|III(a) Ependymomas and choroid plexus tumor|60519046|0-14|All Races|Male and Female|2005|||
15.2|17.3|16.2|983|III(b) Astrocytomas|60519046|0-14|All Races|Male and Female|2005|||
6.3|7.6|6.9|417|III(c) Intracranial and intraspinal embryonal tumors|60519046|0-14|All Races|Male and Female|2005|||
4.4|5.5|4.9|297|III(d) Other gliomas|60519046|0-14|All Races|Male and Female|2005|||
0.4|0.8|0.6|36|III(e) Other specified intracranial & intraspinal neoplasms|60519046|0-14|All Races|Male and Female|2005|||
0.3|0.7|0.5|29|III(f) Unspecified intracranial and intraspinal neoplasms|60519046|0-14|All Races|Male and Female|2005|||
11.0|12.7|11.8|728|IV Neuroblastoma and other peripheral nervous cell tumors|60519046|0-14|All Races|Male and Female|2005|||
10.8|12.6|11.7|719|IV(a) Neuroblastoma and ganglioneuroblastoma|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60519046|0-14|All Races|Male and Female|2005|||
9.8|11.4|10.6|642|IX Soft tissue and other extraosseous sarcomas|60519046|0-14|All Races|Male and Female|2005|||
4.7|5.9|5.3|320|IX(a) Rhabdomyosarcomas|60519046|0-14|All Races|Male and Female|2005|||
0.9|1.4|1.1|69|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|IX(c) Kaposi sarcoma|60519046|0-14|All Races|Male and Female|2005|||
2.9|3.8|3.3|203|IX(d) Other specified soft tissue sarcomas|60519046|0-14|All Races|Male and Female|2005|||
0.6|1.0|0.8|47|IX(e) Unspecified soft tissue sarcomas|60519046|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|18|Not classified by ICCC|60519046|0-14|All Races|Male and Female|2005|||
3.4|4.4|3.9|240|V Retinoblastoma|60519046|0-14|All Races|Male and Female|2005|||
7.5|8.9|8.2|498|VI Renal tumors|60519046|0-14|All Races|Male and Female|2005|||
7.1|8.5|7.8|475|VI(a) Nephroblastoma and other nonepithelial renal tumors|60519046|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|19|VI(b) Renal carcinomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60519046|0-14|All Races|Male and Female|2005|||
2.0|2.8|2.4|145|VII Hepatic tumors|60519046|0-14|All Races|Male and Female|2005|||
1.6|2.3|1.9|116|VII(a) Hepatoblastoma|60519046|0-14|All Races|Male and Female|2005|||
0.3|0.6|0.4|27|VII(b) Hepatic carcinomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60519046|0-14|All Races|Male and Female|2005|||
6.2|7.5|6.8|414|VIII Malignant bone tumors|60519046|0-14|All Races|Male and Female|2005|||
3.3|4.2|3.7|227|VIII(a) Osteosarcomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|VIII(b) Chondrosarcomas|60519046|0-14|All Races|Male and Female|2005|||
2.0|2.8|2.4|146|VIII(c) Ewing tumor and related sarcomas of bone|60519046|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|20|VIII(d) Other specified malignant bone tumors|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60519046|0-14|All Races|Male and Female|2005|||
4.9|6.1|5.5|339|X Germ cell, trophoblastic tumors & neoplasms of gonads|60519046|0-14|All Races|Male and Female|2005|||
1.1|1.7|1.4|83|X(a) Intracranial & intraspinal germ cell tumors|60519046|0-14|All Races|Male and Female|2005|||
1.3|2.0|1.6|100|X(b) Malignant extracranial & extragonadal germ cell tumors|60519046|0-14|All Races|Male and Female|2005|||
1.9|2.7|2.3|139|X(c) Malignant gonadal germ cell tumors|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|X(d) Gonadal carcinomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60519046|0-14|All Races|Male and Female|2005|||
6.3|7.6|6.9|424|XI Other malignant epithelial neoplasms and malignant melanomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60519046|0-14|All Races|Male and Female|2005|||
1.8|2.6|2.2|134|XI(b) Thyroid carcinomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|XI(c) Nasopharyngeal carcinomas|60519046|0-14|All Races|Male and Female|2005|||
2.1|2.9|2.4|149|XI(d) Malignant melanomas|60519046|0-14|All Races|Male and Female|2005|||
~|~|~|~|XI(e) Skin carcinomas|60519046|0-14|All Races|Male and Female|2005|||
1.6|2.3|1.9|118|XI(f) Other and unspecified carcinomas|60519046|0-14|All Races|Male and Female|2005|||
0.4|0.8|0.6|35|XII Other and unspecified malignant neoplasms|60519046|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|18|XII(a) Other specified malignant tumors|60519046|0-14|All Races|Male and Female|2005|||
0.2|0.5|0.3|17|XII(b) Other unspecified malignant tumors|60519046|0-14|All Races|Male and Female|2005|||
154.7|161.0|157.8|9607|All ICCC Groups Combined|60516709|0-14|All Races|Male and Female|2006|||
49.5|53.2|51.3|3121|I Leukemias, myeloproliferative & myelodysplastic diseases|60516709|0-14|All Races|Male and Female|2006|||
37.2|40.3|38.7|2349|I(a) Lymphoid leukemias|60516709|0-14|All Races|Male and Female|2006|||
7.2|8.6|7.9|481|I(b) Acute myeloid leukemias|60516709|0-14|All Races|Male and Female|2006|||
1.4|2.0|1.7|102|I(c) Chronic myeloproliferative diseases|60516709|0-14|All Races|Male and Female|2006|||
1.4|2.1|1.7|106|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60516709|0-14|All Races|Male and Female|2006|||
1.1|1.7|1.4|83|I(e) Unspecified and other specified leukemias|60516709|0-14|All Races|Male and Female|2006|||
15.7|17.8|16.7|1014|II Lymphomas and reticuloendothelial neoplasms|60516709|0-14|All Races|Male and Female|2006|||
5.5|6.8|6.1|372|II(a) Hodgkin lymphomas|60516709|0-14|All Races|Male and Female|2006|||
5.9|7.2|6.5|393|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60516709|0-14|All Races|Male and Female|2006|||
2.1|2.9|2.5|151|II(c) Burkitt lymphoma|60516709|0-14|All Races|Male and Female|2006|||
1.1|1.7|1.4|86|II(d) Miscellaneous lymphoreticular neoplasms|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|II(e) Unspecified lymphomas|60516709|0-14|All Races|Male and Female|2006|||
32.2|35.1|33.6|2036|III CNS and misc intracranial and intraspinal neoplasms|60516709|0-14|All Races|Male and Female|2006|||
2.6|3.5|3.0|185|III(a) Ependymomas and choroid plexus tumor|60516709|0-14|All Races|Male and Female|2006|||
15.1|17.2|16.1|976|III(b) Astrocytomas|60516709|0-14|All Races|Male and Female|2006|||
7.0|8.4|7.6|463|III(c) Intracranial and intraspinal embryonal tumors|60516709|0-14|All Races|Male and Female|2006|||
5.1|6.3|5.7|340|III(d) Other gliomas|60516709|0-14|All Races|Male and Female|2006|||
0.3|0.7|0.5|31|III(e) Other specified intracranial & intraspinal neoplasms|60516709|0-14|All Races|Male and Female|2006|||
0.5|0.9|0.7|41|III(f) Unspecified intracranial and intraspinal neoplasms|60516709|0-14|All Races|Male and Female|2006|||
9.5|11.1|10.3|633|IV Neuroblastoma and other peripheral nervous cell tumors|60516709|0-14|All Races|Male and Female|2006|||
9.4|11.0|10.2|628|IV(a) Neuroblastoma and ganglioneuroblastoma|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60516709|0-14|All Races|Male and Female|2006|||
9.7|11.3|10.5|638|IX Soft tissue and other extraosseous sarcomas|60516709|0-14|All Races|Male and Female|2006|||
4.3|5.5|4.9|295|IX(a) Rhabdomyosarcomas|60516709|0-14|All Races|Male and Female|2006|||
0.9|1.4|1.1|68|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|IX(c) Kaposi sarcoma|60516709|0-14|All Races|Male and Female|2006|||
3.0|3.9|3.4|208|IX(d) Other specified soft tissue sarcomas|60516709|0-14|All Races|Male and Female|2006|||
0.8|1.4|1.1|65|IX(e) Unspecified soft tissue sarcomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|Not classified by ICCC|60516709|0-14|All Races|Male and Female|2006|||
3.6|4.6|4.0|251|V Retinoblastoma|60516709|0-14|All Races|Male and Female|2006|||
7.5|9.0|8.2|502|VI Renal tumors|60516709|0-14|All Races|Male and Female|2006|||
7.2|8.6|7.9|479|VI(a) Nephroblastoma and other nonepithelial renal tumors|60516709|0-14|All Races|Male and Female|2006|||
0.2|0.5|0.3|19|VI(b) Renal carcinomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60516709|0-14|All Races|Male and Female|2006|||
2.2|3.0|2.6|161|VII Hepatic tumors|60516709|0-14|All Races|Male and Female|2006|||
1.8|2.6|2.2|134|VII(a) Hepatoblastoma|60516709|0-14|All Races|Male and Female|2006|||
0.2|0.6|0.4|23|VII(b) Hepatic carcinomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60516709|0-14|All Races|Male and Female|2006|||
6.5|7.8|7.1|430|VIII Malignant bone tumors|60516709|0-14|All Races|Male and Female|2006|||
3.5|4.6|4.0|245|VIII(a) Osteosarcomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|VIII(b) Chondrosarcomas|60516709|0-14|All Races|Male and Female|2006|||
2.1|2.9|2.4|147|VIII(c) Ewing tumor and related sarcomas of bone|60516709|0-14|All Races|Male and Female|2006|||
0.2|0.5|0.3|18|VIII(d) Other specified malignant bone tumors|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60516709|0-14|All Races|Male and Female|2006|||
4.5|5.7|5.1|313|X Germ cell, trophoblastic tumors & neoplasms of gonads|60516709|0-14|All Races|Male and Female|2006|||
1.0|1.6|1.3|77|X(a) Intracranial & intraspinal germ cell tumors|60516709|0-14|All Races|Male and Female|2006|||
1.2|1.8|1.5|92|X(b) Malignant extracranial & extragonadal germ cell tumors|60516709|0-14|All Races|Male and Female|2006|||
1.7|2.5|2.1|128|X(c) Malignant gonadal germ cell tumors|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|X(d) Gonadal carcinomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60516709|0-14|All Races|Male and Female|2006|||
6.8|8.1|7.4|453|XI Other malignant epithelial neoplasms and malignant melanomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60516709|0-14|All Races|Male and Female|2006|||
2.2|3.0|2.6|158|XI(b) Thyroid carcinomas|60516709|0-14|All Races|Male and Female|2006|||
0.2|0.5|0.3|18|XI(c) Nasopharyngeal carcinomas|60516709|0-14|All Races|Male and Female|2006|||
2.1|2.9|2.4|148|XI(d) Malignant melanomas|60516709|0-14|All Races|Male and Female|2006|||
~|~|~|~|XI(e) Skin carcinomas|60516709|0-14|All Races|Male and Female|2006|||
1.5|2.2|1.8|110|XI(f) Other and unspecified carcinomas|60516709|0-14|All Races|Male and Female|2006|||
0.5|1.0|0.8|46|XII Other and unspecified malignant neoplasms|60516709|0-14|All Races|Male and Female|2006|||
0.3|0.6|0.4|27|XII(a) Other specified malignant tumors|60516709|0-14|All Races|Male and Female|2006|||
0.2|0.5|0.3|19|XII(b) Other unspecified malignant tumors|60516709|0-14|All Races|Male and Female|2006|||
157.8|164.2|160.9|9836|All ICCC Groups Combined|60681615|0-14|All Races|Male and Female|2007|||
50.1|53.7|51.9|3165|I Leukemias, myeloproliferative & myelodysplastic diseases|60681615|0-14|All Races|Male and Female|2007|||
38.3|41.5|39.9|2429|I(a) Lymphoid leukemias|60681615|0-14|All Races|Male and Female|2007|||
7.0|8.4|7.7|469|I(b) Acute myeloid leukemias|60681615|0-14|All Races|Male and Female|2007|||
1.3|1.9|1.6|98|I(c) Chronic myeloproliferative diseases|60681615|0-14|All Races|Male and Female|2007|||
1.2|1.9|1.5|95|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60681615|0-14|All Races|Male and Female|2007|||
0.9|1.5|1.2|74|I(e) Unspecified and other specified leukemias|60681615|0-14|All Races|Male and Female|2007|||
15.6|17.7|16.6|1006|II Lymphomas and reticuloendothelial neoplasms|60681615|0-14|All Races|Male and Female|2007|||
4.9|6.0|5.4|329|II(a) Hodgkin lymphomas|60681615|0-14|All Races|Male and Female|2007|||
6.3|7.7|7.0|423|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60681615|0-14|All Races|Male and Female|2007|||
2.3|3.1|2.7|160|II(c) Burkitt lymphoma|60681615|0-14|All Races|Male and Female|2007|||
1.0|1.6|1.3|80|II(d) Miscellaneous lymphoreticular neoplasms|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|II(e) Unspecified lymphomas|60681615|0-14|All Races|Male and Female|2007|||
33.4|36.3|34.8|2116|III CNS and misc intracranial and intraspinal neoplasms|60681615|0-14|All Races|Male and Female|2007|||
2.5|3.3|2.9|176|III(a) Ependymomas and choroid plexus tumor|60681615|0-14|All Races|Male and Female|2007|||
15.5|17.5|16.5|1000|III(b) Astrocytomas|60681615|0-14|All Races|Male and Female|2007|||
7.0|8.4|7.7|469|III(c) Intracranial and intraspinal embryonal tumors|60681615|0-14|All Races|Male and Female|2007|||
5.9|7.2|6.5|394|III(d) Other gliomas|60681615|0-14|All Races|Male and Female|2007|||
0.5|1.0|0.7|45|III(e) Other specified intracranial & intraspinal neoplasms|60681615|0-14|All Races|Male and Female|2007|||
0.4|0.7|0.5|32|III(f) Unspecified intracranial and intraspinal neoplasms|60681615|0-14|All Races|Male and Female|2007|||
10.9|12.6|11.7|730|IV Neuroblastoma and other peripheral nervous cell tumors|60681615|0-14|All Races|Male and Female|2007|||
10.7|12.4|11.5|719|IV(a) Neuroblastoma and ganglioneuroblastoma|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60681615|0-14|All Races|Male and Female|2007|||
10.1|11.8|11.0|669|IX Soft tissue and other extraosseous sarcomas|60681615|0-14|All Races|Male and Female|2007|||
5.1|6.3|5.7|348|IX(a) Rhabdomyosarcomas|60681615|0-14|All Races|Male and Female|2007|||
0.9|1.4|1.1|70|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|IX(c) Kaposi sarcoma|60681615|0-14|All Races|Male and Female|2007|||
2.9|3.8|3.3|201|IX(d) Other specified soft tissue sarcomas|60681615|0-14|All Races|Male and Female|2007|||
0.6|1.1|0.8|49|IX(e) Unspecified soft tissue sarcomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|Not classified by ICCC|60681615|0-14|All Races|Male and Female|2007|||
3.7|4.7|4.2|263|V Retinoblastoma|60681615|0-14|All Races|Male and Female|2007|||
7.9|9.3|8.6|526|VI Renal tumors|60681615|0-14|All Races|Male and Female|2007|||
7.4|8.9|8.1|499|VI(a) Nephroblastoma and other nonepithelial renal tumors|60681615|0-14|All Races|Male and Female|2007|||
0.3|0.6|0.4|26|VI(b) Renal carcinomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60681615|0-14|All Races|Male and Female|2007|||
2.2|3.0|2.6|159|VII Hepatic tumors|60681615|0-14|All Races|Male and Female|2007|||
1.9|2.6|2.2|140|VII(a) Hepatoblastoma|60681615|0-14|All Races|Male and Female|2007|||
0.2|0.5|0.3|19|VII(b) Hepatic carcinomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60681615|0-14|All Races|Male and Female|2007|||
6.1|7.5|6.8|411|VIII Malignant bone tumors|60681615|0-14|All Races|Male and Female|2007|||
3.2|4.2|3.6|220|VIII(a) Osteosarcomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|VIII(b) Chondrosarcomas|60681615|0-14|All Races|Male and Female|2007|||
2.1|2.9|2.5|151|VIII(c) Ewing tumor and related sarcomas of bone|60681615|0-14|All Races|Male and Female|2007|||
0.2|0.4|0.3|16|VIII(d) Other specified malignant bone tumors|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60681615|0-14|All Races|Male and Female|2007|||
4.9|6.1|5.5|338|X Germ cell, trophoblastic tumors & neoplasms of gonads|60681615|0-14|All Races|Male and Female|2007|||
1.1|1.7|1.4|86|X(a) Intracranial & intraspinal germ cell tumors|60681615|0-14|All Races|Male and Female|2007|||
1.0|1.6|1.3|82|X(b) Malignant extracranial & extragonadal germ cell tumors|60681615|0-14|All Races|Male and Female|2007|||
2.2|3.0|2.6|157|X(c) Malignant gonadal germ cell tumors|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|X(d) Gonadal carcinomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60681615|0-14|All Races|Male and Female|2007|||
6.0|7.3|6.6|402|XI Other malignant epithelial neoplasms and malignant melanomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60681615|0-14|All Races|Male and Female|2007|||
1.9|2.6|2.2|136|XI(b) Thyroid carcinomas|60681615|0-14|All Races|Male and Female|2007|||
0.2|0.4|0.3|17|XI(c) Nasopharyngeal carcinomas|60681615|0-14|All Races|Male and Female|2007|||
1.8|2.6|2.2|132|XI(d) Malignant melanomas|60681615|0-14|All Races|Male and Female|2007|||
~|~|~|~|XI(e) Skin carcinomas|60681615|0-14|All Races|Male and Female|2007|||
1.3|2.0|1.6|100|XI(f) Other and unspecified carcinomas|60681615|0-14|All Races|Male and Female|2007|||
0.5|0.9|0.7|41|XII Other and unspecified malignant neoplasms|60681615|0-14|All Races|Male and Female|2007|||
0.2|0.6|0.4|23|XII(a) Other specified malignant tumors|60681615|0-14|All Races|Male and Female|2007|||
0.2|0.5|0.3|18|XII(b) Other unspecified malignant tumors|60681615|0-14|All Races|Male and Female|2007|||
162.3|165.2|163.8|49789|All ICCC Groups Combined|302299456|0-14|All Races|Male and Female|2007-2011|||
52.0|53.7|52.9|16091|I Leukemias, myeloproliferative & myelodysplastic diseases|302299456|0-14|All Races|Male and Female|2007-2011|||
39.9|41.3|40.6|12346|I(a) Lymphoid leukemias|302299456|0-14|All Races|Male and Female|2007-2011|||
7.3|7.9|7.6|2305|I(b) Acute myeloid leukemias|302299456|0-14|All Races|Male and Female|2007-2011|||
1.6|1.9|1.8|544|I(c) Chronic myeloproliferative diseases|302299456|0-14|All Races|Male and Female|2007-2011|||
1.5|1.7|1.6|488|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|302299456|0-14|All Races|Male and Female|2007-2011|||
1.2|1.5|1.3|408|I(e) Unspecified and other specified leukemias|302299456|0-14|All Races|Male and Female|2007-2011|||
17.4|18.4|17.9|5406|II Lymphomas and reticuloendothelial neoplasms|302299456|0-14|All Races|Male and Female|2007-2011|||
5.3|5.8|5.6|1672|II(a) Hodgkin lymphomas|302299456|0-14|All Races|Male and Female|2007-2011|||
6.6|7.2|6.9|2069|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|302299456|0-14|All Races|Male and Female|2007-2011|||
2.4|2.7|2.5|763|II(c) Burkitt lymphoma|302299456|0-14|All Races|Male and Female|2007-2011|||
2.6|3.0|2.8|843|II(d) Miscellaneous lymphoreticular neoplasms|302299456|0-14|All Races|Male and Female|2007-2011|||
0.1|0.3|0.2|59|II(e) Unspecified lymphomas|302299456|0-14|All Races|Male and Female|2007-2011|||
34.0|35.4|34.7|10508|III CNS and misc intracranial and intraspinal neoplasms|302299456|0-14|All Races|Male and Female|2007-2011|||
2.7|3.1|2.9|891|III(a) Ependymomas and choroid plexus tumor|302299456|0-14|All Races|Male and Female|2007-2011|||
16.6|17.5|17.1|5160|III(b) Astrocytomas|302299456|0-14|All Races|Male and Female|2007-2011|||
7.2|7.8|7.5|2276|III(c) Intracranial and intraspinal embryonal tumors|302299456|0-14|All Races|Male and Female|2007-2011|||
5.8|6.4|6.1|1844|III(d) Other gliomas|302299456|0-14|All Races|Male and Female|2007-2011|||
0.5|0.7|0.6|191|III(e) Other specified intracranial & intraspinal neoplasms|302299456|0-14|All Races|Male and Female|2007-2011|||
0.4|0.6|0.5|146|III(f) Unspecified intracranial and intraspinal neoplasms|302299456|0-14|All Races|Male and Female|2007-2011|||
10.7|11.5|11.1|3419|IV Neuroblastoma and other peripheral nervous cell tumors|302299456|0-14|All Races|Male and Female|2007-2011|||
10.5|11.3|10.9|3361|IV(a) Neuroblastoma and ganglioneuroblastoma|302299456|0-14|All Races|Male and Female|2007-2011|||
0.1|0.2|0.2|58|IV(b) Other peripheral nervous cell tumors|302299456|0-14|All Races|Male and Female|2007-2011|||
10.6|11.3|11.0|3324|IX Soft tissue and other extraosseous sarcomas|302299456|0-14|All Races|Male and Female|2007-2011|||
5.0|5.5|5.2|1589|IX(a) Rhabdomyosarcomas|302299456|0-14|All Races|Male and Female|2007-2011|||
0.9|1.1|1.0|308|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|302299456|0-14|All Races|Male and Female|2007-2011|||
~|~|~|~|IX(c) Kaposi sarcoma|302299456|0-14|All Races|Male and Female|2007-2011|||
3.4|3.8|3.6|1085|IX(d) Other specified soft tissue sarcomas|302299456|0-14|All Races|Male and Female|2007-2011|||
1.0|1.2|1.1|336|IX(e) Unspecified soft tissue sarcomas|302299456|0-14|All Races|Male and Female|2007-2011|||
0.2|0.3|0.3|82|Not classified by ICCC|302299456|0-14|All Races|Male and Female|2007-2011|||
4.0|4.5|4.3|1319|V Retinoblastoma|302299456|0-14|All Races|Male and Female|2007-2011|||
8.5|9.2|8.8|2704|VI Renal tumors|302299456|0-14|All Races|Male and Female|2007-2011|||
8.0|8.7|8.4|2568|VI(a) Nephroblastoma and other nonepithelial renal tumors|302299456|0-14|All Races|Male and Female|2007-2011|||
0.4|0.5|0.4|127|VI(b) Renal carcinomas|302299456|0-14|All Races|Male and Female|2007-2011|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|302299456|0-14|All Races|Male and Female|2007-2011|||
2.5|2.9|2.7|833|VII Hepatic tumors|302299456|0-14|All Races|Male and Female|2007-2011|||
2.1|2.5|2.3|712|VII(a) Hepatoblastoma|302299456|0-14|All Races|Male and Female|2007-2011|||
0.3|0.5|0.4|115|VII(b) Hepatic carcinomas|302299456|0-14|All Races|Male and Female|2007-2011|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|302299456|0-14|All Races|Male and Female|2007-2011|||
6.6|7.2|6.9|2070|VIII Malignant bone tumors|302299456|0-14|All Races|Male and Female|2007-2011|||
3.6|4.1|3.8|1149|VIII(a) Osteosarcomas|302299456|0-14|All Races|Male and Female|2007-2011|||
0.1|0.2|0.1|40|VIII(b) Chondrosarcomas|302299456|0-14|All Races|Male and Female|2007-2011|||
2.3|2.7|2.5|747|VIII(c) Ewing tumor and related sarcomas of bone|302299456|0-14|All Races|Male and Female|2007-2011|||
0.2|0.3|0.3|82|VIII(d) Other specified malignant bone tumors|302299456|0-14|All Races|Male and Female|2007-2011|||
0.1|0.2|0.2|52|VIII(e) Unspecified malignant bone tumors|302299456|0-14|All Races|Male and Female|2007-2011|||
5.2|5.7|5.5|1665|X Germ cell, trophoblastic tumors & neoplasms of gonads|302299456|0-14|All Races|Male and Female|2007-2011|||
1.4|1.6|1.5|450|X(a) Intracranial & intraspinal germ cell tumors|302299456|0-14|All Races|Male and Female|2007-2011|||
1.2|1.4|1.3|394|X(b) Malignant extracranial & extragonadal germ cell tumors|302299456|0-14|All Races|Male and Female|2007-2011|||
2.3|2.6|2.5|746|X(c) Malignant gonadal germ cell tumors|302299456|0-14|All Races|Male and Female|2007-2011|||
0.1|0.2|0.1|38|X(d) Gonadal carcinomas|302299456|0-14|All Races|Male and Female|2007-2011|||
0.1|0.2|0.1|37|X(e) Other and unspecified malignant gonadal tumors|302299456|0-14|All Races|Male and Female|2007-2011|||
6.9|7.5|7.2|2158|XI Other malignant epithelial neoplasms and malignant melanomas|302299456|0-14|All Races|Male and Female|2007-2011|||
0.2|0.3|0.2|69|XI(a) Adrenocortical carcinomas|302299456|0-14|All Races|Male and Female|2007-2011|||
2.6|2.9|2.7|824|XI(b) Thyroid carcinomas|302299456|0-14|All Races|Male and Female|2007-2011|||
0.2|0.4|0.3|93|XI(c) Nasopharyngeal carcinomas|302299456|0-14|All Races|Male and Female|2007-2011|||
1.9|2.2|2.0|619|XI(d) Malignant melanomas|302299456|0-14|All Races|Male and Female|2007-2011|||
0.0|0.1|0.1|17|XI(e) Skin carcinomas|302299456|0-14|All Races|Male and Female|2007-2011|||
1.6|1.9|1.8|536|XI(f) Other and unspecified carcinomas|302299456|0-14|All Races|Male and Female|2007-2011|||
0.6|0.8|0.7|210|XII Other and unspecified malignant neoplasms|302299456|0-14|All Races|Male and Female|2007-2011|||
0.3|0.4|0.3|106|XII(a) Other specified malignant tumors|302299456|0-14|All Races|Male and Female|2007-2011|||
0.3|0.4|0.3|104|XII(b) Other unspecified malignant tumors|302299456|0-14|All Races|Male and Female|2007-2011|||
159.9|166.3|163.1|10008|All ICCC Groups Combined|60907384|0-14|All Races|Male and Female|2008|||
51.9|55.5|53.7|3295|I Leukemias, myeloproliferative & myelodysplastic diseases|60907384|0-14|All Races|Male and Female|2008|||
39.3|42.5|40.9|2505|I(a) Lymphoid leukemias|60907384|0-14|All Races|Male and Female|2008|||
7.3|8.7|8.0|493|I(b) Acute myeloid leukemias|60907384|0-14|All Races|Male and Female|2008|||
1.7|2.4|2.0|126|I(c) Chronic myeloproliferative diseases|60907384|0-14|All Races|Male and Female|2008|||
1.3|2.0|1.7|102|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60907384|0-14|All Races|Male and Female|2008|||
0.9|1.4|1.1|69|I(e) Unspecified and other specified leukemias|60907384|0-14|All Races|Male and Female|2008|||
16.0|18.1|17.0|1034|II Lymphomas and reticuloendothelial neoplasms|60907384|0-14|All Races|Male and Female|2008|||
5.7|6.9|6.3|379|II(a) Hodgkin lymphomas|60907384|0-14|All Races|Male and Female|2008|||
6.1|7.4|6.7|406|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60907384|0-14|All Races|Male and Female|2008|||
2.3|3.1|2.7|163|II(c) Burkitt lymphoma|60907384|0-14|All Races|Male and Female|2008|||
0.9|1.5|1.2|72|II(d) Miscellaneous lymphoreticular neoplasms|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|II(e) Unspecified lymphomas|60907384|0-14|All Races|Male and Female|2008|||
33.2|36.2|34.7|2117|III CNS and misc intracranial and intraspinal neoplasms|60907384|0-14|All Races|Male and Female|2008|||
2.2|3.1|2.6|162|III(a) Ependymomas and choroid plexus tumor|60907384|0-14|All Races|Male and Female|2008|||
16.1|18.1|17.1|1041|III(b) Astrocytomas|60907384|0-14|All Races|Male and Female|2008|||
7.4|8.8|8.1|497|III(c) Intracranial and intraspinal embryonal tumors|60907384|0-14|All Races|Male and Female|2008|||
5.2|6.4|5.8|352|III(d) Other gliomas|60907384|0-14|All Races|Male and Female|2008|||
0.5|0.9|0.7|42|III(e) Other specified intracranial & intraspinal neoplasms|60907384|0-14|All Races|Male and Female|2008|||
0.2|0.6|0.4|23|III(f) Unspecified intracranial and intraspinal neoplasms|60907384|0-14|All Races|Male and Female|2008|||
10.1|11.7|10.9|680|IV Neuroblastoma and other peripheral nervous cell tumors|60907384|0-14|All Races|Male and Female|2008|||
9.8|11.4|10.6|663|IV(a) Neuroblastoma and ganglioneuroblastoma|60907384|0-14|All Races|Male and Female|2008|||
0.2|0.4|0.3|17|IV(b) Other peripheral nervous cell tumors|60907384|0-14|All Races|Male and Female|2008|||
10.1|11.8|10.9|667|IX Soft tissue and other extraosseous sarcomas|60907384|0-14|All Races|Male and Female|2008|||
4.7|5.9|5.3|324|IX(a) Rhabdomyosarcomas|60907384|0-14|All Races|Male and Female|2008|||
0.7|1.2|0.9|57|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|IX(c) Kaposi sarcoma|60907384|0-14|All Races|Male and Female|2008|||
2.9|3.9|3.4|207|IX(d) Other specified soft tissue sarcomas|60907384|0-14|All Races|Male and Female|2008|||
1.0|1.6|1.3|78|IX(e) Unspecified soft tissue sarcomas|60907384|0-14|All Races|Male and Female|2008|||
0.1|0.4|0.3|16|Not classified by ICCC|60907384|0-14|All Races|Male and Female|2008|||
3.7|4.7|4.1|262|V Retinoblastoma|60907384|0-14|All Races|Male and Female|2008|||
8.2|9.8|9.0|556|VI Renal tumors|60907384|0-14|All Races|Male and Female|2008|||
7.8|9.3|8.5|528|VI(a) Nephroblastoma and other nonepithelial renal tumors|60907384|0-14|All Races|Male and Female|2008|||
0.3|0.6|0.4|26|VI(b) Renal carcinomas|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60907384|0-14|All Races|Male and Female|2008|||
2.2|3.1|2.6|164|VII Hepatic tumors|60907384|0-14|All Races|Male and Female|2008|||
1.9|2.6|2.2|140|VII(a) Hepatoblastoma|60907384|0-14|All Races|Male and Female|2008|||
0.3|0.6|0.4|24|VII(b) Hepatic carcinomas|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60907384|0-14|All Races|Male and Female|2008|||
6.2|7.5|6.8|411|VIII Malignant bone tumors|60907384|0-14|All Races|Male and Female|2008|||
3.3|4.3|3.8|230|VIII(a) Osteosarcomas|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|VIII(b) Chondrosarcomas|60907384|0-14|All Races|Male and Female|2008|||
2.1|2.9|2.4|148|VIII(c) Ewing tumor and related sarcomas of bone|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|VIII(d) Other specified malignant bone tumors|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60907384|0-14|All Races|Male and Female|2008|||
4.7|5.8|5.2|323|X Germ cell, trophoblastic tumors & neoplasms of gonads|60907384|0-14|All Races|Male and Female|2008|||
1.1|1.7|1.3|81|X(a) Intracranial & intraspinal germ cell tumors|60907384|0-14|All Races|Male and Female|2008|||
1.1|1.7|1.4|90|X(b) Malignant extracranial & extragonadal germ cell tumors|60907384|0-14|All Races|Male and Female|2008|||
1.9|2.7|2.3|141|X(c) Malignant gonadal germ cell tumors|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|X(d) Gonadal carcinomas|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60907384|0-14|All Races|Male and Female|2008|||
6.6|8.0|7.3|444|XI Other malignant epithelial neoplasms and malignant melanomas|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60907384|0-14|All Races|Male and Female|2008|||
2.2|3.0|2.6|157|XI(b) Thyroid carcinomas|60907384|0-14|All Races|Male and Female|2008|||
0.2|0.4|0.3|17|XI(c) Nasopharyngeal carcinomas|60907384|0-14|All Races|Male and Female|2008|||
1.9|2.7|2.3|139|XI(d) Malignant melanomas|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|XI(e) Skin carcinomas|60907384|0-14|All Races|Male and Female|2008|||
1.5|2.3|1.9|114|XI(f) Other and unspecified carcinomas|60907384|0-14|All Races|Male and Female|2008|||
0.4|0.9|0.6|39|XII Other and unspecified malignant neoplasms|60907384|0-14|All Races|Male and Female|2008|||
0.2|0.6|0.4|24|XII(a) Other specified malignant tumors|60907384|0-14|All Races|Male and Female|2008|||
~|~|~|~|XII(b) Other unspecified malignant tumors|60907384|0-14|All Races|Male and Female|2008|||
158.2|164.6|161.3|9913|All ICCC Groups Combined|61087581|0-14|All Races|Male and Female|2009|||
50.3|53.9|52.1|3208|I Leukemias, myeloproliferative & myelodysplastic diseases|61087581|0-14|All Races|Male and Female|2009|||
39.1|42.3|40.6|2505|I(a) Lymphoid leukemias|61087581|0-14|All Races|Male and Female|2009|||
6.6|8.0|7.3|448|I(b) Acute myeloid leukemias|61087581|0-14|All Races|Male and Female|2009|||
1.2|1.9|1.5|94|I(c) Chronic myeloproliferative diseases|61087581|0-14|All Races|Male and Female|2009|||
1.2|1.8|1.5|90|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61087581|0-14|All Races|Male and Female|2009|||
0.9|1.5|1.2|71|I(e) Unspecified and other specified leukemias|61087581|0-14|All Races|Male and Female|2009|||
15.7|17.8|16.7|1019|II Lymphomas and reticuloendothelial neoplasms|61087581|0-14|All Races|Male and Female|2009|||
5.1|6.3|5.7|346|II(a) Hodgkin lymphomas|61087581|0-14|All Races|Male and Female|2009|||
6.4|7.7|7.0|426|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61087581|0-14|All Races|Male and Female|2009|||
2.0|2.8|2.3|142|II(c) Burkitt lymphoma|61087581|0-14|All Races|Male and Female|2009|||
1.2|1.9|1.5|94|II(d) Miscellaneous lymphoreticular neoplasms|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|II(e) Unspecified lymphomas|61087581|0-14|All Races|Male and Female|2009|||
33.2|36.1|34.6|2121|III CNS and misc intracranial and intraspinal neoplasms|61087581|0-14|All Races|Male and Female|2009|||
2.2|3.0|2.6|159|III(a) Ependymomas and choroid plexus tumor|61087581|0-14|All Races|Male and Female|2009|||
15.9|18.0|16.9|1037|III(b) Astrocytomas|61087581|0-14|All Races|Male and Female|2009|||
6.8|8.2|7.5|457|III(c) Intracranial and intraspinal embryonal tumors|61087581|0-14|All Races|Male and Female|2009|||
5.9|7.2|6.5|398|III(d) Other gliomas|61087581|0-14|All Races|Male and Female|2009|||
0.4|0.8|0.6|34|III(e) Other specified intracranial & intraspinal neoplasms|61087581|0-14|All Races|Male and Female|2009|||
0.4|0.8|0.6|36|III(f) Unspecified intracranial and intraspinal neoplasms|61087581|0-14|All Races|Male and Female|2009|||
9.9|11.5|10.7|666|IV Neuroblastoma and other peripheral nervous cell tumors|61087581|0-14|All Races|Male and Female|2009|||
9.8|11.4|10.5|657|IV(a) Neuroblastoma and ganglioneuroblastoma|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|61087581|0-14|All Races|Male and Female|2009|||
9.8|11.5|10.6|651|IX Soft tissue and other extraosseous sarcomas|61087581|0-14|All Races|Male and Female|2009|||
3.9|5.0|4.4|273|IX(a) Rhabdomyosarcomas|61087581|0-14|All Races|Male and Female|2009|||
1.0|1.6|1.3|77|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|IX(c) Kaposi sarcoma|61087581|0-14|All Races|Male and Female|2009|||
3.3|4.3|3.8|229|IX(d) Other specified soft tissue sarcomas|61087581|0-14|All Races|Male and Female|2009|||
0.9|1.5|1.2|72|IX(e) Unspecified soft tissue sarcomas|61087581|0-14|All Races|Male and Female|2009|||
0.2|0.6|0.4|24|Not classified by ICCC|61087581|0-14|All Races|Male and Female|2009|||
3.9|5.0|4.4|278|V Retinoblastoma|61087581|0-14|All Races|Male and Female|2009|||
8.4|9.9|9.1|567|VI Renal tumors|61087581|0-14|All Races|Male and Female|2009|||
7.8|9.3|8.5|529|VI(a) Nephroblastoma and other nonepithelial renal tumors|61087581|0-14|All Races|Male and Female|2009|||
0.4|0.8|0.6|36|VI(b) Renal carcinomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61087581|0-14|All Races|Male and Female|2009|||
1.8|2.6|2.2|137|VII Hepatic tumors|61087581|0-14|All Races|Male and Female|2009|||
1.5|2.2|1.9|116|VII(a) Hepatoblastoma|61087581|0-14|All Races|Male and Female|2009|||
0.2|0.5|0.3|19|VII(b) Hepatic carcinomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61087581|0-14|All Races|Male and Female|2009|||
6.3|7.7|7.0|423|VIII Malignant bone tumors|61087581|0-14|All Races|Male and Female|2009|||
3.5|4.5|4.0|240|VIII(a) Osteosarcomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|VIII(b) Chondrosarcomas|61087581|0-14|All Races|Male and Female|2009|||
2.0|2.8|2.4|143|VIII(c) Ewing tumor and related sarcomas of bone|61087581|0-14|All Races|Male and Female|2009|||
0.3|0.6|0.4|24|VIII(d) Other specified malignant bone tumors|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61087581|0-14|All Races|Male and Female|2009|||
4.9|6.1|5.4|334|X Germ cell, trophoblastic tumors & neoplasms of gonads|61087581|0-14|All Races|Male and Female|2009|||
1.1|1.7|1.4|82|X(a) Intracranial & intraspinal germ cell tumors|61087581|0-14|All Races|Male and Female|2009|||
0.9|1.5|1.2|73|X(b) Malignant extracranial & extragonadal germ cell tumors|61087581|0-14|All Races|Male and Female|2009|||
2.3|3.1|2.7|163|X(c) Malignant gonadal germ cell tumors|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|X(d) Gonadal carcinomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|61087581|0-14|All Races|Male and Female|2009|||
6.5|7.9|7.2|435|XI Other malignant epithelial neoplasms and malignant melanomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|XI(a) Adrenocortical carcinomas|61087581|0-14|All Races|Male and Female|2009|||
2.5|3.3|2.9|174|XI(b) Thyroid carcinomas|61087581|0-14|All Races|Male and Female|2009|||
0.3|0.6|0.4|24|XI(c) Nasopharyngeal carcinomas|61087581|0-14|All Races|Male and Female|2009|||
1.4|2.1|1.7|106|XI(d) Malignant melanomas|61087581|0-14|All Races|Male and Female|2009|||
~|~|~|~|XI(e) Skin carcinomas|61087581|0-14|All Races|Male and Female|2009|||
1.5|2.2|1.8|112|XI(f) Other and unspecified carcinomas|61087581|0-14|All Races|Male and Female|2009|||
0.6|1.1|0.8|50|XII Other and unspecified malignant neoplasms|61087581|0-14|All Races|Male and Female|2009|||
0.2|0.5|0.3|20|XII(a) Other specified malignant tumors|61087581|0-14|All Races|Male and Female|2009|||
0.3|0.7|0.5|30|XII(b) Other unspecified malignant tumors|61087581|0-14|All Races|Male and Female|2009|||
164.1|170.6|167.3|10287|All ICCC Groups Combined|61201748|0-14|All Races|Male and Female|2010|||
52.1|55.8|53.9|3324|I Leukemias, myeloproliferative & myelodysplastic diseases|61201748|0-14|All Races|Male and Female|2010|||
39.2|42.4|40.7|2514|I(a) Lymphoid leukemias|61201748|0-14|All Races|Male and Female|2010|||
6.7|8.1|7.4|456|I(b) Acute myeloid leukemias|61201748|0-14|All Races|Male and Female|2010|||
1.7|2.4|2.0|122|I(c) Chronic myeloproliferative diseases|61201748|0-14|All Races|Male and Female|2010|||
1.7|2.4|2.0|125|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|61201748|0-14|All Races|Male and Female|2010|||
1.4|2.1|1.7|107|I(e) Unspecified and other specified leukemias|61201748|0-14|All Races|Male and Female|2010|||
18.6|20.8|19.7|1203|II Lymphomas and reticuloendothelial neoplasms|61201748|0-14|All Races|Male and Female|2010|||
4.7|5.9|5.3|321|II(a) Hodgkin lymphomas|61201748|0-14|All Races|Male and Female|2010|||
6.6|8.0|7.2|442|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|61201748|0-14|All Races|Male and Female|2010|||
2.1|2.9|2.4|149|II(c) Burkitt lymphoma|61201748|0-14|All Races|Male and Female|2010|||
4.0|5.1|4.6|281|II(d) Miscellaneous lymphoreticular neoplasms|61201748|0-14|All Races|Male and Female|2010|||
~|~|~|~|II(e) Unspecified lymphomas|61201748|0-14|All Races|Male and Female|2010|||
33.5|36.5|34.9|2145|III CNS and misc intracranial and intraspinal neoplasms|61201748|0-14|All Races|Male and Female|2010|||
2.8|3.7|3.2|199|III(a) Ependymomas and choroid plexus tumor|61201748|0-14|All Races|Male and Female|2010|||
16.5|18.7|17.6|1078|III(b) Astrocytomas|61201748|0-14|All Races|Male and Female|2010|||
6.7|8.0|7.3|451|III(c) Intracranial and intraspinal embryonal tumors|61201748|0-14|All Races|Male and Female|2010|||
5.2|6.4|5.8|352|III(d) Other gliomas|61201748|0-14|All Races|Male and Female|2010|||
0.5|0.9|0.7|40|III(e) Other specified intracranial & intraspinal neoplasms|61201748|0-14|All Races|Male and Female|2010|||
0.3|0.6|0.4|25|III(f) Unspecified intracranial and intraspinal neoplasms|61201748|0-14|All Races|Male and Female|2010|||
10.2|11.9|11.0|686|IV Neuroblastoma and other peripheral nervous cell tumors|61201748|0-14|All Races|Male and Female|2010|||
10.1|11.7|10.9|676|IV(a) Neuroblastoma and ganglioneuroblastoma|61201748|0-14|All Races|Male and Female|2010|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|61201748|0-14|All Races|Male and Female|2010|||
10.5|12.2|11.3|695|IX Soft tissue and other extraosseous sarcomas|61201748|0-14|All Races|Male and Female|2010|||
4.9|6.1|5.5|339|IX(a) Rhabdomyosarcomas|61201748|0-14|All Races|Male and Female|2010|||
0.6|1.0|0.8|46|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|61201748|0-14|All Races|Male and Female|2010|||
~|~|~|~|IX(c) Kaposi sarcoma|61201748|0-14|All Races|Male and Female|2010|||
3.4|4.4|3.8|234|IX(d) Other specified soft tissue sarcomas|61201748|0-14|All Races|Male and Female|2010|||
1.0|1.6|1.2|76|IX(e) Unspecified soft tissue sarcomas|61201748|0-14|All Races|Male and Female|2010|||
0.1|0.4|0.3|16|Not classified by ICCC|61201748|0-14|All Races|Male and Female|2010|||
3.9|4.9|4.4|271|V Retinoblastoma|61201748|0-14|All Races|Male and Female|2010|||
7.7|9.2|8.5|525|VI Renal tumors|61201748|0-14|All Races|Male and Female|2010|||
7.4|8.8|8.1|503|VI(a) Nephroblastoma and other nonepithelial renal tumors|61201748|0-14|All Races|Male and Female|2010|||
0.2|0.5|0.3|19|VI(b) Renal carcinomas|61201748|0-14|All Races|Male and Female|2010|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|61201748|0-14|All Races|Male and Female|2010|||
2.6|3.5|3.0|186|VII Hepatic tumors|61201748|0-14|All Races|Male and Female|2010|||
2.1|2.9|2.5|156|VII(a) Hepatoblastoma|61201748|0-14|All Races|Male and Female|2010|||
0.3|0.7|0.5|29|VII(b) Hepatic carcinomas|61201748|0-14|All Races|Male and Female|2010|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|61201748|0-14|All Races|Male and Female|2010|||
6.0|7.3|6.6|401|VIII Malignant bone tumors|61201748|0-14|All Races|Male and Female|2010|||
3.2|4.2|3.7|223|VIII(a) Osteosarcomas|61201748|0-14|All Races|Male and Female|2010|||
~|~|~|~|VIII(b) Chondrosarcomas|61201748|0-14|All Races|Male and Female|2010|||
2.0|2.7|2.3|141|VIII(c) Ewing tumor and related sarcomas of bone|61201748|0-14|All Races|Male and Female|2010|||
0.2|0.5|0.3|18|VIII(d) Other specified malignant bone tumors|61201748|0-14|All Races|Male and Female|2010|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|61201748|0-14|All Races|Male and Female|2010|||
5.5|6.7|6.1|372|X Germ cell, trophoblastic tumors & neoplasms of gonads|61201748|0-14|All Races|Male and Female|2010|||
1.5|2.2|1.8|111|X(a) Intracranial & intraspinal germ cell tumors|61201748|0-14|All Races|Male and Female|2010|||
1.0|1.6|1.3|81|X(b) Malignant extracranial & extragonadal germ cell tumors|61201748|0-14|All Races|Male and Female|2010|||
2.2|3.0|2.6|157|X(c) Malignant gonadal germ cell tumors|61201748|0-14|All Races|Male and Female|2010|||
~|~|~|~|X(d) Gonadal carcinomas|61201748|0-14|All Races|Male and Female|2010|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|61201748|0-14|All Races|Male and Female|2010|||
6.3|7.6|6.9|421|XI Other malignant epithelial neoplasms and malignant melanomas|61201748|0-14|All Races|Male and Female|2010|||
~|~|~|~|XI(a) Adrenocortical carcinomas|61201748|0-14|All Races|Male and Female|2010|||
2.3|3.1|2.7|164|XI(b) Thyroid carcinomas|61201748|0-14|All Races|Male and Female|2010|||
0.2|0.4|0.3|17|XI(c) Nasopharyngeal carcinomas|61201748|0-14|All Races|Male and Female|2010|||
1.5|2.2|1.9|114|XI(d) Malignant melanomas|61201748|0-14|All Races|Male and Female|2010|||
~|~|~|~|XI(e) Skin carcinomas|61201748|0-14|All Races|Male and Female|2010|||
1.5|2.2|1.8|109|XI(f) Other and unspecified carcinomas|61201748|0-14|All Races|Male and Female|2010|||
0.5|0.9|0.7|42|XII Other and unspecified malignant neoplasms|61201748|0-14|All Races|Male and Female|2010|||
0.2|0.6|0.4|23|XII(a) Other specified malignant tumors|61201748|0-14|All Races|Male and Female|2010|||
0.2|0.5|0.3|19|XII(b) Other unspecified malignant tumors|61201748|0-14|All Races|Male and Female|2010|||
162.1|168.6|165.3|10063|All ICCC Groups Combined|60623890|0-14|All Races|Male and Female|2011|||
51.1|54.7|52.9|3224|I Leukemias, myeloproliferative & myelodysplastic diseases|60623890|0-14|All Races|Male and Female|2011|||
39.1|42.4|40.7|2485|I(a) Lymphoid leukemias|60623890|0-14|All Races|Male and Female|2011|||
6.8|8.2|7.5|456|I(b) Acute myeloid leukemias|60623890|0-14|All Races|Male and Female|2011|||
1.4|2.1|1.7|106|I(c) Chronic myeloproliferative diseases|60623890|0-14|All Races|Male and Female|2011|||
1.1|1.7|1.3|81|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|60623890|0-14|All Races|Male and Female|2011|||
1.3|1.9|1.6|96|I(e) Unspecified and other specified leukemias|60623890|0-14|All Races|Male and Female|2011|||
18.5|20.8|19.6|1187|II Lymphomas and reticuloendothelial neoplasms|60623890|0-14|All Races|Male and Female|2011|||
4.6|5.8|5.2|311|II(a) Hodgkin lymphomas|60623890|0-14|All Races|Male and Female|2011|||
5.8|7.1|6.4|389|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|60623890|0-14|All Races|Male and Female|2011|||
2.2|3.0|2.6|156|II(c) Burkitt lymphoma|60623890|0-14|All Races|Male and Female|2011|||
4.7|5.9|5.3|321|II(d) Miscellaneous lymphoreticular neoplasms|60623890|0-14|All Races|Male and Female|2011|||
~|~|~|~|II(e) Unspecified lymphomas|60623890|0-14|All Races|Male and Female|2011|||
32.5|35.4|33.9|2061|III CNS and misc intracranial and intraspinal neoplasms|60623890|0-14|All Races|Male and Female|2011|||
2.8|3.8|3.3|201|III(a) Ependymomas and choroid plexus tumor|60623890|0-14|All Races|Male and Female|2011|||
15.9|18.0|16.9|1028|III(b) Astrocytomas|60623890|0-14|All Races|Male and Female|2011|||
6.2|7.6|6.9|418|III(c) Intracranial and intraspinal embryonal tumors|60623890|0-14|All Races|Male and Female|2011|||
5.2|6.5|5.8|353|III(d) Other gliomas|60623890|0-14|All Races|Male and Female|2011|||
0.3|0.7|0.5|30|III(e) Other specified intracranial & intraspinal neoplasms|60623890|0-14|All Races|Male and Female|2011|||
0.3|0.7|0.5|31|III(f) Unspecified intracranial and intraspinal neoplasms|60623890|0-14|All Races|Male and Female|2011|||
10.2|11.9|11.0|676|IV Neuroblastoma and other peripheral nervous cell tumors|60623890|0-14|All Races|Male and Female|2011|||
10.0|11.7|10.8|664|IV(a) Neuroblastoma and ganglioneuroblastoma|60623890|0-14|All Races|Male and Female|2011|||
~|~|~|~|IV(b) Other peripheral nervous cell tumors|60623890|0-14|All Races|Male and Female|2011|||
10.0|11.7|10.8|659|IX Soft tissue and other extraosseous sarcomas|60623890|0-14|All Races|Male and Female|2011|||
4.5|5.7|5.1|310|IX(a) Rhabdomyosarcomas|60623890|0-14|All Races|Male and Female|2011|||
0.8|1.3|1.0|61|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|60623890|0-14|All Races|Male and Female|2011|||
~|~|~|~|IX(c) Kaposi sarcoma|60623890|0-14|All Races|Male and Female|2011|||
3.2|4.1|3.6|220|IX(d) Other specified soft tissue sarcomas|60623890|0-14|All Races|Male and Female|2011|||
0.8|1.4|1.1|64|IX(e) Unspecified soft tissue sarcomas|60623890|0-14|All Races|Male and Female|2011|||
0.2|0.4|0.3|16|Not classified by ICCC|60623890|0-14|All Races|Male and Female|2011|||
3.6|4.6|4.1|252|V Retinoblastoma|60623890|0-14|All Races|Male and Female|2011|||
8.2|9.8|9.0|551|VI Renal tumors|60623890|0-14|All Races|Male and Female|2011|||
7.9|9.4|8.6|530|VI(a) Nephroblastoma and other nonepithelial renal tumors|60623890|0-14|All Races|Male and Female|2011|||
0.2|0.5|0.3|20|VI(b) Renal carcinomas|60623890|0-14|All Races|Male and Female|2011|||
~|~|~|~|VI(c) Unspecified malignant renal tumors|60623890|0-14|All Races|Male and Female|2011|||
2.7|3.6|3.1|190|VII Hepatic tumors|60623890|0-14|All Races|Male and Female|2011|||
2.2|3.0|2.6|161|VII(a) Hepatoblastoma|60623890|0-14|All Races|Male and Female|2011|||
0.3|0.6|0.4|25|VII(b) Hepatic carcinomas|60623890|0-14|All Races|Male and Female|2011|||
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|60623890|0-14|All Races|Male and Female|2011|||
6.6|7.9|7.2|436|VIII Malignant bone tumors|60623890|0-14|All Races|Male and Female|2011|||
3.6|4.6|4.1|245|VIII(a) Osteosarcomas|60623890|0-14|All Races|Male and Female|2011|||
~|~|~|~|VIII(b) Chondrosarcomas|60623890|0-14|All Races|Male and Female|2011|||
2.4|3.2|2.8|167|VIII(c) Ewing tumor and related sarcomas of bone|60623890|0-14|All Races|Male and Female|2011|||
~|~|~|~|VIII(d) Other specified malignant bone tumors|60623890|0-14|All Races|Male and Female|2011|||
~|~|~|~|VIII(e) Unspecified malignant bone tumors|60623890|0-14|All Races|Male and Female|2011|||
4.5|5.6|5.0|304|X Germ cell, trophoblastic tumors & neoplasms of gonads|60623890|0-14|All Races|Male and Female|2011|||
1.2|1.8|1.5|90|X(a) Intracranial & intraspinal germ cell tumors|60623890|0-14|All Races|Male and Female|2011|||
0.9|1.4|1.1|70|X(b) Malignant extracranial & extragonadal germ cell tumors|60623890|0-14|All Races|Male and Female|2011|||
1.8|2.6|2.2|131|X(c) Malignant gonadal germ cell tumors|60623890|0-14|All Races|Male and Female|2011|||
~|~|~|~|X(d) Gonadal carcinomas|60623890|0-14|All Races|Male and Female|2011|||
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|60623890|0-14|All Races|Male and Female|2011|||
7.0|8.4|7.7|465|XI Other malignant epithelial neoplasms and malignant melanomas|60623890|0-14|All Races|Male and Female|2011|||
~|~|~|~|XI(a) Adrenocortical carcinomas|60623890|0-14|All Races|Male and Female|2011|||
2.8|3.7|3.2|195|XI(b) Thyroid carcinomas|60623890|0-14|All Races|Male and Female|2011|||
0.2|0.5|0.3|19|XI(c) Nasopharyngeal carcinomas|60623890|0-14|All Races|Male and Female|2011|||
1.8|2.6|2.2|132|XI(d) Malignant melanomas|60623890|0-14|All Races|Male and Female|2011|||
~|~|~|~|XI(e) Skin carcinomas|60623890|0-14|All Races|Male and Female|2011|||
1.4|2.1|1.7|103|XI(f) Other and unspecified carcinomas|60623890|0-14|All Races|Male and Female|2011|||
0.5|0.9|0.7|42|XII Other and unspecified malignant neoplasms|60623890|0-14|All Races|Male and Female|2011|||
0.2|0.4|0.3|17|XII(a) Other specified malignant tumors|60623890|0-14|All Races|Male and Female|2011|||
0.3|0.6|0.4|25|XII(b) Other unspecified malignant tumors|60623890|0-14|All Races|Male and Female|2011|||
157.6|163.4|160.5|11678|All ICCC Groups Combined|72909327|0-19|All Races|Male and Female|1999|157.3|163.1|160.2
40.0|43.0|41.5|3022|I Leukemias, myeloproliferative & myelodysplastic diseases|72909327|0-19|All Races|Male and Female|1999|40.0|43.0|41.4
29.6|32.2|30.9|2253|I(a) Lymphoid leukemias|72909327|0-19|All Races|Male and Female|1999|29.6|32.2|30.9
7.5|8.8|8.1|592|I(b) Acute myeloid leukemias|72909327|0-19|All Races|Male and Female|1999|7.5|8.8|8.1
0.8|1.2|1.0|71|I(c) Chronic myeloproliferative diseases|72909327|0-19|All Races|Male and Female|1999|0.8|1.2|1.0
~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|72909327|0-19|All Races|Male and Female|1999|~|~|~
1.1|1.6|1.3|95|I(e) Unspecified and other specified leukemias|72909327|0-19|All Races|Male and Female|1999|1.1|1.6|1.3
22.6|24.8|23.7|1721|II Lymphomas and reticuloendothelial neoplasms|72909327|0-19|All Races|Male and Female|1999|22.5|24.7|23.6
11.3|12.9|12.1|878|II(a) Hodgkin lymphomas|72909327|0-19|All Races|Male and Female|1999|11.3|12.9|12.0
7.1|8.4|7.8|565|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|72909327|0-19|All Races|Male and Female|1999|7.1|8.4|7.7
2.1|2.8|2.4|179|II(c) Burkitt lymphoma|72909327|0-19|All Races|Male and Female|1999|2.1|2.8|2.5
0.5|1.0|0.7|53|II(d) Miscellaneous lymphoreticular neoplasms|72909327|0-19|All Races|Male and Female|1999|0.5|1.0|0.7
0.5|0.8|0.6|46|II(e) Unspecified lymphomas|72909327|0-19|All Races|Male and Female|1999|0.5|0.8|0.6
27.6|30.1|28.8|2105|III CNS and misc intracranial and intraspinal neoplasms|72909327|0-19|All Races|Male and Female|1999|27.7|30.1|28.9
2.3|3.0|2.6|190|III(a) Ependymomas and choroid plexus tumor|72909327|0-19|All Races|Male and Female|1999|2.2|3.0|2.6
12.8|14.6|13.7|998|III(b) Astrocytomas|72909327|0-19|All Races|Male and Female|1999|12.9|14.6|13.7
6.2|7.4|6.8|495|III(c) Intracranial and intraspinal embryonal tumors|72909327|0-19|All Races|Male and Female|1999|6.2|7.4|6.8
4.2|5.2|4.7|344|III(d) Other gliomas|72909327|0-19|All Races|Male and Female|1999|4.2|5.2|4.7
0.3|0.7|0.5|36|III(e) Other specified intracranial & intraspinal neoplasms|72909327|0-19|All Races|Male and Female|1999|0.3|0.7|0.5
0.4|0.8|0.6|42|III(f) Unspecified intracranial and intraspinal neoplasms|72909327|0-19|All Races|Male and Female|1999|0.4|0.8|0.6
7.6|8.9|8.2|594|IV Neuroblastoma and other peripheral nervous cell tumors|72909327|0-19|All Races|Male and Female|1999|7.5|8.8|8.1
7.3|8.6|7.9|573|IV(a) Neuroblastoma and ganglioneuroblastoma|72909327|0-19|All Races|Male and Female|1999|7.2|8.5|7.9
0.2|0.4|0.3|21|IV(b) Other peripheral nervous cell tumors|72909327|0-19|All Races|Male and Female|1999|0.2|0.4|0.3
10.2|11.7|10.9|794|IX Soft tissue and other extraosseous sarcomas|72909327|0-19|All Races|Male and Female|1999|10.1|11.7|10.9
4.1|5.1|4.6|336|IX(a) Rhabdomyosarcomas|72909327|0-19|All Races|Male and Female|1999|4.1|5.1|4.6
0.9|1.4|1.1|83|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|72909327|0-19|All Races|Male and Female|1999|0.9|1.4|1.1
~|~|~|~|IX(c) Kaposi sarcoma|72909327|0-19|All Races|Male and Female|1999|~|~|~
3.5|4.4|3.9|283|IX(d) Other specified soft tissue sarcomas|72909327|0-19|All Races|Male and Female|1999|3.4|4.4|3.9
1.0|1.5|1.2|89|IX(e) Unspecified soft tissue sarcomas|72909327|0-19|All Races|Male and Female|1999|1.0|1.5|1.2
0.2|0.5|0.3|22|Not classified by ICCC|72909327|0-19|All Races|Male and Female|1999|0.2|0.5|0.3
2.9|3.7|3.3|238|V Retinoblastoma|72909327|0-19|All Races|Male and Female|1999|2.9|3.7|3.3
5.8|7.0|6.4|463|VI Renal tumors|72909327|0-19|All Races|Male and Female|1999|5.8|7.0|6.4
5.2|6.4|5.8|420|VI(a) Nephroblastoma and other nonepithelial renal tumors|72909327|0-19|All Races|Male and Female|1999|5.2|6.3|5.8
0.4|0.7|0.5|39|VI(b) Renal carcinomas|72909327|0-19|All Races|Male and Female|1999|0.4|0.7|0.5
~|~|~|~|VI(c) Unspecified malignant renal tumors|72909327|0-19|All Races|Male and Female|1999|~|~|~
1.6|2.3|1.9|141|VII Hepatic tumors|72909327|0-19|All Races|Male and Female|1999|1.6|2.3|1.9
1.0|1.5|1.2|89|VII(a) Hepatoblastoma|72909327|0-19|All Races|Male and Female|1999|1.0|1.5|1.2
0.5|0.9|0.7|51|VII(b) Hepatic carcinomas|72909327|0-19|All Races|Male and Female|1999|0.5|0.9|0.7
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|72909327|0-19|All Races|Male and Female|1999|~|~|~
8.3|9.6|8.9|650|VIII Malignant bone tumors|72909327|0-19|All Races|Male and Female|1999|8.2|9.6|8.9
4.6|5.7|5.1|372|VIII(a) Osteosarcomas|72909327|0-19|All Races|Male and Female|1999|4.6|5.6|5.1
0.2|0.5|0.4|27|VIII(b) Chondrosarcomas|72909327|0-19|All Races|Male and Female|1999|0.2|0.5|0.4
2.4|3.2|2.8|203|VIII(c) Ewing tumor and related sarcomas of bone|72909327|0-19|All Races|Male and Female|1999|2.4|3.2|2.8
0.3|0.7|0.5|36|VIII(d) Other specified malignant bone tumors|72909327|0-19|All Races|Male and Female|1999|0.3|0.7|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|72909327|0-19|All Races|Male and Female|1999|~|~|~
9.6|11.0|10.3|746|X Germ cell, trophoblastic tumors & neoplasms of gonads|72909327|0-19|All Races|Male and Female|1999|9.5|11.0|10.2
1.2|1.7|1.4|104|X(a) Intracranial & intraspinal germ cell tumors|72909327|0-19|All Races|Male and Female|1999|1.2|1.7|1.4
1.1|1.7|1.4|99|X(b) Malignant extracranial & extragonadal germ cell tumors|72909327|0-19|All Races|Male and Female|1999|1.1|1.7|1.4
6.2|7.4|6.8|493|X(c) Malignant gonadal germ cell tumors|72909327|0-19|All Races|Male and Female|1999|6.2|7.4|6.8
0.3|0.6|0.4|32|X(d) Gonadal carcinomas|72909327|0-19|All Races|Male and Female|1999|0.3|0.6|0.4
0.1|0.4|0.2|18|X(e) Other and unspecified malignant gonadal tumors|72909327|0-19|All Races|Male and Female|1999|0.1|0.4|0.2
14.6|16.4|15.5|1122|XI Other malignant epithelial neoplasms and malignant melanomas|72909327|0-19|All Races|Male and Female|1999|14.5|16.3|15.4
0.1|0.4|0.2|17|XI(a) Adrenocortical carcinomas|72909327|0-19|All Races|Male and Female|1999|0.1|0.4|0.2
5.3|6.5|5.9|428|XI(b) Thyroid carcinomas|72909327|0-19|All Races|Male and Female|1999|5.3|6.5|5.9
0.4|0.7|0.5|37|XI(c) Nasopharyngeal carcinomas|72909327|0-19|All Races|Male and Female|1999|0.4|0.7|0.5
4.4|5.4|4.9|353|XI(d) Malignant melanomas|72909327|0-19|All Races|Male and Female|1999|4.3|5.4|4.8
~|~|~|~|XI(e) Skin carcinomas|72909327|0-19|All Races|Male and Female|1999|~|~|~
3.4|4.3|3.9|280|XI(f) Other and unspecified carcinomas|72909327|0-19|All Races|Male and Female|1999|3.4|4.3|3.8
0.6|1.1|0.8|60|XII Other and unspecified malignant neoplasms|72909327|0-19|All Races|Male and Female|1999|0.6|1.1|0.8
0.1|0.4|0.2|16|XII(a) Other specified malignant tumors|72909327|0-19|All Races|Male and Female|1999|0.1|0.4|0.2
0.4|0.8|0.6|44|XII(b) Other unspecified malignant tumors|72909327|0-19|All Races|Male and Female|1999|0.4|0.8|0.6
161.1|167.0|164.0|12317|All ICCC Groups Combined|75211310|0-19|All Races|Male and Female|2000|160.9|166.7|163.8
40.0|42.9|41.5|3107|I Leukemias, myeloproliferative & myelodysplastic diseases|75211310|0-19|All Races|Male and Female|2000|39.9|42.8|41.3
30.7|33.3|32.0|2396|I(a) Lymphoid leukemias|75211310|0-19|All Races|Male and Female|2000|30.6|33.2|31.9
6.5|7.7|7.1|532|I(b) Acute myeloid leukemias|75211310|0-19|All Races|Male and Female|2000|6.5|7.7|7.1
0.7|1.1|0.9|66|I(c) Chronic myeloproliferative diseases|75211310|0-19|All Races|Male and Female|2000|0.7|1.1|0.9
~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|75211310|0-19|All Races|Male and Female|2000|~|~|~
1.1|1.6|1.3|101|I(e) Unspecified and other specified leukemias|75211310|0-19|All Races|Male and Female|2000|1.1|1.6|1.3
23.9|26.1|25.0|1880|II Lymphomas and reticuloendothelial neoplasms|75211310|0-19|All Races|Male and Female|2000|23.9|26.2|25.0
11.6|13.2|12.3|929|II(a) Hodgkin lymphomas|75211310|0-19|All Races|Male and Female|2000|11.6|13.2|12.4
7.6|8.9|8.2|617|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|75211310|0-19|All Races|Male and Female|2000|7.6|8.9|8.2
2.4|3.1|2.7|207|II(c) Burkitt lymphoma|75211310|0-19|All Races|Male and Female|2000|2.4|3.2|2.8
0.8|1.3|1.0|76|II(d) Miscellaneous lymphoreticular neoplasms|75211310|0-19|All Races|Male and Female|2000|0.8|1.3|1.0
0.5|0.9|0.7|51|II(e) Unspecified lymphomas|75211310|0-19|All Races|Male and Female|2000|0.5|0.9|0.7
29.0|31.5|30.3|2275|III CNS and misc intracranial and intraspinal neoplasms|75211310|0-19|All Races|Male and Female|2000|29.0|31.5|30.2
2.0|2.8|2.4|178|III(a) Ependymomas and choroid plexus tumor|75211310|0-19|All Races|Male and Female|2000|2.0|2.7|2.4
14.9|16.7|15.8|1186|III(b) Astrocytomas|75211310|0-19|All Races|Male and Female|2000|14.9|16.7|15.8
6.0|7.1|6.5|491|III(c) Intracranial and intraspinal embryonal tumors|75211310|0-19|All Races|Male and Female|2000|6.0|7.1|6.5
4.0|5.0|4.5|337|III(d) Other gliomas|75211310|0-19|All Races|Male and Female|2000|4.0|5.0|4.5
0.3|0.6|0.4|33|III(e) Other specified intracranial & intraspinal neoplasms|75211310|0-19|All Races|Male and Female|2000|0.3|0.6|0.4
0.5|0.9|0.7|50|III(f) Unspecified intracranial and intraspinal neoplasms|75211310|0-19|All Races|Male and Female|2000|0.5|0.9|0.7
7.0|8.2|7.6|566|IV Neuroblastoma and other peripheral nervous cell tumors|75211310|0-19|All Races|Male and Female|2000|6.9|8.2|7.5
6.9|8.1|7.5|557|IV(a) Neuroblastoma and ganglioneuroblastoma|75211310|0-19|All Races|Male and Female|2000|6.8|8.0|7.4
~|~|~|~|IV(b) Other peripheral nervous cell tumors|75211310|0-19|All Races|Male and Female|2000|~|~|~
11.2|12.8|12.0|900|IX Soft tissue and other extraosseous sarcomas|75211310|0-19|All Races|Male and Female|2000|11.2|12.8|12.0
4.4|5.4|4.9|368|IX(a) Rhabdomyosarcomas|75211310|0-19|All Races|Male and Female|2000|4.4|5.4|4.9
1.0|1.5|1.2|90|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|75211310|0-19|All Races|Male and Female|2000|1.0|1.5|1.2
~|~|~|~|IX(c) Kaposi sarcoma|75211310|0-19|All Races|Male and Female|2000|~|~|~
4.0|4.9|4.4|333|IX(d) Other specified soft tissue sarcomas|75211310|0-19|All Races|Male and Female|2000|4.0|4.9|4.4
1.1|1.7|1.4|105|IX(e) Unspecified soft tissue sarcomas|75211310|0-19|All Races|Male and Female|2000|1.1|1.7|1.4
0.1|0.4|0.2|17|Not classified by ICCC|75211310|0-19|All Races|Male and Female|2000|0.1|0.4|0.2
2.9|3.7|3.3|245|V Retinoblastoma|75211310|0-19|All Races|Male and Female|2000|2.9|3.7|3.3
6.2|7.4|6.8|509|VI Renal tumors|75211310|0-19|All Races|Male and Female|2000|6.2|7.4|6.8
5.7|6.9|6.3|470|VI(a) Nephroblastoma and other nonepithelial renal tumors|75211310|0-19|All Races|Male and Female|2000|5.7|6.8|6.2
0.3|0.7|0.5|37|VI(b) Renal carcinomas|75211310|0-19|All Races|Male and Female|2000|0.3|0.7|0.5
~|~|~|~|VI(c) Unspecified malignant renal tumors|75211310|0-19|All Races|Male and Female|2000|~|~|~
1.5|2.2|1.8|137|VII Hepatic tumors|75211310|0-19|All Races|Male and Female|2000|1.5|2.2|1.8
1.2|1.8|1.5|110|VII(a) Hepatoblastoma|75211310|0-19|All Races|Male and Female|2000|1.2|1.8|1.5
0.2|0.5|0.4|27|VII(b) Hepatic carcinomas|75211310|0-19|All Races|Male and Female|2000|0.2|0.5|0.4
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|75211310|0-19|All Races|Male and Female|2000|~|~|~
7.8|9.2|8.5|639|VIII Malignant bone tumors|75211310|0-19|All Races|Male and Female|2000|7.9|9.2|8.5
4.3|5.3|4.8|359|VIII(a) Osteosarcomas|75211310|0-19|All Races|Male and Female|2000|4.3|5.3|4.8
~|~|~|~|VIII(b) Chondrosarcomas|75211310|0-19|All Races|Male and Female|2000|~|~|~
2.7|3.5|3.1|233|VIII(c) Ewing tumor and related sarcomas of bone|75211310|0-19|All Races|Male and Female|2000|2.7|3.5|3.1
0.1|0.4|0.2|18|VIII(d) Other specified malignant bone tumors|75211310|0-19|All Races|Male and Female|2000|0.1|0.4|0.2
0.1|0.3|0.2|16|VIII(e) Unspecified malignant bone tumors|75211310|0-19|All Races|Male and Female|2000|0.1|0.3|0.2
10.0|11.5|10.7|807|X Germ cell, trophoblastic tumors & neoplasms of gonads|75211310|0-19|All Races|Male and Female|2000|10.0|11.5|10.7
1.4|2.0|1.6|124|X(a) Intracranial & intraspinal germ cell tumors|75211310|0-19|All Races|Male and Female|2000|1.4|2.0|1.6
1.1|1.7|1.4|104|X(b) Malignant extracranial & extragonadal germ cell tumors|75211310|0-19|All Races|Male and Female|2000|1.1|1.7|1.4
6.4|7.7|7.0|529|X(c) Malignant gonadal germ cell tumors|75211310|0-19|All Races|Male and Female|2000|6.4|7.7|7.0
0.3|0.6|0.5|34|X(d) Gonadal carcinomas|75211310|0-19|All Races|Male and Female|2000|0.3|0.6|0.5
0.1|0.3|0.2|16|X(e) Other and unspecified malignant gonadal tumors|75211310|0-19|All Races|Male and Female|2000|0.1|0.3|0.2
14.7|16.5|15.6|1173|XI Other malignant epithelial neoplasms and malignant melanomas|75211310|0-19|All Races|Male and Female|2000|14.7|16.5|15.6
0.2|0.5|0.3|24|XI(a) Adrenocortical carcinomas|75211310|0-19|All Races|Male and Female|2000|0.2|0.5|0.3
5.1|6.2|5.7|426|XI(b) Thyroid carcinomas|75211310|0-19|All Races|Male and Female|2000|5.1|6.2|5.7
0.4|0.7|0.5|40|XI(c) Nasopharyngeal carcinomas|75211310|0-19|All Races|Male and Female|2000|0.4|0.7|0.5
4.6|5.6|5.1|383|XI(d) Malignant melanomas|75211310|0-19|All Races|Male and Female|2000|4.6|5.6|5.1
~|~|~|~|XI(e) Skin carcinomas|75211310|0-19|All Races|Male and Female|2000|~|~|~
3.5|4.4|3.9|294|XI(f) Other and unspecified carcinomas|75211310|0-19|All Races|Male and Female|2000|3.5|4.4|3.9
0.6|1.1|0.8|62|XII Other and unspecified malignant neoplasms|75211310|0-19|All Races|Male and Female|2000|0.6|1.1|0.8
~|~|~|~|XII(a) Other specified malignant tumors|75211310|0-19|All Races|Male and Female|2000|~|~|~
0.5|0.8|0.6|47|XII(b) Other unspecified malignant tumors|75211310|0-19|All Races|Male and Female|2000|0.5|0.8|0.6
169.3|175.3|172.3|12867|All ICCC Groups Combined|74693573|0-19|All Races|Male and Female|2001|169.3|175.3|172.3
44.8|47.9|46.3|3442|I Leukemias, myeloproliferative & myelodysplastic diseases|74693573|0-19|All Races|Male and Female|2001|44.6|47.6|46.1
32.3|34.9|33.6|2487|I(a) Lymphoid leukemias|74693573|0-19|All Races|Male and Female|2001|32.0|34.6|33.3
7.2|8.4|7.8|582|I(b) Acute myeloid leukemias|74693573|0-19|All Races|Male and Female|2001|7.2|8.5|7.8
1.9|2.6|2.2|166|I(c) Chronic myeloproliferative diseases|74693573|0-19|All Races|Male and Female|2001|1.9|2.6|2.2
1.2|1.8|1.5|113|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|74693573|0-19|All Races|Male and Female|2001|1.2|1.8|1.5
1.0|1.5|1.3|94|I(e) Unspecified and other specified leukemias|74693573|0-19|All Races|Male and Female|2001|1.0|1.5|1.3
23.9|26.2|25.0|1877|II Lymphomas and reticuloendothelial neoplasms|74693573|0-19|All Races|Male and Female|2001|24.0|26.3|25.1
11.9|13.5|12.7|951|II(a) Hodgkin lymphomas|74693573|0-19|All Races|Male and Female|2001|11.9|13.6|12.7
8.2|9.6|8.9|668|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|74693573|0-19|All Races|Male and Female|2001|8.3|9.6|8.9
1.9|2.5|2.2|163|II(c) Burkitt lymphoma|74693573|0-19|All Races|Male and Female|2001|1.9|2.5|2.2
0.6|1.0|0.8|60|II(d) Miscellaneous lymphoreticular neoplasms|74693573|0-19|All Races|Male and Female|2001|0.6|1.0|0.8
0.3|0.6|0.5|35|II(e) Unspecified lymphomas|74693573|0-19|All Races|Male and Female|2001|0.3|0.7|0.5
29.0|31.5|30.2|2253|III CNS and misc intracranial and intraspinal neoplasms|74693573|0-19|All Races|Male and Female|2001|28.9|31.4|30.2
2.1|2.9|2.5|184|III(a) Ependymomas and choroid plexus tumor|74693573|0-19|All Races|Male and Female|2001|2.1|2.8|2.5
14.3|16.0|15.1|1127|III(b) Astrocytomas|74693573|0-19|All Races|Male and Female|2001|14.2|16.0|15.1
6.0|7.2|6.6|491|III(c) Intracranial and intraspinal embryonal tumors|74693573|0-19|All Races|Male and Female|2001|6.0|7.2|6.6
4.6|5.6|5.1|378|III(d) Other gliomas|74693573|0-19|All Races|Male and Female|2001|4.6|5.6|5.1
0.4|0.8|0.6|44|III(e) Other specified intracranial & intraspinal neoplasms|74693573|0-19|All Races|Male and Female|2001|0.4|0.8|0.6
0.3|0.6|0.4|29|III(f) Unspecified intracranial and intraspinal neoplasms|74693573|0-19|All Races|Male and Female|2001|0.3|0.6|0.4
8.3|9.7|9.0|671|IV Neuroblastoma and other peripheral nervous cell tumors|74693573|0-19|All Races|Male and Female|2001|8.3|9.7|9.0
8.2|9.5|8.8|659|IV(a) Neuroblastoma and ganglioneuroblastoma|74693573|0-19|All Races|Male and Female|2001|8.2|9.5|8.8
~|~|~|~|IV(b) Other peripheral nervous cell tumors|74693573|0-19|All Races|Male and Female|2001|~|~|~
11.3|12.8|12.0|900|IX Soft tissue and other extraosseous sarcomas|74693573|0-19|All Races|Male and Female|2001|11.3|12.9|12.0
4.6|5.6|5.1|376|IX(a) Rhabdomyosarcomas|74693573|0-19|All Races|Male and Female|2001|4.5|5.6|5.0
1.2|1.7|1.4|109|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|74693573|0-19|All Races|Male and Female|2001|1.2|1.8|1.5
~|~|~|~|IX(c) Kaposi sarcoma|74693573|0-19|All Races|Male and Female|2001|~|~|~
3.7|4.7|4.2|314|IX(d) Other specified soft tissue sarcomas|74693573|0-19|All Races|Male and Female|2001|3.8|4.7|4.2
1.1|1.6|1.3|98|IX(e) Unspecified soft tissue sarcomas|74693573|0-19|All Races|Male and Female|2001|1.1|1.6|1.3
0.2|0.4|0.3|22|Not classified by ICCC|74693573|0-19|All Races|Male and Female|2001|0.2|0.4|0.3
2.9|3.7|3.3|244|V Retinoblastoma|74693573|0-19|All Races|Male and Female|2001|2.9|3.7|3.3
6.2|7.4|6.8|503|VI Renal tumors|74693573|0-19|All Races|Male and Female|2001|6.2|7.3|6.7
5.7|6.8|6.2|460|VI(a) Nephroblastoma and other nonepithelial renal tumors|74693573|0-19|All Races|Male and Female|2001|5.6|6.7|6.2
0.4|0.7|0.5|41|VI(b) Renal carcinomas|74693573|0-19|All Races|Male and Female|2001|0.4|0.7|0.5
~|~|~|~|VI(c) Unspecified malignant renal tumors|74693573|0-19|All Races|Male and Female|2001|~|~|~
1.5|2.2|1.8|136|VII Hepatic tumors|74693573|0-19|All Races|Male and Female|2001|1.5|2.2|1.8
1.0|1.6|1.3|95|VII(a) Hepatoblastoma|74693573|0-19|All Races|Male and Female|2001|1.0|1.6|1.3
0.4|0.7|0.5|40|VII(b) Hepatic carcinomas|74693573|0-19|All Races|Male and Female|2001|0.4|0.7|0.5
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|74693573|0-19|All Races|Male and Female|2001|~|~|~
8.9|10.3|9.6|718|VIII Malignant bone tumors|74693573|0-19|All Races|Male and Female|2001|8.9|10.3|9.6
4.7|5.7|5.2|388|VIII(a) Osteosarcomas|74693573|0-19|All Races|Male and Female|2001|4.7|5.7|5.2
0.2|0.5|0.4|27|VIII(b) Chondrosarcomas|74693573|0-19|All Races|Male and Female|2001|0.2|0.5|0.4
3.1|3.9|3.5|261|VIII(c) Ewing tumor and related sarcomas of bone|74693573|0-19|All Races|Male and Female|2001|3.1|3.9|3.5
0.3|0.6|0.4|32|VIII(d) Other specified malignant bone tumors|74693573|0-19|All Races|Male and Female|2001|0.3|0.6|0.4
~|~|~|~|VIII(e) Unspecified malignant bone tumors|74693573|0-19|All Races|Male and Female|2001|~|~|~
9.8|11.3|10.6|795|X Germ cell, trophoblastic tumors & neoplasms of gonads|74693573|0-19|All Races|Male and Female|2001|9.9|11.4|10.6
1.3|1.9|1.6|121|X(a) Intracranial & intraspinal germ cell tumors|74693573|0-19|All Races|Male and Female|2001|1.3|1.9|1.6
1.3|1.9|1.6|122|X(b) Malignant extracranial & extragonadal germ cell tumors|74693573|0-19|All Races|Male and Female|2001|1.4|2.0|1.6
6.1|7.3|6.7|504|X(c) Malignant gonadal germ cell tumors|74693573|0-19|All Races|Male and Female|2001|6.2|7.4|6.7
0.2|0.5|0.3|26|X(d) Gonadal carcinomas|74693573|0-19|All Races|Male and Female|2001|0.2|0.5|0.3
0.2|0.4|0.3|22|X(e) Other and unspecified malignant gonadal tumors|74693573|0-19|All Races|Male and Female|2001|0.2|0.4|0.3
15.6|17.5|16.5|1242|XI Other malignant epithelial neoplasms and malignant melanomas|74693573|0-19|All Races|Male and Female|2001|15.7|17.6|16.6
0.1|0.3|0.2|16|XI(a) Adrenocortical carcinomas|74693573|0-19|All Races|Male and Female|2001|0.1|0.3|0.2
5.2|6.3|5.8|434|XI(b) Thyroid carcinomas|74693573|0-19|All Races|Male and Female|2001|5.3|6.4|5.8
0.4|0.8|0.6|43|XI(c) Nasopharyngeal carcinomas|74693573|0-19|All Races|Male and Female|2001|0.4|0.8|0.6
5.3|6.4|5.8|439|XI(d) Malignant melanomas|74693573|0-19|All Races|Male and Female|2001|5.3|6.5|5.9
~|~|~|~|XI(e) Skin carcinomas|74693573|0-19|All Races|Male and Female|2001|~|~|~
3.6|4.5|4.1|305|XI(f) Other and unspecified carcinomas|74693573|0-19|All Races|Male and Female|2001|3.6|4.6|4.1
0.7|1.1|0.9|64|XII Other and unspecified malignant neoplasms|74693573|0-19|All Races|Male and Female|2001|0.7|1.1|0.9
0.2|0.5|0.4|28|XII(a) Other specified malignant tumors|74693573|0-19|All Races|Male and Female|2001|0.2|0.5|0.4
0.3|0.7|0.5|36|XII(b) Other unspecified malignant tumors|74693573|0-19|All Races|Male and Female|2001|0.3|0.7|0.5
168.6|174.6|171.6|13026|All ICCC Groups Combined|75875139|0-19|All Races|Male and Female|2002|168.7|174.7|171.7
43.7|46.7|45.2|3411|I Leukemias, myeloproliferative & myelodysplastic diseases|75875139|0-19|All Races|Male and Female|2002|43.5|46.5|45.0
30.8|33.4|32.1|2417|I(a) Lymphoid leukemias|75875139|0-19|All Races|Male and Female|2002|30.6|33.2|31.9
7.6|9.0|8.3|630|I(b) Acute myeloid leukemias|75875139|0-19|All Races|Male and Female|2002|7.7|9.0|8.3
1.8|2.4|2.1|159|I(c) Chronic myeloproliferative diseases|75875139|0-19|All Races|Male and Female|2002|1.8|2.4|2.1
1.3|1.8|1.5|116|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|75875139|0-19|All Races|Male and Female|2002|1.3|1.8|1.5
0.9|1.5|1.2|89|I(e) Unspecified and other specified leukemias|75875139|0-19|All Races|Male and Female|2002|0.9|1.4|1.2
23.3|25.5|24.4|1864|II Lymphomas and reticuloendothelial neoplasms|75875139|0-19|All Races|Male and Female|2002|23.5|25.7|24.6
11.4|13.0|12.2|934|II(a) Hodgkin lymphomas|75875139|0-19|All Races|Male and Female|2002|11.5|13.1|12.3
7.6|9.0|8.3|631|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|75875139|0-19|All Races|Male and Female|2002|7.7|9.0|8.3
2.4|3.1|2.7|207|II(c) Burkitt lymphoma|75875139|0-19|All Races|Male and Female|2002|2.4|3.1|2.7
0.7|1.1|0.9|66|II(d) Miscellaneous lymphoreticular neoplasms|75875139|0-19|All Races|Male and Female|2002|0.7|1.1|0.9
0.2|0.5|0.3|26|II(e) Unspecified lymphomas|75875139|0-19|All Races|Male and Female|2002|0.2|0.5|0.3
30.3|32.8|31.5|2382|III CNS and misc intracranial and intraspinal neoplasms|75875139|0-19|All Races|Male and Female|2002|30.1|32.7|31.4
2.6|3.4|3.0|227|III(a) Ependymomas and choroid plexus tumor|75875139|0-19|All Races|Male and Female|2002|2.6|3.4|3.0
14.4|16.2|15.3|1158|III(b) Astrocytomas|75875139|0-19|All Races|Male and Female|2002|14.4|16.2|15.3
5.9|7.1|6.5|488|III(c) Intracranial and intraspinal embryonal tumors|75875139|0-19|All Races|Male and Female|2002|5.9|7.0|6.4
5.1|6.2|5.6|424|III(d) Other gliomas|75875139|0-19|All Races|Male and Female|2002|5.1|6.1|5.6
0.5|0.9|0.7|55|III(e) Other specified intracranial & intraspinal neoplasms|75875139|0-19|All Races|Male and Female|2002|0.5|0.9|0.7
0.3|0.6|0.4|30|III(f) Unspecified intracranial and intraspinal neoplasms|75875139|0-19|All Races|Male and Female|2002|0.3|0.6|0.4
7.8|9.1|8.4|638|IV Neuroblastoma and other peripheral nervous cell tumors|75875139|0-19|All Races|Male and Female|2002|7.8|9.1|8.4
7.6|8.9|8.2|620|IV(a) Neuroblastoma and ganglioneuroblastoma|75875139|0-19|All Races|Male and Female|2002|7.5|8.8|8.2
0.1|0.4|0.2|18|IV(b) Other peripheral nervous cell tumors|75875139|0-19|All Races|Male and Female|2002|0.1|0.4|0.2
11.2|12.7|11.9|906|IX Soft tissue and other extraosseous sarcomas|75875139|0-19|All Races|Male and Female|2002|11.2|12.7|11.9
4.5|5.5|5.0|374|IX(a) Rhabdomyosarcomas|75875139|0-19|All Races|Male and Female|2002|4.4|5.5|4.9
1.0|1.5|1.2|93|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|75875139|0-19|All Races|Male and Female|2002|1.0|1.5|1.2
~|~|~|~|IX(c) Kaposi sarcoma|75875139|0-19|All Races|Male and Female|2002|~|~|~
4.3|5.3|4.7|363|IX(d) Other specified soft tissue sarcomas|75875139|0-19|All Races|Male and Female|2002|4.3|5.3|4.8
0.8|1.2|1.0|76|IX(e) Unspecified soft tissue sarcomas|75875139|0-19|All Races|Male and Female|2002|0.8|1.3|1.0
0.2|0.5|0.3|24|Not classified by ICCC|75875139|0-19|All Races|Male and Female|2002|0.2|0.5|0.3
2.4|3.2|2.8|211|V Retinoblastoma|75875139|0-19|All Races|Male and Female|2002|2.4|3.2|2.8
5.9|7.1|6.5|488|VI Renal tumors|75875139|0-19|All Races|Male and Female|2002|5.9|7.0|6.4
5.5|6.6|6.0|454|VI(a) Nephroblastoma and other nonepithelial renal tumors|75875139|0-19|All Races|Male and Female|2002|5.4|6.6|6.0
0.3|0.6|0.4|33|VI(b) Renal carcinomas|75875139|0-19|All Races|Male and Female|2002|0.3|0.6|0.4
~|~|~|~|VI(c) Unspecified malignant renal tumors|75875139|0-19|All Races|Male and Female|2002|~|~|~
1.4|2.0|1.7|129|VII Hepatic tumors|75875139|0-19|All Races|Male and Female|2002|1.4|2.0|1.7
1.0|1.5|1.2|90|VII(a) Hepatoblastoma|75875139|0-19|All Races|Male and Female|2002|1.0|1.5|1.2
0.4|0.7|0.5|38|VII(b) Hepatic carcinomas|75875139|0-19|All Races|Male and Female|2002|0.4|0.7|0.5
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|75875139|0-19|All Races|Male and Female|2002|~|~|~
8.6|10.0|9.3|709|VIII Malignant bone tumors|75875139|0-19|All Races|Male and Female|2002|8.7|10.1|9.3
4.5|5.5|5.0|381|VIII(a) Osteosarcomas|75875139|0-19|All Races|Male and Female|2002|4.5|5.6|5.0
0.3|0.7|0.5|37|VIII(b) Chondrosarcomas|75875139|0-19|All Races|Male and Female|2002|0.3|0.7|0.5
2.7|3.5|3.1|238|VIII(c) Ewing tumor and related sarcomas of bone|75875139|0-19|All Races|Male and Female|2002|2.8|3.6|3.1
0.4|0.7|0.5|41|VIII(d) Other specified malignant bone tumors|75875139|0-19|All Races|Male and Female|2002|0.4|0.7|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|75875139|0-19|All Races|Male and Female|2002|~|~|~
10.5|12.0|11.2|860|X Germ cell, trophoblastic tumors & neoplasms of gonads|75875139|0-19|All Races|Male and Female|2002|10.6|12.1|11.3
1.4|2.0|1.7|129|X(a) Intracranial & intraspinal germ cell tumors|75875139|0-19|All Races|Male and Female|2002|1.4|2.0|1.7
1.3|1.9|1.6|123|X(b) Malignant extracranial & extragonadal germ cell tumors|75875139|0-19|All Races|Male and Female|2002|1.3|1.9|1.6
6.7|8.0|7.3|560|X(c) Malignant gonadal germ cell tumors|75875139|0-19|All Races|Male and Female|2002|6.8|8.0|7.4
0.2|0.5|0.3|24|X(d) Gonadal carcinomas|75875139|0-19|All Races|Male and Female|2002|0.2|0.5|0.3
0.2|0.5|0.3|24|X(e) Other and unspecified malignant gonadal tumors|75875139|0-19|All Races|Male and Female|2002|0.2|0.5|0.3
16.5|18.3|17.4|1332|XI Other malignant epithelial neoplasms and malignant melanomas|75875139|0-19|All Races|Male and Female|2002|16.6|18.5|17.6
0.2|0.4|0.3|19|XI(a) Adrenocortical carcinomas|75875139|0-19|All Races|Male and Female|2002|0.2|0.4|0.3
5.2|6.2|5.7|435|XI(b) Thyroid carcinomas|75875139|0-19|All Races|Male and Female|2002|5.2|6.3|5.7
0.5|0.8|0.6|48|XI(c) Nasopharyngeal carcinomas|75875139|0-19|All Races|Male and Female|2002|0.5|0.8|0.6
6.1|7.3|6.7|512|XI(d) Malignant melanomas|75875139|0-19|All Races|Male and Female|2002|6.2|7.4|6.7
~|~|~|~|XI(e) Skin carcinomas|75875139|0-19|All Races|Male and Female|2002|~|~|~
3.6|4.5|4.0|310|XI(f) Other and unspecified carcinomas|75875139|0-19|All Races|Male and Female|2002|3.6|4.6|4.1
0.7|1.2|0.9|72|XII Other and unspecified malignant neoplasms|75875139|0-19|All Races|Male and Female|2002|0.7|1.2|0.9
0.3|0.7|0.5|37|XII(a) Other specified malignant tumors|75875139|0-19|All Races|Male and Female|2002|0.3|0.7|0.5
0.3|0.6|0.5|35|XII(b) Other unspecified malignant tumors|75875139|0-19|All Races|Male and Female|2002|0.3|0.6|0.5
164.3|170.0|167.1|13381|All ICCC Groups Combined|79843536|0-19|All Races|Male and Female|2003|164.8|170.5|167.6
42.0|44.9|43.4|3454|I Leukemias, myeloproliferative & myelodysplastic diseases|79843536|0-19|All Races|Male and Female|2003|41.8|44.7|43.3
29.7|32.1|30.9|2445|I(a) Lymphoid leukemias|79843536|0-19|All Races|Male and Female|2003|29.4|31.9|30.6
7.1|8.4|7.7|621|I(b) Acute myeloid leukemias|79843536|0-19|All Races|Male and Female|2003|7.2|8.4|7.8
1.9|2.6|2.2|178|I(c) Chronic myeloproliferative diseases|79843536|0-19|All Races|Male and Female|2003|1.9|2.6|2.2
1.4|1.9|1.6|130|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|79843536|0-19|All Races|Male and Female|2003|1.4|1.9|1.6
0.8|1.2|1.0|80|I(e) Unspecified and other specified leukemias|79843536|0-19|All Races|Male and Female|2003|0.8|1.2|1.0
23.0|25.1|24.1|1936|II Lymphomas and reticuloendothelial neoplasms|79843536|0-19|All Races|Male and Female|2003|23.2|25.4|24.2
11.6|13.1|12.4|1000|II(a) Hodgkin lymphomas|79843536|0-19|All Races|Male and Female|2003|11.8|13.3|12.5
7.4|8.7|8.0|645|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|79843536|0-19|All Races|Male and Female|2003|7.5|8.7|8.1
2.3|3.0|2.6|206|II(c) Burkitt lymphoma|79843536|0-19|All Races|Male and Female|2003|2.2|3.0|2.6
0.7|1.1|0.9|68|II(d) Miscellaneous lymphoreticular neoplasms|79843536|0-19|All Races|Male and Female|2003|0.7|1.1|0.9
0.1|0.3|0.2|17|II(e) Unspecified lymphomas|79843536|0-19|All Races|Male and Female|2003|0.1|0.3|0.2
28.8|31.2|30.0|2389|III CNS and misc intracranial and intraspinal neoplasms|79843536|0-19|All Races|Male and Female|2003|28.7|31.1|29.9
2.0|2.7|2.3|187|III(a) Ependymomas and choroid plexus tumor|79843536|0-19|All Races|Male and Female|2003|2.0|2.7|2.3
14.4|16.1|15.2|1212|III(b) Astrocytomas|79843536|0-19|All Races|Male and Female|2003|14.3|16.1|15.2
5.6|6.7|6.1|486|III(c) Intracranial and intraspinal embryonal tumors|79843536|0-19|All Races|Male and Female|2003|5.6|6.7|6.1
4.7|5.7|5.2|413|III(d) Other gliomas|79843536|0-19|All Races|Male and Female|2003|4.7|5.7|5.2
0.6|1.0|0.8|63|III(e) Other specified intracranial & intraspinal neoplasms|79843536|0-19|All Races|Male and Female|2003|0.6|1.0|0.8
0.2|0.5|0.3|28|III(f) Unspecified intracranial and intraspinal neoplasms|79843536|0-19|All Races|Male and Female|2003|0.2|0.5|0.4
7.5|8.8|8.1|649|IV Neuroblastoma and other peripheral nervous cell tumors|79843536|0-19|All Races|Male and Female|2003|7.5|8.8|8.1
7.4|8.6|8.0|636|IV(a) Neuroblastoma and ganglioneuroblastoma|79843536|0-19|All Races|Male and Female|2003|7.4|8.6|8.0
~|~|~|~|IV(b) Other peripheral nervous cell tumors|79843536|0-19|All Races|Male and Female|2003|~|~|~
11.3|12.9|12.1|969|IX Soft tissue and other extraosseous sarcomas|79843536|0-19|All Races|Male and Female|2003|11.4|12.9|12.1
4.3|5.3|4.8|382|IX(a) Rhabdomyosarcomas|79843536|0-19|All Races|Male and Female|2003|4.3|5.3|4.8
1.2|1.7|1.4|114|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|79843536|0-19|All Races|Male and Female|2003|1.2|1.7|1.4
~|~|~|~|IX(c) Kaposi sarcoma|79843536|0-19|All Races|Male and Female|2003|~|~|~
4.1|5.1|4.6|371|IX(d) Other specified soft tissue sarcomas|79843536|0-19|All Races|Male and Female|2003|4.2|5.1|4.6
1.0|1.5|1.2|99|IX(e) Unspecified soft tissue sarcomas|79843536|0-19|All Races|Male and Female|2003|1.0|1.5|1.2
0.2|0.4|0.3|22|Not classified by ICCC|79843536|0-19|All Races|Male and Female|2003|0.2|0.4|0.3
2.6|3.4|3.0|240|V Retinoblastoma|79843536|0-19|All Races|Male and Female|2003|2.6|3.4|3.0
6.2|7.3|6.7|532|VI Renal tumors|79843536|0-19|All Races|Male and Female|2003|6.1|7.3|6.7
5.6|6.7|6.1|485|VI(a) Nephroblastoma and other nonepithelial renal tumors|79843536|0-19|All Races|Male and Female|2003|5.5|6.6|6.1
0.4|0.7|0.5|43|VI(b) Renal carcinomas|79843536|0-19|All Races|Male and Female|2003|0.4|0.7|0.5
~|~|~|~|VI(c) Unspecified malignant renal tumors|79843536|0-19|All Races|Male and Female|2003|~|~|~
1.8|2.5|2.1|172|VII Hepatic tumors|79843536|0-19|All Races|Male and Female|2003|1.8|2.5|2.2
1.3|1.8|1.5|123|VII(a) Hepatoblastoma|79843536|0-19|All Races|Male and Female|2003|1.3|1.8|1.5
0.4|0.8|0.6|49|VII(b) Hepatic carcinomas|79843536|0-19|All Races|Male and Female|2003|0.5|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|79843536|0-19|All Races|Male and Female|2003|~|~|~
8.1|9.4|8.7|704|VIII Malignant bone tumors|79843536|0-19|All Races|Male and Female|2003|8.2|9.5|8.8
4.8|5.8|5.3|430|VIII(a) Osteosarcomas|79843536|0-19|All Races|Male and Female|2003|4.9|5.9|5.4
0.2|0.4|0.2|20|VIII(b) Chondrosarcomas|79843536|0-19|All Races|Male and Female|2003|0.2|0.4|0.3
2.3|3.0|2.6|210|VIII(c) Ewing tumor and related sarcomas of bone|79843536|0-19|All Races|Male and Female|2003|2.3|3.0|2.6
0.2|0.5|0.3|27|VIII(d) Other specified malignant bone tumors|79843536|0-19|All Races|Male and Female|2003|0.2|0.5|0.3
0.1|0.3|0.2|17|VIII(e) Unspecified malignant bone tumors|79843536|0-19|All Races|Male and Female|2003|0.1|0.3|0.2
9.6|11.0|10.3|832|X Germ cell, trophoblastic tumors & neoplasms of gonads|79843536|0-19|All Races|Male and Female|2003|9.7|11.2|10.4
1.1|1.6|1.4|110|X(a) Intracranial & intraspinal germ cell tumors|79843536|0-19|All Races|Male and Female|2003|1.1|1.7|1.4
1.2|1.7|1.4|116|X(b) Malignant extracranial & extragonadal germ cell tumors|79843536|0-19|All Races|Male and Female|2003|1.2|1.7|1.5
6.2|7.3|6.7|546|X(c) Malignant gonadal germ cell tumors|79843536|0-19|All Races|Male and Female|2003|6.3|7.4|6.8
0.2|0.5|0.4|30|X(d) Gonadal carcinomas|79843536|0-19|All Races|Male and Female|2003|0.3|0.5|0.4
0.2|0.5|0.4|30|X(e) Other and unspecified malignant gonadal tumors|79843536|0-19|All Races|Male and Female|2003|0.3|0.5|0.4
16.3|18.1|17.2|1397|XI Other malignant epithelial neoplasms and malignant melanomas|79843536|0-19|All Races|Male and Female|2003|16.6|18.4|17.5
0.2|0.4|0.2|20|XI(a) Adrenocortical carcinomas|79843536|0-19|All Races|Male and Female|2003|0.2|0.4|0.3
5.5|6.6|6.0|491|XI(b) Thyroid carcinomas|79843536|0-19|All Races|Male and Female|2003|5.6|6.7|6.1
0.5|0.9|0.7|53|XI(c) Nasopharyngeal carcinomas|79843536|0-19|All Races|Male and Female|2003|0.5|0.9|0.7
5.4|6.5|5.9|481|XI(d) Malignant melanomas|79843536|0-19|All Races|Male and Female|2003|5.5|6.6|6.0
~|~|~|~|XI(e) Skin carcinomas|79843536|0-19|All Races|Male and Female|2003|~|~|~
3.8|4.7|4.2|344|XI(f) Other and unspecified carcinomas|79843536|0-19|All Races|Male and Female|2003|3.9|4.8|4.3
0.8|1.3|1.1|85|XII Other and unspecified malignant neoplasms|79843536|0-19|All Races|Male and Female|2003|0.9|1.3|1.1
0.3|0.6|0.5|38|XII(a) Other specified malignant tumors|79843536|0-19|All Races|Male and Female|2003|0.3|0.7|0.5
0.4|0.8|0.6|47|XII(b) Other unspecified malignant tumors|79843536|0-19|All Races|Male and Female|2003|0.4|0.8|0.6
170.5|176.3|173.4|14246|All ICCC Groups Combined|81754354|0-19|All Races|Male and Female|2004|171.4|177.1|174.3
44.5|47.5|46.0|3750|I Leukemias, myeloproliferative & myelodysplastic diseases|81754354|0-19|All Races|Male and Female|2004|44.4|47.4|45.9
31.9|34.4|33.1|2692|I(a) Lymphoid leukemias|81754354|0-19|All Races|Male and Female|2004|31.7|34.2|32.9
7.6|8.8|8.2|675|I(b) Acute myeloid leukemias|81754354|0-19|All Races|Male and Female|2004|7.6|8.9|8.3
1.7|2.4|2.0|169|I(c) Chronic myeloproliferative diseases|81754354|0-19|All Races|Male and Female|2004|1.8|2.4|2.1
1.1|1.6|1.4|111|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|81754354|0-19|All Races|Male and Female|2004|1.1|1.6|1.4
1.0|1.5|1.3|103|I(e) Unspecified and other specified leukemias|81754354|0-19|All Races|Male and Female|2004|1.0|1.5|1.3
23.1|25.2|24.1|1995|II Lymphomas and reticuloendothelial neoplasms|81754354|0-19|All Races|Male and Female|2004|23.3|25.5|24.4
11.1|12.6|11.8|985|II(a) Hodgkin lymphomas|81754354|0-19|All Races|Male and Female|2004|11.3|12.8|12.0
7.9|9.2|8.5|704|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|81754354|0-19|All Races|Male and Female|2004|8.0|9.3|8.6
2.0|2.7|2.4|192|II(c) Burkitt lymphoma|81754354|0-19|All Races|Male and Female|2004|2.0|2.7|2.3
0.9|1.3|1.1|87|II(d) Miscellaneous lymphoreticular neoplasms|81754354|0-19|All Races|Male and Female|2004|0.9|1.3|1.1
0.2|0.5|0.3|27|II(e) Unspecified lymphomas|81754354|0-19|All Races|Male and Female|2004|0.2|0.5|0.3
30.5|33.0|31.8|2585|III CNS and misc intracranial and intraspinal neoplasms|81754354|0-19|All Races|Male and Female|2004|30.4|32.9|31.6
2.4|3.1|2.7|221|III(a) Ependymomas and choroid plexus tumor|81754354|0-19|All Races|Male and Female|2004|2.4|3.1|2.7
15.3|17.0|16.1|1316|III(b) Astrocytomas|81754354|0-19|All Races|Male and Female|2004|15.2|17.0|16.1
6.0|7.2|6.6|533|III(c) Intracranial and intraspinal embryonal tumors|81754354|0-19|All Races|Male and Female|2004|6.0|7.1|6.5
4.6|5.6|5.1|415|III(d) Other gliomas|81754354|0-19|All Races|Male and Female|2004|4.6|5.6|5.1
0.5|0.9|0.7|59|III(e) Other specified intracranial & intraspinal neoplasms|81754354|0-19|All Races|Male and Female|2004|0.5|0.9|0.7
0.4|0.7|0.5|41|III(f) Unspecified intracranial and intraspinal neoplasms|81754354|0-19|All Races|Male and Female|2004|0.4|0.7|0.5
7.8|9.1|8.4|691|IV Neuroblastoma and other peripheral nervous cell tumors|81754354|0-19|All Races|Male and Female|2004|7.8|9.1|8.5
7.6|8.8|8.2|669|IV(a) Neuroblastoma and ganglioneuroblastoma|81754354|0-19|All Races|Male and Female|2004|7.6|8.8|8.2
0.2|0.4|0.3|22|IV(b) Other peripheral nervous cell tumors|81754354|0-19|All Races|Male and Female|2004|0.2|0.4|0.3
11.3|12.8|12.1|994|IX Soft tissue and other extraosseous sarcomas|81754354|0-19|All Races|Male and Female|2004|11.4|12.9|12.2
3.9|4.8|4.3|355|IX(a) Rhabdomyosarcomas|81754354|0-19|All Races|Male and Female|2004|3.9|4.8|4.3
1.1|1.6|1.4|113|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|81754354|0-19|All Races|Male and Female|2004|1.1|1.7|1.4
~|~|~|~|IX(c) Kaposi sarcoma|81754354|0-19|All Races|Male and Female|2004|~|~|~
4.6|5.6|5.1|422|IX(d) Other specified soft tissue sarcomas|81754354|0-19|All Races|Male and Female|2004|4.7|5.7|5.2
1.0|1.5|1.2|101|IX(e) Unspecified soft tissue sarcomas|81754354|0-19|All Races|Male and Female|2004|1.0|1.5|1.2
0.2|0.5|0.3|26|Not classified by ICCC|81754354|0-19|All Races|Male and Female|2004|0.2|0.5|0.3
2.8|3.6|3.2|265|V Retinoblastoma|81754354|0-19|All Races|Male and Female|2004|2.9|3.7|3.2
6.0|7.1|6.5|528|VI Renal tumors|81754354|0-19|All Races|Male and Female|2004|5.9|7.0|6.5
5.4|6.5|5.9|480|VI(a) Nephroblastoma and other nonepithelial renal tumors|81754354|0-19|All Races|Male and Female|2004|5.4|6.4|5.9
0.4|0.7|0.5|45|VI(b) Renal carcinomas|81754354|0-19|All Races|Male and Female|2004|0.4|0.7|0.6
~|~|~|~|VI(c) Unspecified malignant renal tumors|81754354|0-19|All Races|Male and Female|2004|~|~|~
2.1|2.8|2.4|198|VII Hepatic tumors|81754354|0-19|All Races|Male and Female|2004|2.1|2.8|2.4
1.5|2.1|1.8|144|VII(a) Hepatoblastoma|81754354|0-19|All Races|Male and Female|2004|1.5|2.1|1.8
0.4|0.8|0.6|49|VII(b) Hepatic carcinomas|81754354|0-19|All Races|Male and Female|2004|0.4|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|81754354|0-19|All Races|Male and Female|2004|~|~|~
8.3|9.6|8.9|737|VIII Malignant bone tumors|81754354|0-19|All Races|Male and Female|2004|8.4|9.7|9.0
4.6|5.6|5.1|422|VIII(a) Osteosarcomas|81754354|0-19|All Races|Male and Female|2004|4.7|5.7|5.2
0.4|0.7|0.5|41|VIII(b) Chondrosarcomas|81754354|0-19|All Races|Male and Female|2004|0.4|0.7|0.5
2.3|3.1|2.7|222|VIII(c) Ewing tumor and related sarcomas of bone|81754354|0-19|All Races|Male and Female|2004|2.4|3.1|2.7
0.3|0.6|0.5|39|VIII(d) Other specified malignant bone tumors|81754354|0-19|All Races|Male and Female|2004|0.3|0.7|0.5
~|~|~|~|VIII(e) Unspecified malignant bone tumors|81754354|0-19|All Races|Male and Female|2004|~|~|~
10.4|11.8|11.1|923|X Germ cell, trophoblastic tumors & neoplasms of gonads|81754354|0-19|All Races|Male and Female|2004|10.6|12.0|11.3
1.5|2.1|1.8|147|X(a) Intracranial & intraspinal germ cell tumors|81754354|0-19|All Races|Male and Female|2004|1.5|2.1|1.8
1.1|1.6|1.3|109|X(b) Malignant extracranial & extragonadal germ cell tumors|81754354|0-19|All Races|Male and Female|2004|1.1|1.6|1.3
6.7|7.9|7.3|608|X(c) Malignant gonadal germ cell tumors|81754354|0-19|All Races|Male and Female|2004|6.9|8.1|7.4
0.3|0.5|0.4|32|X(d) Gonadal carcinomas|81754354|0-19|All Races|Male and Female|2004|0.3|0.6|0.4
0.2|0.5|0.3|27|X(e) Other and unspecified malignant gonadal tumors|81754354|0-19|All Races|Male and Female|2004|0.2|0.5|0.3
16.9|18.7|17.8|1484|XI Other malignant epithelial neoplasms and malignant melanomas|81754354|0-19|All Races|Male and Female|2004|17.2|19.1|18.2
0.1|0.4|0.2|19|XI(a) Adrenocortical carcinomas|81754354|0-19|All Races|Male and Female|2004|0.1|0.4|0.2
6.2|7.3|6.7|562|XI(b) Thyroid carcinomas|81754354|0-19|All Races|Male and Female|2004|6.3|7.5|6.9
0.4|0.7|0.5|46|XI(c) Nasopharyngeal carcinomas|81754354|0-19|All Races|Male and Female|2004|0.4|0.8|0.6
5.9|7.0|6.5|538|XI(d) Malignant melanomas|81754354|0-19|All Races|Male and Female|2004|6.0|7.2|6.6
~|~|~|~|XI(e) Skin carcinomas|81754354|0-19|All Races|Male and Female|2004|~|~|~
3.3|4.2|3.7|311|XI(f) Other and unspecified carcinomas|81754354|0-19|All Races|Male and Female|2004|3.4|4.3|3.8
0.7|1.1|0.8|70|XII Other and unspecified malignant neoplasms|81754354|0-19|All Races|Male and Female|2004|0.7|1.1|0.9
0.2|0.5|0.4|29|XII(a) Other specified malignant tumors|81754354|0-19|All Races|Male and Female|2004|0.2|0.5|0.4
0.4|0.7|0.5|41|XII(b) Other unspecified malignant tumors|81754354|0-19|All Races|Male and Female|2004|0.4|0.7|0.5
168.8|174.5|171.6|14180|All ICCC Groups Combined|82005260|0-19|All Races|Male and Female|2005|170.1|175.8|172.9
43.0|45.9|44.4|3635|I Leukemias, myeloproliferative & myelodysplastic diseases|82005260|0-19|All Races|Male and Female|2005|42.9|45.8|44.3
30.8|33.2|32.0|2609|I(a) Lymphoid leukemias|82005260|0-19|All Races|Male and Female|2005|30.6|33.1|31.8
6.9|8.1|7.5|622|I(b) Acute myeloid leukemias|82005260|0-19|All Races|Male and Female|2005|7.0|8.2|7.6
1.7|2.3|2.0|163|I(c) Chronic myeloproliferative diseases|82005260|0-19|All Races|Male and Female|2005|1.7|2.3|2.0
1.3|1.9|1.6|129|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82005260|0-19|All Races|Male and Female|2005|1.3|1.9|1.6
1.1|1.6|1.4|112|I(e) Unspecified and other specified leukemias|82005260|0-19|All Races|Male and Female|2005|1.1|1.6|1.4
24.7|26.9|25.8|2152|II Lymphomas and reticuloendothelial neoplasms|82005260|0-19|All Races|Male and Female|2005|25.1|27.4|26.2
11.9|13.5|12.7|1068|II(a) Hodgkin lymphomas|82005260|0-19|All Races|Male and Female|2005|12.3|13.8|13.0
8.4|9.7|9.0|751|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82005260|0-19|All Races|Male and Female|2005|8.5|9.8|9.2
2.2|2.9|2.5|204|II(c) Burkitt lymphoma|82005260|0-19|All Races|Male and Female|2005|2.2|2.9|2.5
1.0|1.5|1.2|101|II(d) Miscellaneous lymphoreticular neoplasms|82005260|0-19|All Races|Male and Female|2005|1.0|1.5|1.2
0.2|0.5|0.3|28|II(e) Unspecified lymphomas|82005260|0-19|All Races|Male and Female|2005|0.2|0.5|0.3
28.5|30.9|29.7|2419|III CNS and misc intracranial and intraspinal neoplasms|82005260|0-19|All Races|Male and Female|2005|28.3|30.7|29.5
2.6|3.3|2.9|239|III(a) Ependymomas and choroid plexus tumor|82005260|0-19|All Races|Male and Female|2005|2.6|3.3|2.9
14.3|16.0|15.1|1233|III(b) Astrocytomas|82005260|0-19|All Races|Male and Female|2005|14.2|15.9|15.0
5.3|6.4|5.8|474|III(c) Intracranial and intraspinal embryonal tumors|82005260|0-19|All Races|Male and Female|2005|5.3|6.3|5.8
4.3|5.2|4.7|385|III(d) Other gliomas|82005260|0-19|All Races|Male and Female|2005|4.2|5.2|4.7
0.5|0.8|0.6|52|III(e) Other specified intracranial & intraspinal neoplasms|82005260|0-19|All Races|Male and Female|2005|0.5|0.8|0.6
0.3|0.6|0.4|36|III(f) Unspecified intracranial and intraspinal neoplasms|82005260|0-19|All Races|Male and Female|2005|0.3|0.6|0.4
8.4|9.8|9.1|747|IV Neuroblastoma and other peripheral nervous cell tumors|82005260|0-19|All Races|Male and Female|2005|8.5|9.8|9.1
8.2|9.5|8.9|729|IV(a) Neuroblastoma and ganglioneuroblastoma|82005260|0-19|All Races|Male and Female|2005|8.3|9.6|8.9
0.1|0.3|0.2|18|IV(b) Other peripheral nervous cell tumors|82005260|0-19|All Races|Male and Female|2005|0.1|0.3|0.2
11.6|13.1|12.3|1017|IX Soft tissue and other extraosseous sarcomas|82005260|0-19|All Races|Male and Female|2005|11.7|13.2|12.4
4.4|5.4|4.9|399|IX(a) Rhabdomyosarcomas|82005260|0-19|All Races|Male and Female|2005|4.4|5.4|4.9
1.2|1.7|1.4|117|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82005260|0-19|All Races|Male and Female|2005|1.2|1.7|1.4
~|~|~|~|IX(c) Kaposi sarcoma|82005260|0-19|All Races|Male and Female|2005|~|~|~
4.4|5.4|4.9|410|IX(d) Other specified soft tissue sarcomas|82005260|0-19|All Races|Male and Female|2005|4.5|5.5|5.0
0.8|1.3|1.1|87|IX(e) Unspecified soft tissue sarcomas|82005260|0-19|All Races|Male and Female|2005|0.8|1.3|1.1
0.2|0.4|0.3|23|Not classified by ICCC|82005260|0-19|All Races|Male and Female|2005|0.2|0.4|0.3
2.6|3.3|2.9|242|V Retinoblastoma|82005260|0-19|All Races|Male and Female|2005|2.6|3.3|3.0
6.1|7.3|6.7|545|VI Renal tumors|82005260|0-19|All Races|Male and Female|2005|6.1|7.2|6.6
5.5|6.6|6.0|491|VI(a) Nephroblastoma and other nonepithelial renal tumors|82005260|0-19|All Races|Male and Female|2005|5.5|6.5|6.0
0.4|0.8|0.6|50|VI(b) Renal carcinomas|82005260|0-19|All Races|Male and Female|2005|0.5|0.8|0.6
~|~|~|~|VI(c) Unspecified malignant renal tumors|82005260|0-19|All Races|Male and Female|2005|~|~|~
1.7|2.3|2.0|167|VII Hepatic tumors|82005260|0-19|All Races|Male and Female|2005|1.7|2.4|2.0
1.2|1.7|1.4|117|VII(a) Hepatoblastoma|82005260|0-19|All Races|Male and Female|2005|1.2|1.7|1.4
0.4|0.8|0.6|48|VII(b) Hepatic carcinomas|82005260|0-19|All Races|Male and Female|2005|0.4|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82005260|0-19|All Races|Male and Female|2005|~|~|~
8.2|9.5|8.8|733|VIII Malignant bone tumors|82005260|0-19|All Races|Male and Female|2005|8.3|9.6|8.9
4.5|5.5|5.0|417|VIII(a) Osteosarcomas|82005260|0-19|All Races|Male and Female|2005|4.6|5.6|5.1
0.2|0.4|0.3|23|VIII(b) Chondrosarcomas|82005260|0-19|All Races|Male and Female|2005|0.2|0.4|0.3
2.6|3.3|2.9|241|VIII(c) Ewing tumor and related sarcomas of bone|82005260|0-19|All Races|Male and Female|2005|2.6|3.3|2.9
0.3|0.6|0.4|35|VIII(d) Other specified malignant bone tumors|82005260|0-19|All Races|Male and Female|2005|0.3|0.6|0.4
0.1|0.3|0.2|17|VIII(e) Unspecified malignant bone tumors|82005260|0-19|All Races|Male and Female|2005|0.1|0.3|0.2
10.7|12.2|11.4|962|X Germ cell, trophoblastic tumors & neoplasms of gonads|82005260|0-19|All Races|Male and Female|2005|11.0|12.5|11.7
1.3|1.9|1.6|132|X(a) Intracranial & intraspinal germ cell tumors|82005260|0-19|All Races|Male and Female|2005|1.3|1.9|1.6
1.3|1.9|1.6|134|X(b) Malignant extracranial & extragonadal germ cell tumors|82005260|0-19|All Races|Male and Female|2005|1.4|1.9|1.6
6.9|8.1|7.5|637|X(c) Malignant gonadal germ cell tumors|82005260|0-19|All Races|Male and Female|2005|7.2|8.4|7.8
0.2|0.5|0.4|31|X(d) Gonadal carcinomas|82005260|0-19|All Races|Male and Female|2005|0.3|0.5|0.4
0.2|0.5|0.3|28|X(e) Other and unspecified malignant gonadal tumors|82005260|0-19|All Races|Male and Female|2005|0.2|0.5|0.3
16.5|18.3|17.4|1464|XI Other malignant epithelial neoplasms and malignant melanomas|82005260|0-19|All Races|Male and Female|2005|16.9|18.8|17.9
~|~|~|~|XI(a) Adrenocortical carcinomas|82005260|0-19|All Races|Male and Female|2005|~|~|~
5.5|6.6|6.0|511|XI(b) Thyroid carcinomas|82005260|0-19|All Races|Male and Female|2005|5.7|6.8|6.2
0.3|0.5|0.4|33|XI(c) Nasopharyngeal carcinomas|82005260|0-19|All Races|Male and Female|2005|0.3|0.6|0.4
6.0|7.1|6.5|547|XI(d) Malignant melanomas|82005260|0-19|All Races|Male and Female|2005|6.1|7.3|6.7
~|~|~|~|XI(e) Skin carcinomas|82005260|0-19|All Races|Male and Female|2005|~|~|~
3.8|4.7|4.2|354|XI(f) Other and unspecified carcinomas|82005260|0-19|All Races|Male and Female|2005|3.9|4.8|4.3
0.7|1.1|0.9|74|XII Other and unspecified malignant neoplasms|82005260|0-19|All Races|Male and Female|2005|0.7|1.1|0.9
0.3|0.5|0.4|31|XII(a) Other specified malignant tumors|82005260|0-19|All Races|Male and Female|2005|0.3|0.5|0.4
0.4|0.7|0.5|43|XII(b) Other unspecified malignant tumors|82005260|0-19|All Races|Male and Female|2005|0.4|0.7|0.5
168.8|174.5|171.7|14246|All ICCC Groups Combined|82324418|0-19|All Races|Male and Female|2006|170.2|175.9|173.0
45.2|48.1|46.6|3834|I Leukemias, myeloproliferative & myelodysplastic diseases|82324418|0-19|All Races|Male and Female|2006|45.1|48.1|46.6
31.9|34.4|33.1|2711|I(a) Lymphoid leukemias|82324418|0-19|All Races|Male and Female|2006|31.7|34.2|32.9
7.6|8.8|8.2|680|I(b) Acute myeloid leukemias|82324418|0-19|All Races|Male and Female|2006|7.7|8.9|8.3
2.0|2.6|2.3|191|I(c) Chronic myeloproliferative diseases|82324418|0-19|All Races|Male and Female|2006|2.0|2.7|2.3
1.4|1.9|1.6|134|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82324418|0-19|All Races|Male and Female|2006|1.4|1.9|1.6
1.2|1.7|1.4|118|I(e) Unspecified and other specified leukemias|82324418|0-19|All Races|Male and Female|2006|1.2|1.7|1.4
23.9|26.0|24.9|2090|II Lymphomas and reticuloendothelial neoplasms|82324418|0-19|All Races|Male and Female|2006|24.3|26.5|25.4
11.7|13.2|12.4|1051|II(a) Hodgkin lymphomas|82324418|0-19|All Races|Male and Female|2006|12.0|13.6|12.8
8.0|9.3|8.7|722|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82324418|0-19|All Races|Male and Female|2006|8.1|9.4|8.8
2.1|2.8|2.4|200|II(c) Burkitt lymphoma|82324418|0-19|All Races|Male and Female|2006|2.1|2.8|2.4
0.9|1.4|1.1|94|II(d) Miscellaneous lymphoreticular neoplasms|82324418|0-19|All Races|Male and Female|2006|0.9|1.4|1.1
0.2|0.4|0.3|23|II(e) Unspecified lymphomas|82324418|0-19|All Races|Male and Female|2006|0.2|0.4|0.3
29.6|32.0|30.8|2525|III CNS and misc intracranial and intraspinal neoplasms|82324418|0-19|All Races|Male and Female|2006|29.5|31.9|30.7
2.5|3.2|2.8|231|III(a) Ependymomas and choroid plexus tumor|82324418|0-19|All Races|Male and Female|2006|2.5|3.2|2.8
14.3|16.0|15.1|1244|III(b) Astrocytomas|82324418|0-19|All Races|Male and Female|2006|14.3|16.0|15.1
5.8|6.9|6.3|514|III(c) Intracranial and intraspinal embryonal tumors|82324418|0-19|All Races|Male and Female|2006|5.7|6.8|6.2
4.9|5.9|5.4|439|III(d) Other gliomas|82324418|0-19|All Races|Male and Female|2006|4.8|5.9|5.3
0.4|0.8|0.6|47|III(e) Other specified intracranial & intraspinal neoplasms|82324418|0-19|All Races|Male and Female|2006|0.4|0.8|0.6
0.5|0.8|0.6|50|III(f) Unspecified intracranial and intraspinal neoplasms|82324418|0-19|All Races|Male and Female|2006|0.5|0.8|0.6
7.3|8.5|7.9|649|IV Neuroblastoma and other peripheral nervous cell tumors|82324418|0-19|All Races|Male and Female|2006|7.3|8.5|7.9
7.1|8.3|7.7|636|IV(a) Neuroblastoma and ganglioneuroblastoma|82324418|0-19|All Races|Male and Female|2006|7.1|8.3|7.7
~|~|~|~|IV(b) Other peripheral nervous cell tumors|82324418|0-19|All Races|Male and Female|2006|~|~|~
10.9|12.3|11.6|962|IX Soft tissue and other extraosseous sarcomas|82324418|0-19|All Races|Male and Female|2006|11.0|12.4|11.7
4.1|5.0|4.6|374|IX(a) Rhabdomyosarcomas|82324418|0-19|All Races|Male and Female|2006|4.1|5.0|4.5
1.1|1.6|1.3|109|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82324418|0-19|All Races|Male and Female|2006|1.1|1.6|1.3
~|~|~|~|IX(c) Kaposi sarcoma|82324418|0-19|All Races|Male and Female|2006|~|~|~
4.0|4.9|4.4|372|IX(d) Other specified soft tissue sarcomas|82324418|0-19|All Races|Male and Female|2006|4.1|5.0|4.5
1.0|1.5|1.2|103|IX(e) Unspecified soft tissue sarcomas|82324418|0-19|All Races|Male and Female|2006|1.0|1.5|1.3
0.2|0.4|0.3|24|Not classified by ICCC|82324418|0-19|All Races|Male and Female|2006|0.2|0.4|0.3
2.7|3.4|3.0|252|V Retinoblastoma|82324418|0-19|All Races|Male and Female|2006|2.7|3.5|3.1
6.1|7.3|6.7|547|VI Renal tumors|82324418|0-19|All Races|Male and Female|2006|6.1|7.2|6.6
5.4|6.5|6.0|486|VI(a) Nephroblastoma and other nonepithelial renal tumors|82324418|0-19|All Races|Male and Female|2006|5.4|6.5|5.9
0.5|0.9|0.7|56|VI(b) Renal carcinomas|82324418|0-19|All Races|Male and Female|2006|0.5|0.9|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|82324418|0-19|All Races|Male and Female|2006|~|~|~
2.0|2.7|2.3|192|VII Hepatic tumors|82324418|0-19|All Races|Male and Female|2006|2.0|2.7|2.3
1.4|1.9|1.6|136|VII(a) Hepatoblastoma|82324418|0-19|All Races|Male and Female|2006|1.4|2.0|1.7
0.5|0.8|0.6|52|VII(b) Hepatic carcinomas|82324418|0-19|All Races|Male and Female|2006|0.5|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82324418|0-19|All Races|Male and Female|2006|~|~|~
8.7|10.0|9.3|778|VIII Malignant bone tumors|82324418|0-19|All Races|Male and Female|2006|8.8|10.1|9.5
4.9|5.9|5.4|451|VIII(a) Osteosarcomas|82324418|0-19|All Races|Male and Female|2006|5.0|6.0|5.5
0.1|0.3|0.2|17|VIII(b) Chondrosarcomas|82324418|0-19|All Races|Male and Female|2006|0.1|0.3|0.2
2.7|3.4|3.0|252|VIII(c) Ewing tumor and related sarcomas of bone|82324418|0-19|All Races|Male and Female|2006|2.7|3.5|3.1
0.4|0.7|0.5|42|VIII(d) Other specified malignant bone tumors|82324418|0-19|All Races|Male and Female|2006|0.4|0.7|0.5
0.1|0.3|0.2|16|VIII(e) Unspecified malignant bone tumors|82324418|0-19|All Races|Male and Female|2006|0.1|0.3|0.2
9.5|10.9|10.2|865|X Germ cell, trophoblastic tumors & neoplasms of gonads|82324418|0-19|All Races|Male and Female|2006|9.8|11.2|10.5
1.3|1.8|1.5|126|X(a) Intracranial & intraspinal germ cell tumors|82324418|0-19|All Races|Male and Female|2006|1.3|1.8|1.5
1.2|1.8|1.5|126|X(b) Malignant extracranial & extragonadal germ cell tumors|82324418|0-19|All Races|Male and Female|2006|1.3|1.8|1.5
5.8|6.9|6.4|543|X(c) Malignant gonadal germ cell tumors|82324418|0-19|All Races|Male and Female|2006|6.1|7.2|6.6
0.3|0.6|0.5|41|X(d) Gonadal carcinomas|82324418|0-19|All Races|Male and Female|2006|0.4|0.7|0.5
0.2|0.5|0.3|29|X(e) Other and unspecified malignant gonadal tumors|82324418|0-19|All Races|Male and Female|2006|0.2|0.5|0.4
16.2|18.0|17.1|1454|XI Other malignant epithelial neoplasms and malignant melanomas|82324418|0-19|All Races|Male and Female|2006|16.8|18.6|17.7
0.1|0.3|0.2|16|XI(a) Adrenocortical carcinomas|82324418|0-19|All Races|Male and Female|2006|0.1|0.3|0.2
6.1|7.2|6.6|564|XI(b) Thyroid carcinomas|82324418|0-19|All Races|Male and Female|2006|6.3|7.4|6.9
0.5|0.8|0.6|55|XI(c) Nasopharyngeal carcinomas|82324418|0-19|All Races|Male and Female|2006|0.5|0.9|0.7
4.9|5.9|5.4|459|XI(d) Malignant melanomas|82324418|0-19|All Races|Male and Female|2006|5.1|6.1|5.6
~|~|~|~|XI(e) Skin carcinomas|82324418|0-19|All Races|Male and Female|2006|~|~|~
3.7|4.6|4.2|353|XI(f) Other and unspecified carcinomas|82324418|0-19|All Races|Male and Female|2006|3.9|4.8|4.3
0.7|1.1|0.9|74|XII Other and unspecified malignant neoplasms|82324418|0-19|All Races|Male and Female|2006|0.7|1.1|0.9
0.4|0.7|0.5|41|XII(a) Other specified malignant tumors|82324418|0-19|All Races|Male and Female|2006|0.4|0.7|0.5
0.3|0.6|0.4|33|XII(b) Other unspecified malignant tumors|82324418|0-19|All Races|Male and Female|2006|0.3|0.6|0.4
172.6|178.3|175.4|14659|All ICCC Groups Combined|82749431|0-19|All Races|Male and Female|2007|174.3|180.0|177.1
45.6|48.6|47.1|3893|I Leukemias, myeloproliferative & myelodysplastic diseases|82749431|0-19|All Races|Male and Female|2007|45.6|48.5|47.0
32.9|35.5|34.2|2808|I(a) Lymphoid leukemias|82749431|0-19|All Races|Male and Female|2007|32.7|35.2|33.9
7.3|8.6|7.9|662|I(b) Acute myeloid leukemias|82749431|0-19|All Races|Male and Female|2007|7.4|8.6|8.0
2.1|2.8|2.4|206|I(c) Chronic myeloproliferative diseases|82749431|0-19|All Races|Male and Female|2007|2.2|2.9|2.5
1.2|1.7|1.4|121|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82749431|0-19|All Races|Male and Female|2007|1.2|1.7|1.5
0.9|1.4|1.2|96|I(e) Unspecified and other specified leukemias|82749431|0-19|All Races|Male and Female|2007|0.9|1.4|1.2
23.8|26.0|24.9|2098|II Lymphomas and reticuloendothelial neoplasms|82749431|0-19|All Races|Male and Female|2007|24.3|26.5|25.4
11.4|12.8|12.1|1033|II(a) Hodgkin lymphomas|82749431|0-19|All Races|Male and Female|2007|11.7|13.3|12.5
8.0|9.3|8.7|724|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82749431|0-19|All Races|Male and Female|2007|8.1|9.4|8.7
2.3|3.0|2.6|215|II(c) Burkitt lymphoma|82749431|0-19|All Races|Male and Female|2007|2.3|3.0|2.6
0.9|1.3|1.1|90|II(d) Miscellaneous lymphoreticular neoplasms|82749431|0-19|All Races|Male and Female|2007|0.9|1.3|1.1
0.3|0.6|0.4|36|II(e) Unspecified lymphomas|82749431|0-19|All Races|Male and Female|2007|0.3|0.6|0.4
30.3|32.7|31.5|2591|III CNS and misc intracranial and intraspinal neoplasms|82749431|0-19|All Races|Male and Female|2007|30.1|32.5|31.3
2.2|2.9|2.5|206|III(a) Ependymomas and choroid plexus tumor|82749431|0-19|All Races|Male and Female|2007|2.2|2.9|2.5
14.8|16.5|15.7|1293|III(b) Astrocytomas|82749431|0-19|All Races|Male and Female|2007|14.8|16.5|15.6
5.9|7.0|6.5|530|III(c) Intracranial and intraspinal embryonal tumors|82749431|0-19|All Races|Male and Female|2007|5.9|7.0|6.4
5.2|6.2|5.7|466|III(d) Other gliomas|82749431|0-19|All Races|Male and Female|2007|5.1|6.2|5.6
0.5|0.9|0.7|57|III(e) Other specified intracranial & intraspinal neoplasms|82749431|0-19|All Races|Male and Female|2007|0.5|0.9|0.7
0.3|0.6|0.5|39|III(f) Unspecified intracranial and intraspinal neoplasms|82749431|0-19|All Races|Male and Female|2007|0.3|0.6|0.5
8.3|9.6|9.0|748|IV Neuroblastoma and other peripheral nervous cell tumors|82749431|0-19|All Races|Male and Female|2007|8.4|9.7|9.0
8.1|9.4|8.7|730|IV(a) Neuroblastoma and ganglioneuroblastoma|82749431|0-19|All Races|Male and Female|2007|8.2|9.5|8.8
0.1|0.3|0.2|18|IV(b) Other peripheral nervous cell tumors|82749431|0-19|All Races|Male and Female|2007|0.1|0.3|0.2
11.7|13.2|12.5|1042|IX Soft tissue and other extraosseous sarcomas|82749431|0-19|All Races|Male and Female|2007|11.8|13.4|12.6
4.7|5.7|5.2|427|IX(a) Rhabdomyosarcomas|82749431|0-19|All Races|Male and Female|2007|4.7|5.7|5.2
1.1|1.6|1.4|115|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82749431|0-19|All Races|Male and Female|2007|1.1|1.7|1.4
~|~|~|~|IX(c) Kaposi sarcoma|82749431|0-19|All Races|Male and Female|2007|~|~|~
4.3|5.2|4.7|401|IX(d) Other specified soft tissue sarcomas|82749431|0-19|All Races|Male and Female|2007|4.4|5.3|4.8
0.9|1.4|1.1|96|IX(e) Unspecified soft tissue sarcomas|82749431|0-19|All Races|Male and Female|2007|0.9|1.4|1.2
0.1|0.4|0.2|19|Not classified by ICCC|82749431|0-19|All Races|Male and Female|2007|0.1|0.4|0.2
2.8|3.5|3.1|263|V Retinoblastoma|82749431|0-19|All Races|Male and Female|2007|2.8|3.6|3.2
6.3|7.5|6.9|566|VI Renal tumors|82749431|0-19|All Races|Male and Female|2007|6.3|7.4|6.8
5.7|6.8|6.2|510|VI(a) Nephroblastoma and other nonepithelial renal tumors|82749431|0-19|All Races|Male and Female|2007|5.6|6.7|6.2
0.5|0.8|0.6|54|VI(b) Renal carcinomas|82749431|0-19|All Races|Male and Female|2007|0.5|0.9|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|82749431|0-19|All Races|Male and Female|2007|~|~|~
2.0|2.7|2.3|194|VII Hepatic tumors|82749431|0-19|All Races|Male and Female|2007|2.0|2.7|2.3
1.4|2.0|1.7|141|VII(a) Hepatoblastoma|82749431|0-19|All Races|Male and Female|2007|1.4|2.0|1.7
0.5|0.8|0.6|53|VII(b) Hepatic carcinomas|82749431|0-19|All Races|Male and Female|2007|0.5|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82749431|0-19|All Races|Male and Female|2007|~|~|~
8.1|9.3|8.7|726|VIII Malignant bone tumors|82749431|0-19|All Races|Male and Female|2007|8.1|9.4|8.8
4.2|5.1|4.7|390|VIII(a) Osteosarcomas|82749431|0-19|All Races|Male and Female|2007|4.3|5.2|4.7
0.2|0.5|0.4|31|VIII(b) Chondrosarcomas|82749431|0-19|All Races|Male and Female|2007|0.3|0.5|0.4
2.7|3.5|3.1|256|VIII(c) Ewing tumor and related sarcomas of bone|82749431|0-19|All Races|Male and Female|2007|2.7|3.5|3.1
0.2|0.5|0.3|28|VIII(d) Other specified malignant bone tumors|82749431|0-19|All Races|Male and Female|2007|0.2|0.5|0.3
0.2|0.4|0.3|21|VIII(e) Unspecified malignant bone tumors|82749431|0-19|All Races|Male and Female|2007|0.2|0.4|0.3
10.4|11.8|11.0|947|X Germ cell, trophoblastic tumors & neoplasms of gonads|82749431|0-19|All Races|Male and Female|2007|10.7|12.2|11.4
1.3|1.9|1.6|134|X(a) Intracranial & intraspinal germ cell tumors|82749431|0-19|All Races|Male and Female|2007|1.4|1.9|1.6
1.1|1.7|1.4|118|X(b) Malignant extracranial & extragonadal germ cell tumors|82749431|0-19|All Races|Male and Female|2007|1.2|1.7|1.4
6.9|8.0|7.4|641|X(c) Malignant gonadal germ cell tumors|82749431|0-19|All Races|Male and Female|2007|7.2|8.4|7.7
0.2|0.5|0.3|30|X(d) Gonadal carcinomas|82749431|0-19|All Races|Male and Female|2007|0.2|0.5|0.4
0.2|0.4|0.3|24|X(e) Other and unspecified malignant gonadal tumors|82749431|0-19|All Races|Male and Female|2007|0.2|0.4|0.3
16.6|18.4|17.5|1506|XI Other malignant epithelial neoplasms and malignant melanomas|82749431|0-19|All Races|Male and Female|2007|17.3|19.1|18.2
~|~|~|~|XI(a) Adrenocortical carcinomas|82749431|0-19|All Races|Male and Female|2007|~|~|~
6.7|7.8|7.3|626|XI(b) Thyroid carcinomas|82749431|0-19|All Races|Male and Female|2007|7.0|8.2|7.6
0.5|0.8|0.6|52|XI(c) Nasopharyngeal carcinomas|82749431|0-19|All Races|Male and Female|2007|0.5|0.8|0.6
4.9|5.9|5.3|459|XI(d) Malignant melanomas|82749431|0-19|All Races|Male and Female|2007|5.1|6.1|5.5
~|~|~|~|XI(e) Skin carcinomas|82749431|0-19|All Races|Male and Female|2007|~|~|~
3.6|4.5|4.0|345|XI(f) Other and unspecified carcinomas|82749431|0-19|All Races|Male and Female|2007|3.7|4.6|4.2
0.6|1.0|0.8|66|XII Other and unspecified malignant neoplasms|82749431|0-19|All Races|Male and Female|2007|0.6|1.0|0.8
0.2|0.5|0.3|29|XII(a) Other specified malignant tumors|82749431|0-19|All Races|Male and Female|2007|0.2|0.5|0.4
0.3|0.6|0.4|37|XII(b) Other unspecified malignant tumors|82749431|0-19|All Races|Male and Female|2007|0.3|0.6|0.4
175.9|178.5|177.2|73511|All ICCC Groups Combined|411503198|0-19|All Races|Male and Female|2007-2011|177.4|179.9|178.6
47.0|48.4|47.7|19620|I Leukemias, myeloproliferative & myelodysplastic diseases|411503198|0-19|All Races|Male and Female|2007-2011|47.0|48.4|47.7
33.9|35.1|34.5|14138|I(a) Lymphoid leukemias|411503198|0-19|All Races|Male and Female|2007-2011|33.8|34.9|34.4
7.7|8.2|8.0|3307|I(b) Acute myeloid leukemias|411503198|0-19|All Races|Male and Female|2007-2011|7.8|8.3|8.0
2.3|2.6|2.4|1008|I(c) Chronic myeloproliferative diseases|411503198|0-19|All Races|Male and Female|2007-2011|2.3|2.6|2.4
1.4|1.6|1.5|627|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|411503198|0-19|All Races|Male and Female|2007-2011|1.4|1.6|1.5
1.2|1.4|1.3|540|I(e) Unspecified and other specified leukemias|411503198|0-19|All Races|Male and Female|2007-2011|1.2|1.4|1.3
25.5|26.5|26.0|10851|II Lymphomas and reticuloendothelial neoplasms|411503198|0-19|All Races|Male and Female|2007-2011|25.9|26.9|26.4
11.9|12.6|12.3|5184|II(a) Hodgkin lymphomas|411503198|0-19|All Races|Male and Female|2007-2011|12.3|12.9|12.6
8.4|9.0|8.7|3602|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|411503198|0-19|All Races|Male and Female|2007-2011|8.5|9.0|8.8
2.3|2.6|2.4|999|II(c) Burkitt lymphoma|411503198|0-19|All Races|Male and Female|2007-2011|2.3|2.6|2.4
2.1|2.4|2.2|923|II(d) Miscellaneous lymphoreticular neoplasms|411503198|0-19|All Races|Male and Female|2007-2011|2.1|2.4|2.2
0.3|0.4|0.3|143|II(e) Unspecified lymphomas|411503198|0-19|All Races|Male and Female|2007-2011|0.3|0.4|0.3
30.9|32.0|31.5|12896|III CNS and misc intracranial and intraspinal neoplasms|411503198|0-19|All Races|Male and Female|2007-2011|30.8|31.9|31.3
2.4|2.7|2.6|1058|III(a) Ependymomas and choroid plexus tumor|411503198|0-19|All Races|Male and Female|2007-2011|2.4|2.7|2.6
15.6|16.3|15.9|6539|III(b) Astrocytomas|411503198|0-19|All Races|Male and Female|2007-2011|15.5|16.3|15.9
6.0|6.5|6.3|2571|III(c) Intracranial and intraspinal embryonal tumors|411503198|0-19|All Races|Male and Female|2007-2011|6.0|6.5|6.2
5.4|5.8|5.6|2290|III(d) Other gliomas|411503198|0-19|All Races|Male and Female|2007-2011|5.3|5.8|5.6
0.5|0.7|0.6|255|III(e) Other specified intracranial & intraspinal neoplasms|411503198|0-19|All Races|Male and Female|2007-2011|0.5|0.7|0.6
0.4|0.5|0.4|183|III(f) Unspecified intracranial and intraspinal neoplasms|411503198|0-19|All Races|Male and Female|2007-2011|0.4|0.5|0.4
8.2|8.8|8.5|3501|IV Neuroblastoma and other peripheral nervous cell tumors|411503198|0-19|All Races|Male and Female|2007-2011|8.2|8.8|8.5
8.0|8.5|8.3|3404|IV(a) Neuroblastoma and ganglioneuroblastoma|411503198|0-19|All Races|Male and Female|2007-2011|8.0|8.6|8.3
0.2|0.3|0.2|97|IV(b) Other peripheral nervous cell tumors|411503198|0-19|All Races|Male and Female|2007-2011|0.2|0.3|0.2
11.9|12.6|12.2|5073|IX Soft tissue and other extraosseous sarcomas|411503198|0-19|All Races|Male and Female|2007-2011|12.0|12.7|12.3
4.7|5.1|4.9|2003|IX(a) Rhabdomyosarcomas|411503198|0-19|All Races|Male and Female|2007-2011|4.7|5.1|4.9
1.1|1.3|1.2|514|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|411503198|0-19|All Races|Male and Female|2007-2011|1.1|1.4|1.2
0.0|0.1|0.1|24|IX(c) Kaposi sarcoma|411503198|0-19|All Races|Male and Female|2007-2011|0.0|0.1|0.1
4.5|4.9|4.7|1958|IX(d) Other specified soft tissue sarcomas|411503198|0-19|All Races|Male and Female|2007-2011|4.5|5.0|4.8
1.3|1.5|1.4|574|IX(e) Unspecified soft tissue sarcomas|411503198|0-19|All Races|Male and Female|2007-2011|1.3|1.5|1.4
0.2|0.4|0.3|122|Not classified by ICCC|411503198|0-19|All Races|Male and Female|2007-2011|0.2|0.4|0.3
3.0|3.4|3.2|1319|V Retinoblastoma|411503198|0-19|All Races|Male and Female|2007-2011|3.0|3.4|3.2
6.8|7.3|7.0|2894|VI Renal tumors|411503198|0-19|All Races|Male and Female|2007-2011|6.8|7.3|7.0
6.1|6.6|6.4|2606|VI(a) Nephroblastoma and other nonepithelial renal tumors|411503198|0-19|All Races|Male and Female|2007-2011|6.1|6.6|6.3
0.6|0.7|0.7|277|VI(b) Renal carcinomas|411503198|0-19|All Races|Male and Female|2007-2011|0.6|0.8|0.7
~|~|~|~|VI(c) Unspecified malignant renal tumors|411503198|0-19|All Races|Male and Female|2007-2011|~|~|~
2.2|2.5|2.4|976|VII Hepatic tumors|411503198|0-19|All Races|Male and Female|2007-2011|2.2|2.5|2.4
1.6|1.9|1.7|719|VII(a) Hepatoblastoma|411503198|0-19|All Races|Male and Female|2007-2011|1.6|1.9|1.7
0.5|0.7|0.6|248|VII(b) Hepatic carcinomas|411503198|0-19|All Races|Male and Female|2007-2011|0.5|0.7|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|411503198|0-19|All Races|Male and Female|2007-2011|~|~|~
8.4|8.9|8.7|3590|VIII Malignant bone tumors|411503198|0-19|All Races|Male and Female|2007-2011|8.4|9.0|8.7
4.7|5.1|4.9|2016|VIII(a) Osteosarcomas|411503198|0-19|All Races|Male and Female|2007-2011|4.7|5.1|4.9
0.3|0.4|0.3|138|VIII(b) Chondrosarcomas|411503198|0-19|All Races|Male and Female|2007-2011|0.3|0.4|0.3
2.7|3.1|2.9|1195|VIII(c) Ewing tumor and related sarcomas of bone|411503198|0-19|All Races|Male and Female|2007-2011|2.7|3.1|2.9
0.3|0.4|0.4|159|VIII(d) Other specified malignant bone tumors|411503198|0-19|All Races|Male and Female|2007-2011|0.3|0.5|0.4
0.2|0.2|0.2|82|VIII(e) Unspecified malignant bone tumors|411503198|0-19|All Races|Male and Female|2007-2011|0.2|0.2|0.2
10.8|11.4|11.1|4700|X Germ cell, trophoblastic tumors & neoplasms of gonads|411503198|0-19|All Races|Male and Female|2007-2011|11.1|11.8|11.4
1.6|1.9|1.7|713|X(a) Intracranial & intraspinal germ cell tumors|411503198|0-19|All Races|Male and Female|2007-2011|1.6|1.9|1.7
1.3|1.5|1.4|572|X(b) Malignant extracranial & extragonadal germ cell tumors|411503198|0-19|All Races|Male and Female|2007-2011|1.3|1.5|1.4
7.0|7.6|7.3|3118|X(c) Malignant gonadal germ cell tumors|411503198|0-19|All Races|Male and Female|2007-2011|7.3|7.8|7.6
0.4|0.5|0.4|183|X(d) Gonadal carcinomas|411503198|0-19|All Races|Male and Female|2007-2011|0.4|0.5|0.4
0.2|0.3|0.3|114|X(e) Other and unspecified malignant gonadal tumors|411503198|0-19|All Races|Male and Female|2007-2011|0.2|0.3|0.3
17.6|18.4|18.0|7651|XI Other malignant epithelial neoplasms and malignant melanomas|411503198|0-19|All Races|Male and Female|2007-2011|18.2|19.0|18.6
0.2|0.3|0.2|93|XI(a) Adrenocortical carcinomas|411503198|0-19|All Races|Male and Female|2007-2011|0.2|0.3|0.2
7.9|8.4|8.2|3479|XI(b) Thyroid carcinomas|411503198|0-19|All Races|Male and Female|2007-2011|8.2|8.7|8.5
0.5|0.7|0.6|256|XI(c) Nasopharyngeal carcinomas|411503198|0-19|All Races|Male and Female|2007-2011|0.5|0.7|0.6
4.4|4.8|4.6|1956|XI(d) Malignant melanomas|411503198|0-19|All Races|Male and Female|2007-2011|4.5|5.0|4.8
0.1|0.1|0.1|37|XI(e) Skin carcinomas|411503198|0-19|All Races|Male and Female|2007-2011|0.1|0.1|0.1
4.1|4.5|4.3|1830|XI(f) Other and unspecified carcinomas|411503198|0-19|All Races|Male and Female|2007-2011|4.2|4.7|4.4
0.7|0.9|0.8|318|XII Other and unspecified malignant neoplasms|411503198|0-19|All Races|Male and Female|2007-2011|0.7|0.9|0.8
0.3|0.4|0.4|147|XII(a) Other specified malignant tumors|411503198|0-19|All Races|Male and Female|2007-2011|0.3|0.4|0.4
0.3|0.5|0.4|171|XII(b) Other unspecified malignant tumors|411503198|0-19|All Races|Male and Female|2007-2011|0.4|0.5|0.4
174.1|179.9|177.0|14856|All ICCC Groups Combined|83118264|0-19|All Races|Male and Female|2008|175.9|181.6|178.7
46.9|49.9|48.4|4021|I Leukemias, myeloproliferative & myelodysplastic diseases|83118264|0-19|All Races|Male and Female|2008|46.9|49.9|48.4
33.6|36.2|34.9|2887|I(a) Lymphoid leukemias|83118264|0-19|All Races|Male and Female|2008|33.5|36.0|34.7
7.7|8.9|8.3|695|I(b) Acute myeloid leukemias|83118264|0-19|All Races|Male and Female|2008|7.8|9.0|8.4
2.2|2.9|2.6|217|I(c) Chronic myeloproliferative diseases|83118264|0-19|All Races|Male and Female|2008|2.3|3.0|2.6
1.3|1.8|1.6|130|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|83118264|0-19|All Races|Male and Female|2008|1.3|1.9|1.6
0.9|1.3|1.1|92|I(e) Unspecified and other specified leukemias|83118264|0-19|All Races|Male and Female|2008|0.9|1.4|1.1
24.3|26.4|25.3|2145|II Lymphomas and reticuloendothelial neoplasms|83118264|0-19|All Races|Male and Female|2008|24.7|26.9|25.8
12.1|13.6|12.8|1099|II(a) Hodgkin lymphomas|83118264|0-19|All Races|Male and Female|2008|12.5|14.0|13.2
8.1|9.4|8.7|734|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|83118264|0-19|All Races|Male and Female|2008|8.2|9.5|8.8
2.2|2.9|2.5|210|II(c) Burkitt lymphoma|83118264|0-19|All Races|Male and Female|2008|2.2|2.9|2.5
0.7|1.1|0.9|76|II(d) Miscellaneous lymphoreticular neoplasms|83118264|0-19|All Races|Male and Female|2008|0.7|1.1|0.9
0.2|0.5|0.3|26|II(e) Unspecified lymphomas|83118264|0-19|All Races|Male and Female|2008|0.2|0.5|0.3
30.4|32.8|31.6|2616|III CNS and misc intracranial and intraspinal neoplasms|83118264|0-19|All Races|Male and Female|2008|30.3|32.7|31.5
2.0|2.7|2.3|195|III(a) Ependymomas and choroid plexus tumor|83118264|0-19|All Races|Male and Female|2008|2.0|2.7|2.3
15.0|16.8|15.9|1314|III(b) Astrocytomas|83118264|0-19|All Races|Male and Female|2008|15.0|16.7|15.8
6.2|7.3|6.7|554|III(c) Intracranial and intraspinal embryonal tumors|83118264|0-19|All Races|Male and Female|2008|6.1|7.2|6.7
5.1|6.1|5.6|460|III(d) Other gliomas|83118264|0-19|All Races|Male and Female|2008|5.0|6.1|5.5
0.5|0.9|0.7|57|III(e) Other specified intracranial & intraspinal neoplasms|83118264|0-19|All Races|Male and Female|2008|0.5|0.9|0.7
0.3|0.6|0.4|36|III(f) Unspecified intracranial and intraspinal neoplasms|83118264|0-19|All Races|Male and Female|2008|0.3|0.6|0.4
7.7|9.0|8.3|697|IV Neuroblastoma and other peripheral nervous cell tumors|83118264|0-19|All Races|Male and Female|2008|7.8|9.0|8.4
7.4|8.6|8.0|671|IV(a) Neuroblastoma and ganglioneuroblastoma|83118264|0-19|All Races|Male and Female|2008|7.5|8.7|8.1
0.2|0.5|0.3|26|IV(b) Other peripheral nervous cell tumors|83118264|0-19|All Races|Male and Female|2008|0.2|0.5|0.3
11.5|13.0|12.2|1023|IX Soft tissue and other extraosseous sarcomas|83118264|0-19|All Races|Male and Female|2008|11.6|13.1|12.3
4.6|5.6|5.1|424|IX(a) Rhabdomyosarcomas|83118264|0-19|All Races|Male and Female|2008|4.6|5.6|5.1
0.9|1.3|1.1|90|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|83118264|0-19|All Races|Male and Female|2008|0.9|1.3|1.1
~|~|~|~|IX(c) Kaposi sarcoma|83118264|0-19|All Races|Male and Female|2008|~|~|~
4.1|5.0|4.5|381|IX(d) Other specified soft tissue sarcomas|83118264|0-19|All Races|Male and Female|2008|4.1|5.1|4.6
1.2|1.8|1.5|126|IX(e) Unspecified soft tissue sarcomas|83118264|0-19|All Races|Male and Female|2008|1.3|1.8|1.5
0.2|0.4|0.3|23|Not classified by ICCC|83118264|0-19|All Races|Male and Female|2008|0.2|0.4|0.3
2.7|3.5|3.1|262|V Retinoblastoma|83118264|0-19|All Races|Male and Female|2008|2.8|3.6|3.2
6.6|7.8|7.2|600|VI Renal tumors|83118264|0-19|All Races|Male and Female|2008|6.7|7.8|7.2
5.9|7.0|6.4|533|VI(a) Nephroblastoma and other nonepithelial renal tumors|83118264|0-19|All Races|Male and Female|2008|5.9|7.0|6.4
0.6|1.0|0.8|64|VI(b) Renal carcinomas|83118264|0-19|All Races|Male and Female|2008|0.6|1.0|0.8
~|~|~|~|VI(c) Unspecified malignant renal tumors|83118264|0-19|All Races|Male and Female|2008|~|~|~
1.9|2.6|2.3|190|VII Hepatic tumors|83118264|0-19|All Races|Male and Female|2008|2.0|2.6|2.3
1.4|2.0|1.7|142|VII(a) Hepatoblastoma|83118264|0-19|All Races|Male and Female|2008|1.4|2.0|1.7
0.4|0.7|0.6|47|VII(b) Hepatic carcinomas|83118264|0-19|All Races|Male and Female|2008|0.4|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|83118264|0-19|All Races|Male and Female|2008|~|~|~
8.1|9.4|8.7|731|VIII Malignant bone tumors|83118264|0-19|All Races|Male and Female|2008|8.2|9.5|8.8
4.5|5.4|4.9|412|VIII(a) Osteosarcomas|83118264|0-19|All Races|Male and Female|2008|4.5|5.5|5.0
0.3|0.6|0.4|34|VIII(b) Chondrosarcomas|83118264|0-19|All Races|Male and Female|2008|0.3|0.6|0.4
2.4|3.2|2.8|232|VIII(c) Ewing tumor and related sarcomas of bone|83118264|0-19|All Races|Male and Female|2008|2.4|3.2|2.8
0.3|0.5|0.4|32|VIII(d) Other specified malignant bone tumors|83118264|0-19|All Races|Male and Female|2008|0.3|0.5|0.4
0.2|0.4|0.2|21|VIII(e) Unspecified malignant bone tumors|83118264|0-19|All Races|Male and Female|2008|0.2|0.4|0.3
10.2|11.6|10.9|938|X Germ cell, trophoblastic tumors & neoplasms of gonads|83118264|0-19|All Races|Male and Female|2008|10.6|12.0|11.3
1.4|2.0|1.7|143|X(a) Intracranial & intraspinal germ cell tumors|83118264|0-19|All Races|Male and Female|2008|1.5|2.0|1.7
1.2|1.7|1.4|124|X(b) Malignant extracranial & extragonadal germ cell tumors|83118264|0-19|All Races|Male and Female|2008|1.2|1.8|1.5
6.7|7.8|7.3|630|X(c) Malignant gonadal germ cell tumors|83118264|0-19|All Races|Male and Female|2008|7.0|8.2|7.6
0.2|0.5|0.3|29|X(d) Gonadal carcinomas|83118264|0-19|All Races|Male and Female|2008|0.2|0.5|0.3
~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|83118264|0-19|All Races|Male and Female|2008|~|~|~
17.1|18.9|18.0|1549|XI Other malignant epithelial neoplasms and malignant melanomas|83118264|0-19|All Races|Male and Female|2008|17.7|19.6|18.6
0.1|0.4|0.2|19|XI(a) Adrenocortical carcinomas|83118264|0-19|All Races|Male and Female|2008|0.1|0.4|0.2
7.4|8.6|8.0|688|XI(b) Thyroid carcinomas|83118264|0-19|All Races|Male and Female|2008|7.7|8.9|8.3
0.4|0.7|0.5|46|XI(c) Nasopharyngeal carcinomas|83118264|0-19|All Races|Male and Female|2008|0.4|0.7|0.6
4.4|5.3|4.8|416|XI(d) Malignant melanomas|83118264|0-19|All Races|Male and Female|2008|4.5|5.5|5.0
~|~|~|~|XI(e) Skin carcinomas|83118264|0-19|All Races|Male and Female|2008|~|~|~
3.9|4.8|4.4|376|XI(f) Other and unspecified carcinomas|83118264|0-19|All Races|Male and Female|2008|4.1|5.0|4.5
0.6|0.9|0.7|61|XII Other and unspecified malignant neoplasms|83118264|0-19|All Races|Male and Female|2008|0.6|0.9|0.7
0.3|0.5|0.4|31|XII(a) Other specified malignant tumors|83118264|0-19|All Races|Male and Female|2008|0.3|0.5|0.4
0.2|0.5|0.4|30|XII(b) Other unspecified malignant tumors|83118264|0-19|All Races|Male and Female|2008|0.2|0.5|0.4
173.0|178.6|175.8|14767|All ICCC Groups Combined|83280391|0-19|All Races|Male and Female|2009|174.5|180.2|177.3
45.4|48.3|46.8|3902|I Leukemias, myeloproliferative & myelodysplastic diseases|83280391|0-19|All Races|Male and Female|2009|45.4|48.3|46.9
33.2|35.7|34.4|2856|I(a) Lymphoid leukemias|83280391|0-19|All Races|Male and Female|2009|33.0|35.6|34.3
7.0|8.2|7.6|640|I(b) Acute myeloid leukemias|83280391|0-19|All Races|Male and Female|2009|7.1|8.3|7.7
1.9|2.6|2.2|189|I(c) Chronic myeloproliferative diseases|83280391|0-19|All Races|Male and Female|2009|2.0|2.6|2.3
1.2|1.7|1.4|119|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|83280391|0-19|All Races|Male and Female|2009|1.2|1.7|1.4
1.0|1.4|1.2|98|I(e) Unspecified and other specified leukemias|83280391|0-19|All Races|Male and Female|2009|1.0|1.4|1.2
24.1|26.2|25.1|2129|II Lymphomas and reticuloendothelial neoplasms|83280391|0-19|All Races|Male and Female|2009|24.5|26.7|25.6
11.8|13.3|12.5|1073|II(a) Hodgkin lymphomas|83280391|0-19|All Races|Male and Female|2009|12.1|13.7|12.9
8.2|9.5|8.9|745|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|83280391|0-19|All Races|Male and Female|2009|8.3|9.6|8.9
1.9|2.6|2.2|183|II(c) Burkitt lymphoma|83280391|0-19|All Races|Male and Female|2009|1.9|2.5|2.2
1.0|1.5|1.2|102|II(d) Miscellaneous lymphoreticular neoplasms|83280391|0-19|All Races|Male and Female|2009|1.0|1.5|1.2
0.2|0.4|0.3|26|II(e) Unspecified lymphomas|83280391|0-19|All Races|Male and Female|2009|0.2|0.5|0.3
30.1|32.5|31.3|2592|III CNS and misc intracranial and intraspinal neoplasms|83280391|0-19|All Races|Male and Female|2009|29.9|32.3|31.1
2.1|2.8|2.5|206|III(a) Ependymomas and choroid plexus tumor|83280391|0-19|All Races|Male and Female|2009|2.1|2.8|2.5
14.8|16.5|15.6|1299|III(b) Astrocytomas|83280391|0-19|All Races|Male and Female|2009|14.8|16.5|15.6
5.7|6.8|6.2|514|III(c) Intracranial and intraspinal embryonal tumors|83280391|0-19|All Races|Male and Female|2009|5.6|6.7|6.2
5.3|6.4|5.9|483|III(d) Other gliomas|83280391|0-19|All Races|Male and Female|2009|5.3|6.3|5.8
0.4|0.7|0.6|47|III(e) Other specified intracranial & intraspinal neoplasms|83280391|0-19|All Races|Male and Female|2009|0.4|0.8|0.6
0.4|0.7|0.5|43|III(f) Unspecified intracranial and intraspinal neoplasms|83280391|0-19|All Races|Male and Female|2009|0.4|0.7|0.5
7.6|8.8|8.2|680|IV Neuroblastoma and other peripheral nervous cell tumors|83280391|0-19|All Races|Male and Female|2009|7.6|8.8|8.2
7.4|8.6|8.0|662|IV(a) Neuroblastoma and ganglioneuroblastoma|83280391|0-19|All Races|Male and Female|2009|7.4|8.6|7.9
0.1|0.3|0.2|18|IV(b) Other peripheral nervous cell tumors|83280391|0-19|All Races|Male and Female|2009|0.1|0.3|0.2
11.3|12.8|12.0|1011|IX Soft tissue and other extraosseous sarcomas|83280391|0-19|All Races|Male and Female|2009|11.4|12.9|12.1
3.8|4.7|4.2|350|IX(a) Rhabdomyosarcomas|83280391|0-19|All Races|Male and Female|2009|3.8|4.7|4.2
1.3|1.8|1.5|128|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|83280391|0-19|All Races|Male and Female|2009|1.3|1.8|1.5
~|~|~|~|IX(c) Kaposi sarcoma|83280391|0-19|All Races|Male and Female|2009|~|~|~
4.4|5.4|4.9|411|IX(d) Other specified soft tissue sarcomas|83280391|0-19|All Races|Male and Female|2009|4.5|5.4|4.9
1.1|1.6|1.4|115|IX(e) Unspecified soft tissue sarcomas|83280391|0-19|All Races|Male and Female|2009|1.1|1.7|1.4
0.3|0.5|0.4|32|Not classified by ICCC|83280391|0-19|All Races|Male and Female|2009|0.3|0.5|0.4
2.9|3.7|3.3|278|V Retinoblastoma|83280391|0-19|All Races|Male and Female|2009|3.0|3.8|3.3
6.7|7.9|7.3|608|VI Renal tumors|83280391|0-19|All Races|Male and Female|2009|6.7|7.9|7.3
5.9|7.1|6.5|539|VI(a) Nephroblastoma and other nonepithelial renal tumors|83280391|0-19|All Races|Male and Female|2009|5.9|7.0|6.5
0.6|1.0|0.8|67|VI(b) Renal carcinomas|83280391|0-19|All Races|Male and Female|2009|0.6|1.0|0.8
~|~|~|~|VI(c) Unspecified malignant renal tumors|83280391|0-19|All Races|Male and Female|2009|~|~|~
1.7|2.3|2.0|167|VII Hepatic tumors|83280391|0-19|All Races|Male and Female|2009|1.7|2.3|2.0
1.1|1.7|1.4|116|VII(a) Hepatoblastoma|83280391|0-19|All Races|Male and Female|2009|1.2|1.7|1.4
0.4|0.8|0.6|49|VII(b) Hepatic carcinomas|83280391|0-19|All Races|Male and Female|2009|0.4|0.8|0.6
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|83280391|0-19|All Races|Male and Female|2009|~|~|~
8.3|9.6|8.9|749|VIII Malignant bone tumors|83280391|0-19|All Races|Male and Female|2009|8.4|9.7|9.0
4.6|5.5|5.0|422|VIII(a) Osteosarcomas|83280391|0-19|All Races|Male and Female|2009|4.6|5.6|5.1
0.2|0.4|0.3|25|VIII(b) Chondrosarcomas|83280391|0-19|All Races|Male and Female|2009|0.2|0.4|0.3
2.6|3.3|2.9|244|VIII(c) Ewing tumor and related sarcomas of bone|83280391|0-19|All Races|Male and Female|2009|2.6|3.3|2.9
0.4|0.7|0.5|41|VIII(d) Other specified malignant bone tumors|83280391|0-19|All Races|Male and Female|2009|0.4|0.7|0.5
0.1|0.3|0.2|17|VIII(e) Unspecified malignant bone tumors|83280391|0-19|All Races|Male and Female|2009|0.1|0.3|0.2
10.8|12.2|11.5|986|X Germ cell, trophoblastic tumors & neoplasms of gonads|83280391|0-19|All Races|Male and Female|2009|11.1|12.6|11.8
1.4|1.9|1.6|138|X(a) Intracranial & intraspinal germ cell tumors|83280391|0-19|All Races|Male and Female|2009|1.4|2.0|1.7
1.1|1.6|1.3|114|X(b) Malignant extracranial & extragonadal germ cell tumors|83280391|0-19|All Races|Male and Female|2009|1.1|1.6|1.4
7.0|8.1|7.5|653|X(c) Malignant gonadal germ cell tumors|83280391|0-19|All Races|Male and Female|2009|7.3|8.5|7.8
0.4|0.8|0.6|52|X(d) Gonadal carcinomas|83280391|0-19|All Races|Male and Female|2009|0.5|0.8|0.6
0.2|0.5|0.3|29|X(e) Other and unspecified malignant gonadal tumors|83280391|0-19|All Races|Male and Female|2009|0.2|0.5|0.3
17.2|19.0|18.1|1556|XI Other malignant epithelial neoplasms and malignant melanomas|83280391|0-19|All Races|Male and Female|2009|17.8|19.6|18.7
0.2|0.4|0.3|22|XI(a) Adrenocortical carcinomas|83280391|0-19|All Races|Male and Female|2009|0.2|0.4|0.3
7.6|8.8|8.2|706|XI(b) Thyroid carcinomas|83280391|0-19|All Races|Male and Female|2009|7.9|9.1|8.5
0.5|0.9|0.7|57|XI(c) Nasopharyngeal carcinomas|83280391|0-19|All Races|Male and Female|2009|0.5|0.9|0.7
4.0|4.9|4.4|382|XI(d) Malignant melanomas|83280391|0-19|All Races|Male and Female|2009|4.1|5.1|4.6
~|~|~|~|XI(e) Skin carcinomas|83280391|0-19|All Races|Male and Female|2009|~|~|~
4.0|4.9|4.4|381|XI(f) Other and unspecified carcinomas|83280391|0-19|All Races|Male and Female|2009|4.1|5.1|4.6
0.7|1.1|0.9|77|XII Other and unspecified malignant neoplasms|83280391|0-19|All Races|Male and Female|2009|0.7|1.2|0.9
0.2|0.5|0.4|30|XII(a) Other specified malignant tumors|83280391|0-19|All Races|Male and Female|2009|0.2|0.5|0.4
0.4|0.7|0.6|47|XII(b) Other unspecified malignant tumors|83280391|0-19|All Races|Male and Female|2009|0.4|0.8|0.6
175.6|181.4|178.5|14942|All ICCC Groups Combined|83180982|0-19|All Races|Male and Female|2010|176.8|182.5|179.6
47.0|50.0|48.5|4035|I Leukemias, myeloproliferative & myelodysplastic diseases|83180982|0-19|All Races|Male and Female|2010|47.0|50.0|48.5
33.1|35.6|34.3|2848|I(a) Lymphoid leukemias|83180982|0-19|All Races|Male and Female|2010|33.0|35.5|34.2
7.4|8.7|8.0|674|I(b) Acute myeloid leukemias|83180982|0-19|All Races|Male and Female|2010|7.5|8.7|8.1
2.3|3.0|2.6|219|I(c) Chronic myeloproliferative diseases|83180982|0-19|All Races|Male and Female|2010|2.3|3.0|2.6
1.6|2.2|1.9|159|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|83180982|0-19|All Races|Male and Female|2010|1.6|2.2|1.9
1.4|1.9|1.6|135|I(e) Unspecified and other specified leukemias|83180982|0-19|All Races|Male and Female|2010|1.4|1.9|1.6
26.0|28.3|27.1|2286|II Lymphomas and reticuloendothelial neoplasms|83180982|0-19|All Races|Male and Female|2010|26.4|28.6|27.5
11.2|12.7|11.9|1017|II(a) Hodgkin lymphomas|83180982|0-19|All Races|Male and Female|2010|11.5|13.0|12.2
8.1|9.4|8.7|731|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|83180982|0-19|All Races|Male and Female|2010|8.2|9.4|8.8
2.1|2.8|2.4|200|II(c) Burkitt lymphoma|83180982|0-19|All Races|Male and Female|2010|2.1|2.8|2.4
3.3|4.2|3.7|309|II(d) Miscellaneous lymphoreticular neoplasms|83180982|0-19|All Races|Male and Female|2010|3.3|4.2|3.7
0.2|0.5|0.3|29|II(e) Unspecified lymphomas|83180982|0-19|All Races|Male and Female|2010|0.2|0.5|0.3
30.0|32.4|31.2|2583|III CNS and misc intracranial and intraspinal neoplasms|83180982|0-19|All Races|Male and Female|2010|29.9|32.3|31.1
2.4|3.1|2.8|231|III(a) Ependymomas and choroid plexus tumor|83180982|0-19|All Races|Male and Female|2010|2.4|3.2|2.8
15.2|17.0|16.1|1335|III(b) Astrocytomas|83180982|0-19|All Races|Male and Female|2010|15.2|16.9|16.0
5.5|6.6|6.0|499|III(c) Intracranial and intraspinal embryonal tumors|83180982|0-19|All Races|Male and Female|2010|5.5|6.5|6.0
4.8|5.8|5.3|438|III(d) Other gliomas|83180982|0-19|All Races|Male and Female|2010|4.8|5.8|5.3
0.5|0.8|0.6|51|III(e) Other specified intracranial & intraspinal neoplasms|83180982|0-19|All Races|Male and Female|2010|0.5|0.8|0.6
0.2|0.5|0.4|29|III(f) Unspecified intracranial and intraspinal neoplasms|83180982|0-19|All Races|Male and Female|2010|0.2|0.5|0.3
7.9|9.1|8.5|704|IV Neuroblastoma and other peripheral nervous cell tumors|83180982|0-19|All Races|Male and Female|2010|7.8|9.1|8.5
7.7|8.9|8.3|687|IV(a) Neuroblastoma and ganglioneuroblastoma|83180982|0-19|All Races|Male and Female|2010|7.7|8.9|8.3
0.1|0.3|0.2|17|IV(b) Other peripheral nervous cell tumors|83180982|0-19|All Races|Male and Female|2010|0.1|0.3|0.2
11.8|13.3|12.5|1047|IX Soft tissue and other extraosseous sarcomas|83180982|0-19|All Races|Male and Female|2010|11.8|13.4|12.6
4.7|5.7|5.2|433|IX(a) Rhabdomyosarcomas|83180982|0-19|All Races|Male and Female|2010|4.7|5.7|5.2
0.8|1.2|1.0|81|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|83180982|0-19|All Races|Male and Female|2010|0.8|1.2|1.0
~|~|~|~|IX(c) Kaposi sarcoma|83180982|0-19|All Races|Male and Female|2010|~|~|~
4.2|5.2|4.7|392|IX(d) Other specified soft tissue sarcomas|83180982|0-19|All Races|Male and Female|2010|4.3|5.2|4.7
1.4|1.9|1.6|138|IX(e) Unspecified soft tissue sarcomas|83180982|0-19|All Races|Male and Female|2010|1.4|2.0|1.7
0.2|0.4|0.3|21|Not classified by ICCC|83180982|0-19|All Races|Male and Female|2010|0.2|0.4|0.3
2.9|3.7|3.3|271|V Retinoblastoma|83180982|0-19|All Races|Male and Female|2010|2.9|3.7|3.3
6.1|7.2|6.6|553|VI Renal tumors|83180982|0-19|All Races|Male and Female|2010|6.1|7.2|6.6
5.6|6.7|6.1|510|VI(a) Nephroblastoma and other nonepithelial renal tumors|83180982|0-19|All Races|Male and Female|2010|5.6|6.7|6.1
0.3|0.6|0.5|40|VI(b) Renal carcinomas|83180982|0-19|All Races|Male and Female|2010|0.3|0.7|0.5
~|~|~|~|VI(c) Unspecified malignant renal tumors|83180982|0-19|All Races|Male and Female|2010|~|~|~
2.3|3.0|2.6|218|VII Hepatic tumors|83180982|0-19|All Races|Male and Female|2010|2.3|3.0|2.6
1.6|2.2|1.9|159|VII(a) Hepatoblastoma|83180982|0-19|All Races|Male and Female|2010|1.6|2.2|1.9
0.5|0.9|0.7|57|VII(b) Hepatic carcinomas|83180982|0-19|All Races|Male and Female|2010|0.5|0.9|0.7
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|83180982|0-19|All Races|Male and Female|2010|~|~|~
7.6|8.8|8.2|684|VIII Malignant bone tumors|83180982|0-19|All Races|Male and Female|2010|7.6|8.9|8.2
4.3|5.2|4.7|394|VIII(a) Osteosarcomas|83180982|0-19|All Races|Male and Female|2010|4.3|5.2|4.7
0.2|0.5|0.4|30|VIII(b) Chondrosarcomas|83180982|0-19|All Races|Male and Female|2010|0.2|0.5|0.4
2.2|2.9|2.6|213|VIII(c) Ewing tumor and related sarcomas of bone|83180982|0-19|All Races|Male and Female|2010|2.2|2.9|2.6
0.3|0.6|0.4|34|VIII(d) Other specified malignant bone tumors|83180982|0-19|All Races|Male and Female|2010|0.3|0.6|0.4
~|~|~|~|VIII(e) Unspecified malignant bone tumors|83180982|0-19|All Races|Male and Female|2010|~|~|~
10.7|12.1|11.4|969|X Germ cell, trophoblastic tumors & neoplasms of gonads|83180982|0-19|All Races|Male and Female|2010|10.9|12.4|11.6
1.7|2.3|2.0|164|X(a) Intracranial & intraspinal germ cell tumors|83180982|0-19|All Races|Male and Female|2010|1.7|2.3|2.0
1.1|1.6|1.3|109|X(b) Malignant extracranial & extragonadal germ cell tumors|83180982|0-19|All Races|Male and Female|2010|1.1|1.6|1.3
6.7|7.8|7.2|619|X(c) Malignant gonadal germ cell tumors|83180982|0-19|All Races|Male and Female|2010|6.9|8.1|7.4
0.4|0.7|0.5|46|X(d) Gonadal carcinomas|83180982|0-19|All Races|Male and Female|2010|0.4|0.7|0.6
0.2|0.5|0.4|31|X(e) Other and unspecified malignant gonadal tumors|83180982|0-19|All Races|Male and Female|2010|0.3|0.5|0.4
16.8|18.6|17.7|1511|XI Other malignant epithelial neoplasms and malignant melanomas|83180982|0-19|All Races|Male and Female|2010|17.3|19.1|18.2
0.1|0.4|0.2|20|XI(a) Adrenocortical carcinomas|83180982|0-19|All Races|Male and Female|2010|0.1|0.4|0.2
7.8|9.0|8.4|719|XI(b) Thyroid carcinomas|83180982|0-19|All Races|Male and Female|2010|8.0|9.3|8.6
0.4|0.8|0.6|50|XI(c) Nasopharyngeal carcinomas|83180982|0-19|All Races|Male and Female|2010|0.4|0.8|0.6
3.6|4.5|4.0|343|XI(d) Malignant melanomas|83180982|0-19|All Races|Male and Female|2010|3.7|4.6|4.1
~|~|~|~|XI(e) Skin carcinomas|83180982|0-19|All Races|Male and Female|2010|~|~|~
3.9|4.8|4.3|371|XI(f) Other and unspecified carcinomas|83180982|0-19|All Races|Male and Female|2010|4.0|4.9|4.5
0.5|0.9|0.7|60|XII Other and unspecified malignant neoplasms|83180982|0-19|All Races|Male and Female|2010|0.6|0.9|0.7
0.3|0.5|0.4|31|XII(a) Other specified malignant tumors|83180982|0-19|All Races|Male and Female|2010|0.3|0.5|0.4
0.2|0.5|0.3|29|XII(b) Other unspecified malignant tumors|83180982|0-19|All Races|Male and Female|2010|0.2|0.5|0.3
175.8|181.6|178.7|14754|All ICCC Groups Combined|82095288|0-19|All Races|Male and Female|2011|176.8|182.6|179.7
46.3|49.3|47.8|3929|I Leukemias, myeloproliferative & myelodysplastic diseases|82095288|0-19|All Races|Male and Female|2011|46.4|49.4|47.9
33.5|36.1|34.8|2851|I(a) Lymphoid leukemias|82095288|0-19|All Races|Male and Female|2011|33.5|36.0|34.7
7.4|8.7|8.0|664|I(b) Acute myeloid leukemias|82095288|0-19|All Races|Male and Female|2011|7.5|8.7|8.1
1.9|2.5|2.2|181|I(c) Chronic myeloproliferative diseases|82095288|0-19|All Races|Male and Female|2011|1.9|2.6|2.2
1.0|1.5|1.3|105|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|82095288|0-19|All Races|Male and Female|2011|1.0|1.5|1.3
1.3|1.9|1.6|128|I(e) Unspecified and other specified leukemias|82095288|0-19|All Races|Male and Female|2011|1.3|1.9|1.6
26.1|28.4|27.2|2258|II Lymphomas and reticuloendothelial neoplasms|82095288|0-19|All Races|Male and Female|2011|26.4|28.7|27.5
11.0|12.5|11.8|985|II(a) Hodgkin lymphomas|82095288|0-19|All Races|Male and Female|2011|11.3|12.8|12.0
7.8|9.0|8.4|693|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|82095288|0-19|All Races|Male and Female|2011|7.8|9.1|8.4
2.1|2.8|2.5|202|II(c) Burkitt lymphoma|82095288|0-19|All Races|Male and Female|2011|2.1|2.8|2.5
3.9|4.8|4.3|352|II(d) Miscellaneous lymphoreticular neoplasms|82095288|0-19|All Races|Male and Female|2011|3.9|4.8|4.3
0.2|0.5|0.3|26|II(e) Unspecified lymphomas|82095288|0-19|All Races|Male and Female|2011|0.2|0.5|0.3
30.2|32.7|31.5|2578|III CNS and misc intracranial and intraspinal neoplasms|82095288|0-19|All Races|Male and Female|2011|30.2|32.6|31.4
2.4|3.2|2.8|228|III(a) Ependymomas and choroid plexus tumor|82095288|0-19|All Races|Male and Female|2011|2.4|3.2|2.8
15.4|17.1|16.2|1330|III(b) Astrocytomas|82095288|0-19|All Races|Male and Female|2011|15.3|17.1|16.2
5.5|6.6|6.0|492|III(c) Intracranial and intraspinal embryonal tumors|82095288|0-19|All Races|Male and Female|2011|5.5|6.5|6.0
5.0|6.0|5.5|448|III(d) Other gliomas|82095288|0-19|All Races|Male and Female|2011|5.0|6.0|5.5
0.4|0.7|0.5|43|III(e) Other specified intracranial & intraspinal neoplasms|82095288|0-19|All Races|Male and Female|2011|0.4|0.7|0.5
0.3|0.6|0.5|37|III(f) Unspecified intracranial and intraspinal neoplasms|82095288|0-19|All Races|Male and Female|2011|0.3|0.6|0.5
7.8|9.1|8.4|691|IV Neuroblastoma and other peripheral nervous cell tumors|82095288|0-19|All Races|Male and Female|2011|7.8|9.1|8.4
7.6|8.8|8.2|672|IV(a) Neuroblastoma and ganglioneuroblastoma|82095288|0-19|All Races|Male and Female|2011|7.6|8.8|8.2
0.1|0.4|0.2|19|IV(b) Other peripheral nervous cell tumors|82095288|0-19|All Races|Male and Female|2011|0.1|0.4|0.2
11.1|12.6|11.9|979|IX Soft tissue and other extraosseous sarcomas|82095288|0-19|All Races|Male and Female|2011|11.2|12.7|11.9
4.1|5.1|4.6|377|IX(a) Rhabdomyosarcomas|82095288|0-19|All Races|Male and Female|2011|4.1|5.1|4.6
1.0|1.5|1.3|104|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|82095288|0-19|All Races|Male and Female|2011|1.0|1.5|1.3
~|~|~|~|IX(c) Kaposi sarcoma|82095288|0-19|All Races|Male and Female|2011|~|~|~
4.2|5.2|4.7|387|IX(d) Other specified soft tissue sarcomas|82095288|0-19|All Races|Male and Female|2011|4.3|5.2|4.7
1.0|1.5|1.2|102|IX(e) Unspecified soft tissue sarcomas|82095288|0-19|All Races|Male and Female|2011|1.0|1.5|1.2
0.2|0.5|0.3|28|Not classified by ICCC|82095288|0-19|All Races|Male and Female|2011|0.2|0.5|0.3
2.7|3.5|3.1|252|V Retinoblastoma|82095288|0-19|All Races|Male and Female|2011|2.7|3.5|3.1
6.6|7.8|7.2|589|VI Renal tumors|82095288|0-19|All Races|Male and Female|2011|6.6|7.8|7.2
6.0|7.1|6.5|535|VI(a) Nephroblastoma and other nonepithelial renal tumors|82095288|0-19|All Races|Male and Female|2011|6.0|7.1|6.5
0.5|0.8|0.6|53|VI(b) Renal carcinomas|82095288|0-19|All Races|Male and Female|2011|0.5|0.8|0.6
~|~|~|~|VI(c) Unspecified malignant renal tumors|82095288|0-19|All Races|Male and Female|2011|~|~|~
2.2|2.9|2.6|211|VII Hepatic tumors|82095288|0-19|All Races|Male and Female|2011|2.2|2.9|2.6
1.7|2.3|2.0|162|VII(a) Hepatoblastoma|82095288|0-19|All Races|Male and Female|2011|1.7|2.3|2.0
0.4|0.7|0.5|44|VII(b) Hepatic carcinomas|82095288|0-19|All Races|Male and Female|2011|0.4|0.7|0.5
~|~|~|~|VII(c) Unspecified malignant hepatic tumors|82095288|0-19|All Races|Male and Female|2011|~|~|~
8.1|9.4|8.7|719|VIII Malignant bone tumors|82095288|0-19|All Races|Male and Female|2011|8.1|9.4|8.8
4.5|5.5|5.0|412|VIII(a) Osteosarcomas|82095288|0-19|All Races|Male and Female|2011|4.5|5.5|5.0
0.1|0.4|0.2|19|VIII(b) Chondrosarcomas|82095288|0-19|All Races|Male and Female|2011|0.1|0.4|0.2
2.7|3.5|3.1|254|VIII(c) Ewing tumor and related sarcomas of bone|82095288|0-19|All Races|Male and Female|2011|2.7|3.5|3.1
0.2|0.4|0.3|24|VIII(d) Other specified malignant bone tumors|82095288|0-19|All Races|Male and Female|2011|0.2|0.4|0.3
~|~|~|~|VIII(e) Unspecified malignant bone tumors|82095288|0-19|All Races|Male and Female|2011|~|~|~
9.9|11.3|10.6|885|X Germ cell, trophoblastic tumors & neoplasms of gonads|82095288|0-19|All Races|Male and Female|2011|10.1|11.5|10.8
1.4|1.9|1.6|135|X(a) Intracranial & intraspinal germ cell tumors|82095288|0-19|All Races|Male and Female|2011|1.4|1.9|1.6
1.1|1.6|1.3|109|X(b) Malignant extracranial & extragonadal germ cell tumors|82095288|0-19|All Races|Male and Female|2011|1.1|1.6|1.3
6.5|7.6|7.1|595|X(c) Malignant gonadal germ cell tumors|82095288|0-19|All Races|Male and Female|2011|6.7|7.9|7.2
0.2|0.5|0.3|26|X(d) Gonadal carcinomas|82095288|0-19|All Races|Male and Female|2011|0.2|0.5|0.3
0.1|0.4|0.2|20|X(e) Other and unspecified malignant gonadal tumors|82095288|0-19|All Races|Male and Female|2011|0.1|0.4|0.2
17.9|19.7|18.8|1576|XI Other malignant epithelial neoplasms and malignant melanomas|82095288|0-19|All Races|Male and Female|2011|18.3|20.2|19.2
0.1|0.3|0.2|18|XI(a) Adrenocortical carcinomas|82095288|0-19|All Races|Male and Female|2011|0.1|0.3|0.2
8.5|9.8|9.2|770|XI(b) Thyroid carcinomas|82095288|0-19|All Races|Male and Female|2011|8.7|10.1|9.4
0.5|0.8|0.6|52|XI(c) Nasopharyngeal carcinomas|82095288|0-19|All Races|Male and Female|2011|0.5|0.8|0.6
3.9|4.8|4.3|362|XI(d) Malignant melanomas|82095288|0-19|All Races|Male and Female|2011|4.0|4.9|4.4
~|~|~|~|XI(e) Skin carcinomas|82095288|0-19|All Races|Male and Female|2011|~|~|~
3.9|4.8|4.4|367|XI(f) Other and unspecified carcinomas|82095288|0-19|All Races|Male and Female|2011|4.0|5.0|4.5
0.5|0.9|0.7|59|XII Other and unspecified malignant neoplasms|82095288|0-19|All Races|Male and Female|2011|0.5|0.9|0.7
0.2|0.5|0.3|27|XII(a) Other specified malignant tumors|82095288|0-19|All Races|Male and Female|2011|0.2|0.5|0.3
0.3|0.5|0.4|32|XII(b) Other unspecified malignant tumors|82095288|0-19|All Races|Male and Female|2011|0.3|0.6|0.4
